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ABSTRACT 
Hypochlorous acid (HOCl) is a powerful oxidant produced by activated phagocytes at sites 
of inflammation to kill a wide range of pathogens. Yet, it may also damage and kill the 
neighbouring host cells. The abundance of dead macrophages in atherosclerotic plaques 
and their colocalization with HOCl-modified proteins implicate HOCl may play a role in 
killing macrophages, contributing to disease progression. The first part of this research was 
to investigate the cytotoxic effect and cell death mechanism(s) of HOCl on macrophages. 
Macrophages require efficient defense mechanism(s) against HOCl to function properly at 
inflammatory sites. The second part of the thesis was to examine the antioxidative effects 
of glutathione (GSH) and 7,8-dihydroneopterin (7,8-NP) on HOCl-induced cellular 
damage in macrophages. GSH is an efficient scavenger of HOCl and a major intracellular 
antioxidant against oxidative stress, whereas 7,8-NP is secreted by human macrophages 
upon interferon-γ (IFN-γ) induction during inflammation and can also scavenge HOCl.  
 
HOCl caused concentration-dependent cell viability loss in human monocyte derived 
macrophage (HMDM) cells above a specific concentration threshold. HOCl reacted with 
HMDMs to cause viability loss within the first 10 minutes of treatment, and it posed no 
latent effect on the cells afterwards regardless of the HOCl concentrations. The lack of 
caspase-3 activation, rapid influx of propidium iodide (PI) dye, rapid loss of intracellular 
ATP and cell morphological changes (cell swelling, cell membrane integrity loss and 
rupture) were observed in HMDM cells treated with HOCl. These results indicate that 
HOCl caused HMDM cells to undergo necrotic cell death. In addition to the loss of 
intracellular ATP, HOCl also caused rapid loss of GAPDH enzymatic activity and 
mitochondrial membrane potential, indicating impairment of the metabolic energy 
production. Loss of the mitochondrial membrane potential was mediated by mitochondrial 
permeability transition (MPT), as blocking MPT pore formation using cyclosporin A (CSA) 
prevented mitochondrial membrane potential loss. 
 
HOCl caused an increase in cytosolic calcium ion (Ca2+) level, which was due to both 
intra- and extra-cellular sources. However, extracellular sources only contributed 
significantly above a certain HOCl concentration. Preventing cytosolic Ca2+ increase 
significantly inhibited HOCl-induced cell viability loss. This suggests that cytosolic Ca2+ 
increase was associated with HOCl-induced necrotic cell death in HMDM cells, possibly 
via the activation of Ca2+-dependent calpain cysteine proteases. Calpain inhibitors 
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xvii
prevented HOCl-induced lysosomal destabilisation and cell viability loss in HMDM cells. 
Calpains induced HOCl-induced necrotic cell death possibly by degrading cytoskeletal and 
other cellular proteins, or causing the release of cathepsin proteases from ruptured 
lysosomes that also degraded cellular components. The HOCl-induced cytosolic Ca2+ 
increase also caused mitochondrial Ca2+ accumulation and MPT activation-mediated 
mitochondrial membrane potential loss. MPT activation, like calpain activation, was also 
associated with the HOCl-induced necrotic cell death, as preventing MPT activation 
completely inhibited HOCl-induced cell viability loss. The involvement of both calpain 
activation and MPT activation in HOCl-induced necrotic cell death in HMDM cells 
implies a cause and effect relationship between these two events.  
 
HMDM cells depleted of intracellular GSH using diethyl maleate showed increased 
susceptibility towards HOCl insult compared to HMDM cells with intact intracellular GSH 
levels, indicating that intracellular GSH played an important role in protecting HMDM 
cells against HOCl exposure. Intracellular GSH level in each HMDM cell preparation 
directly correlated with HOCl concentration required to kill 50% of population for each 
cell preparation, indicating intracellular GSH concentrations determine the efficiency of 
GSH in preventing HOCl-induced damage to HMDM cells. Intracellular GSH and cell 
viability loss induced by 400 μM HOCl were significantly prevented by 300 μM 
extracellular 7,8-NP, indicating that added 7,8-NP is an efficient scavenger of HOCl and 
out-competed intracellular GSH for HOCl. The amount of 7,8-NP synthesized by HMDM 
cells upon IFN-γ induction was too low to efficiently prevent HOCl-mediated intracellular 
GSH and cell viability loss. 
 
HOCl clearly causes HMDM cells to undergo necrosis when the concentration exceeds the 
intracellular GSH concentrations. Above this concentration HOCl causes oxidative damage 
to the Ca2+ ion channels on cell and ER membranes, resulting in an influx of Ca2+ ions into 
the cytosol and possibly the mitochondria. The rise in Ca2+ ions triggers calpain activation, 
resulting in the MPT-mediated loss of mitochondrial membrane potential, lysosomal 
instability and cellular necrosis. 
Chapter 1 1
_____________________________________________________________________________________________________________ 
 1 INTRODUCTION 
 
 
1.1 Overview 
It has been well documented that reactive oxygen species (ROS) play important roles in 
killing invading pathogens and in immune response. Yet, increasingly more literature has 
implicated that overproduction of ROS can cause extensive damage to surrounding tissues, 
leading to progression of a range of inflammatory diseases; including atherosclerosis, 
Alzheimer’s and Parkinson’s diseases.   
 
One important ROS present during inflammation is hypochlorous acid (HOCl), which is 
secreted by phagocytes including neutrophils, monocytes and certain subtypes of 
macrophages via myeloperoxidase (MPO) enzyme. HOCl shows high reactivity with a 
range of biomolecules, including proteins, phospholipids and nucleic acids, which makes it 
an efficient bactericidal agent. However, it also means that HOCl is capable of damaging 
the surrounding host cells at inflammatory sites. For instance, dead macrophages that 
contributed to disease progression of atherosclerosis, were found colocalizing with HOCl-
modified proteins and MPO in atherosclerotic plaques, implicating a role for HOCl in 
killing macrophages and atherosclerotic disease progression.  
 
For macrophages to survive in the inflammatory environment, they must be able to 
neutralise ROS and other damaging biomolecules that they are exposed to. Glutathione 
(GSH) is considered the major intracellular antioxidant against ROS and is an efficient 
scavenger of HOCl. 7,8-dihydroneopterin (7,8-NP), synthesized by macrophages upon 
interferon-γ induction during inflammation, was previously found to scavenge HOCl. It is 
therefore possible that GSH and 7,8-NP play important roles in protecting macrophages 
against HOCl insult.  
 
This research will examine the cell death mechanism ensued in human monocyte-derived 
macrophage (HMDM) cells after HOCl exposure, and determine whether GSH and 7,8-NP 
act as efficient antioxidants for protecting HMDM cells against HOCl insult.  
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1.2 Inflammation 
Inflammation is the localised protective response of tissues against microbial infection or 
damaged host cells, involving the removal of such irritants by phagocytic cells. There are 
two types of inflammation: acute and chronic inflammation. When animal tissues are 
injured, an acute inflammatory response develops. This is characterised by the rapid 
migration of neutrophils from the circulation into inflamed areas, through the endothelial 
cell (EC) monolayer lining the blood vessels, in response to chemotactic factors formed in 
the inflamed areas. Subsequently, the invading microbes and dead or damaged cells are 
removed by neutrophils via phagocytosis. At a later stage of inflammation, monocytes are 
recruited to the inflamed areas and undergo differentiation into macrophages, regulated by 
the chemotactic factors and cytokines produced by the activated neutrophils and 
endothelial cells. Macrophages show increased contents of lysosomal enzymes, metabolic 
activity, motility and phagocytic and microbicidal capacity compared to monocytes. The 
inflammatory event usually ends here. However, if the bacteria are not completely 
eliminated or the tissue injury continues, chronic inflammation can develop (Halliwell and 
Gutteridge, 2007).  
 
 
1.3 Atherosclerosis as an inflammatory disease 
Atherosclerosis is a disease with inflammation mediators playing crucial roles in its 
progression and so is now recognised as a chronic inflammatory disease (see below). This 
disease is characterised by a local thickening of the artery wall, resulting from the 
accumulation of lipids, dead cells and fibrous elements in the intima. Complications such 
as cardiovascular disease, heart infarction and stroke may then occur, which are the most 
common causes of death in developed countries (Halliwell & Gutteridge, 2007).  
 
Atherosclerosis is a progressive disease, beginning with changes to endothelial cells (ECs) 
that allow the attraction, adherence and transmigration of monocytes through the 
endothelium (Ross, 1993) (Figure 1.1). The changes can be initiated by the accumulation 
of low density lipoprotein (LDL) in the intima, which is oxidatively modified by reactive 
oxygen species (ROS) produced in ECs, resident macrophages or smooth muscle cells 
(SMCs) (Lusis, 2000; Steffens and Mach, 2004; Glass and Witztum, 2001) (See also 
section 1.4). The resulting “minimally oxidised” LDL (mmLDL) stimulates the overlying 
ECs to produce a number of pro-inflammatory molecules, chemotactic factors and growth 
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factors, which assist in recruiting the circulating monocytes and T cells into the intima and 
in the differentiation of monocytes into macrophages. Once mmLDL is oxidised further 
(now referred to as oxidised LDL or oxLDL), it is recognised and taken up by 
macrophages via the macrophage scavenger receptors, especially SR-A and CD36 (Glass 
and Witztum, 2001). This leads to the accumulation of cholesterol esters in the 
macrophage cytoplasm and subsequently the formation of foam cells (lipid-laden 
macrophages), which are the major component of the early stage arterial lesion often 
described as a fatty streak.   
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Figure 1.1 Initiating events in the development of a fatty streak lesion. 
LDL is oxidatively modified in the sub-endothelial space to mmLDL, which is further 
oxidised to generate oxLDL. Endothelial cells were stimulated to express adhesion and 
chemotatic molecules by mmLDL, inflammatory cytokines and oxLDL, allowing 
monocytes to attach to endothelial cells and migrate into the intima through the tight 
junctions. The intimal monocytes then differentiate into macrophages, which express 
scavenger receptors, CD36 and SR-A. These scavenger receptors promote oxLDL uptake. 
The oxLDL cholesterol being taken up is subject to esterification and storage in lipid 
droplets, leading to foam cell formation.  
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In the intima, T cells and macrophages can be activated via many ways (Hansson et al., 
2006). For instance, T cells are activated by their ligation to the antigens (such as oxLDL) 
that are bound to the major histocompatibility complex (MHC) molecules on the surface of 
macrophages. The activated T cells then release pro-inflammatory cytokines such as 
interferon-γ (IFN-γ) and tumor necrosis factor (TNF), which stimulate the activation of 
macrophages. Interaction between CD40 receptor on T cells and CD40 on macrophages 
can also activate T cells. The end result of T cell and macrophage activation is the 
secretion of cytokines, growth factors and reactive species, which facilitate the recruitment 
of more inflammatory cells, migration of SMCs to the intima and proliferation of SMCs. 
These events allow a fatty streak to develop into a fibrous plaque. This more complicated 
plaque consists of a fibrous cap containing mostly SMCs and extracellular matrix (ECM) 
(Ross, 1999). ECM is composed mainly of collagen, elastin, proteoglycans, glycoproteins, 
fibrin and other forms of collagen (Halliwell and Gutteridge, 2007; Stary et al., 1995). This 
fibrous cap covers an area rich in macrophages, SMCs and T cells. Often there is a deeper 
necrotic core, which contains debris from dead cells, extracellular lipid deposits and 
cholesterol crystals (Glass & Witztum, 2001). Calcification and neovascularisation may 
occur to make fibrous plaques more complicated and less stable (Lusis, 2000).   
 
Plaque ruptures expose plaque lipids and tissue factor to blood components, initiating the 
coagulation cascade, platelet adherence, thrombosis and hence leads to the onset of an 
acute ischaemic event. This event is more likely to occur in lesions heavily infiltrated by 
foam cells, and those with thin fibrous caps and large necrotic cores (Davies et al., 1993; 
Lee and Libby, 1997). Activated macrophages can contribute to thinning of fibrous caps by 
producing matrix metalloproteinases (MMPs), which degrade the connective tissue that 
strengthens the fibrous caps (Galis et al., 1994; Brown et al., 1995). The oxidised lipid in 
the necrotic core will be pro-inflammatory and cytotoxic, promoting further destabilisation 
of the plaque.  
 
The appearance of macrophages and lymphocytes within atherosclerotic lesions 
exemplifies a site where both innate and adaptive immunity contribute towards the disease 
progression. The immediate site of plaque rupture or superficial erosion is rich in 
macrophages and to a lesser extent T lymphocytes, with abundant expression of HLA-DR 
antigens on both the inflammatory cells and the adjacent SMCs (Libby & Hansson, 1991; 
van der Wal et al., 1994). HLA-DR antigens are class II major histocompatibility complex 
(MHC II) membrane bound glycoproteins that play an important role in the regulation of 
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immune response. The detection of inflammatory markers and antibodies in patients 
provides additional support for the inflammatory nature of the atherosclerotic lesion. Xu et 
al., (1993) demonstrated a strong correlation between anti-heat shock protein 65 antibodies 
and carotid atherosclerosis. In addition, the level of the inflammatory marker C-reactive 
protein is elevated in early and late stages of atherosclerotic lesions (Patrick and Uzick, 
2001) and in most of the patients with a diagnosis of unstable angina. Neopterin, another 
inflammatory marker, is also elevated in patients with vascular disease (Schumacher et al., 
1992; Tatzber et al., 1991). IFN-γ is a molecule that stimulates the synthesis of 7,8-
dihydroneopterin (the reduced form of neopterin) from macrophages, and it is detected in 
elevated levels in atherosclerotic plaques of both humans and mice (Hansson et al., 1989a; 
Zhou et al., 1998) (see section 1.6.2). Various infectious agents have also been shown to 
initiate or promote inflammatory atherogenesis. Chlamydia pneumonia, Helicobacter 
pylori and cytomegalo-virus have been identified in cardiovascular atheroma (Osterud & 
Bjorklid, 2003; Torgano et al., 1999).  
 
 
1.4 ROS and atherosclerosis 
ROS appear to play important roles in the development of atherosclerosis. It is a collective 
term that includes not only the oxygen radicals with unpaired electron(s) such as 
superoxide (O2
•-), peroxyl (RO2
•) and hydroxyl radicals (OH•), but also some non-radical 
derivatives such as hydrogen peroxide (H2O2), hypochlorous acid (HOCl) and 
peroxynitrite (ONOO
-
) (Halliwell and Gutteridge, 2007). There are a number of sources of 
ROS that contribute to the progression of atherosclerosis. MPO enzyme is responsible for 
the HOCl production (Glass and Witztum, 2001), and both MPO enzyme and HOCl 
(detected as 3-chlorotyrosine) have been found colocalising in atherosclerotic plaques 
(Daugherty et al., 1994; Malle et al., 2000; Sugiyama et al., 2001). Inducible nitric oxide 
synthase (iNOS) catalyses the generation of NO, which contributes to LDL oxidation in 
vivo (Glass and Witztum, 2001). Inhibitors of iNOS have been shown to decrease 
atherosclerosis in mice (Detmers et al., 2000).  
 
ROS can contribute to lesion formation in many ways. Depending on the types and 
availability, ROS can oxidise lipid or protein (apolipoprotein B-100) components of LDL, 
hence transforming LDL to a high uptake form that is internalised by macrophages and 
resulting in foam cell formation. OxLDL taken up by macrophages may eventually impose 
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an oxidative stress on these cells and cause some foam cells to die by apoptosis or necrosis, 
which contributes to necrotic core formation. H2O2 can signal growth factor generation and 
cell proliferation, which have long been implicated in atherosclerosis (Cromheeke et al., 
1999; Stocker and Keaney, 2004). Moreover, ROS can induce the loss of nitric oxide, 
which is thought to be anti-atherogenic by inhibiting LDL peroxidation and deterring 
thrombosis, phagocyte adhesion to endothelium and nuclear factor κB (NF-κB) activation 
(Halliwell and Gutteridge, 2007). ROS can also cause endothelial dysfunction (Cai and 
Harrison, 2000) and destabilise atherosclerotic plaques. The presence of oxidation products 
of lipids and (lipo)proteins in atherosclerotic plaques further support the roles ROS play in 
the lesion development (Stocker and Keaney, 2004; Leeuwenburgh et al., 1997) (see 
section 1.5.4).  
 
 
1.5 Hypochlorous acid (HOCl) 
Hypochlorous acid (HOCl) is a powerful 2-electron oxidizing agent and a weak acid with 
pKa approximately 7.5, hence it is present in equal mixture with its conjugate base 
hypochlorite (-OCl) at pH 7.4. For the purpose of simplicity, HOCl/-OCl will be referred to 
as HOCl in this thesis. HOCl also readily decomposes to liberate chlorine (Cl2) gas. 
However, this only occurs at much lower pH (Pullar et al., 2000). It has important 
antibacterial properties, but excessive or mis-directed production of HOCl has been 
implicated in several diseases, including atherosclerosis, arthritis and some cancers 
associated with inflammation (Klebanoff, 2005).  
 
1.5.1 Sources of HOCl and phagocytosis 
Phagocytes such as neutrophils, monocytes and macrophages play a crucial role in host 
defenses against microbial pathogens via phagocytosis. The ROS generated in these cells, 
including O2
•-, OH•, H2O2 and HOCl (Figure 1.2), together with microbicidal peptides and 
proteases, are proposed to constitute their antimicrobial arsenal. HOCl is suggested to be 
one of the major ROS generated in neutrophils for killing (Jiang et al., 1997; Hazen et al., 
1996b; Wagner et al., 1986; Foote et al., 1983; Albrich et al., 1981) or inhibiting cell 
growth (Mckenna and Davies, 1988) of phagocytosed bacteria. It is also produced in 
monocytes and certain types of macrophages (Halliwell and Gutteridge, 2007).  
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When coated with opsonins (generally complement or antibody), microorganisms bind to 
specific receptors on the surface of the neutrophil. Invagination of the neutrophil cell 
membrane then occurs until the microorganism is completely enclosed in an intracellular 
phagosome. This is followed by a burst of oxygen consumption, known as the respiratory 
burst. NADPH oxidases then use electrons derived from intracellular NADPH to convert 
most of the extra oxygen consumed to O2
•-. Concurrently, cytoplasmic granules fuse with 
the phagosomal membrane causing more ROS generation including HOCl production, 
which is catalysed by myeloperoxidase (MPO) enzyme (Figure 1.2). The degranulation 
and the generation of ROS result in the killing and degradation of the engulfed bacteria.   
 
 
Figure 1.2 Possible ROS generating reactions with stimulated neutrophils. 
During respiratory burst, most of the oxygen consumed is converted to O2
•- via NADPH 
oxidase catalysis. O2
•- then undergoes a dismutation reaction to form H2O2. HOCl is 
produced in the presence of MPO and chloride ions (Cl-). OH• can be formed via the O2
•--
driven Fenton reaction between H2O2 and an appropriate transition metal catalyst, and via 
the reaction of HOCl with O2
•-. Singlet oxygen could theoretically be produced from the 
reaction of HOCl and H2O2. Chloramines (R-NHCl) are generated indirectly through the 
reaction of HOCl with amines. HOCl can also oxidize SCN- into hypothiocyanite (OSCN-) 
which also has antibacterial effects. This scheme is adapted from Hampton et al. (1998b).  
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1.5.1.1 NADPH oxidase 
NADPH oxidase is present in neutrophils, eosinophils, monocytes and macrophages. It is 
also found in vascular cells, but not identical to the ones found in leukocytes (Klebanoff, 
2005). This oxidase is in an inactive form in resting cells as two membrane-bound and four 
cytosolic components (El-Benna et al., 2005). The NADPH binding site is located within 
the membrane-bound components. During activation, the cytoplasmic components of the 
NADPH oxidase form a complex with the membrane-bound components.  
 
While phagocytic stimuli cause ROS production largely within the phagosome, soluble 
stimuli such as immune complexes, complement protein C5a, N-formyl peptides and 
tumour necrosis factor (TNF-α) cause the activation of NADPH oxidase over the surface of 
the plasma membrane (Goldstein et al., 1975; Nathan, 1987). This can lead to the release 
of oxidants and granule proteins into the extracellular space. This extracellular release of 
products from activated neutrophils also occurs through a process called “frustrated 
phagocytosis”, where the neutrophil is in contact with a non-ingestible, immune-complex 
coated surface (Chatham et al., 1994; Blackburn et al., 1995).  
 
1.5.1.2 Myeloperoxidase (MPO) 
MPO is a tetrameric and heavily glycosylated heme protein with a molecular weight of 
approximately 150 kDa. It is composed of two identical disulfide-linked dimers, each of 
which possesses a protoporphyrin-containing 59-64 kDa heavy subunit and a 14 kDa light 
subunit (Podrez et al., 2000). MPO is sequestered in azurophil granules of neutrophils, 
where it comprises 2 to 5% of total neutrophil proteins (Halliwell and Gutteridge, 2007). It 
is also present in monocytes and in certain subtypes of macrophages and has been found 
upregulated in disease state brain cells (Green et al., 2004; Nagra et al., 1997). 
 
Active MPO can lead to the formation of a range of oxidation products by catalysing the 
oxidation of a range of substrates and by the reaction of the oxidation products with other 
substrates. MPO uses H2O2 to oxidise halide ions such as chloride, bromide and iodide to 
form hypochlorous, hypobromous and hypoiodous acid, respectively (Harrison and Schultz, 
1976; Halliwell and Gutteridge, 2007) (Figure 1.3). MPO can also oxidise thiocyanate 
anions into hypothiocyanite (Hampton et al., 1998b). However, the high chloride ion 
concentrations in phagocyte cytoplasm and extracellular fluids suggest that HOCl is the 
major physiological product of MPO activity (Thomas and Fishman, 1986). Indeed, 28 to 
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70% of the H2O2 produced by neutrophils has been detected as HOCl (Foote et al., 1983; 
Weiss et al., 1982). HOCl can subsequently react with O2•-, amines and H2O2 to generate 
OH•, chloramines and singlet oxygen, respectively (Klebanoff, 2005). MPO also uses H2O2 
to oxidize a variety of aromatic compounds (RH) (Figure 1.3), tyrosine residues 
(Klebanoff, 2005) and nitrite (Eiserich et al., 2002) to generate their respective radicals.  
 
 
 
 
Figure 1.3 Reactions of MPO.  
H2O2 reacts with the ferric iron of MPO (MP3+) to form the redox intermediate compound I. 
Compound I oxidizes a halide (chloride, thiocyanate or bromide) by a single 2-electron 
transfer to produce the respective hypohalous acids (HOCl, HOSCN or HOBr), 
regenerating the native MP3+ state. MPO also oxidizes numerous organic substrates (RH) 
by two successive 1-electron transfers involving the enzyme intermediates, compound I 
and compound II. Compound II can be reduced to the active, native MP3+ state by O2
•-, as 
well as by a number of other reducing agents. O2
•- can also react with the native MPO to 
form an unstable compound III (Winterbourn et al., 1985), which is turned over by a 
second reaction with superoxide. The scheme is adapted from Hampton et al. (1998b).  
 
 
MPO appears critical for oxidative killing of microorganisms in experimental systems. 
Neutrophils isolated from the blood of MPO-deficient individuals were inefficient in 
killing a variety of microorganisms (Lehrer and Cline, 1969; Kitahara et al., 1981). In 
addition, inhibitors of MPO such as azide, cyanide and salicylhydroxamic acid impair 
killing by normal cells (Klebanoff, 1970; Humphreys et al., 1989). Furthermore, the 
cytoplasm of neutrophils that lack granule enzymes but generate H2O2, only kill bacteria if 
they are coated with MPO before ingestion (Hampton et al., 1998b).  
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Following phagocytosis, neutrophils undergo degranulation and MPO is rapidly released 
into the phagosome. However, leakage or secretion of MPO to the outside of the cell 
through incomplete closure of the phagosome or “frustrated phagocytosis” also occurs 
(Vissers et al., 1985) (see also section 1.5.1.1). This leakage of MPO can induce damage 
to surrounding tissue, and is thought to contribute to the pathogenesis of several diseases 
(Malle et al., 2000; Daugherty et al., 1994; Baldus et al., 2002).  
 
1.5.2 Biological reactions of HOCl 
HOCl is not known to be a substrate for any enzymatic scavenging system, but reacts with 
a range of biomolecules such as DNA, lipids, proteins and free thiols at different reactivity 
(see below). How vulnerable a particular target is towards HOCl also depends on what else 
is present to compete for HOCl, on relative concentrations and on its accessibility to HOCl.  
 
HOCl can react with nucleotides and DNA, with the base moiety being the major target 
(Whiteman et al., 1997; Spencer et al., 2000). HOCl reacts with both the heterocyclic (NH-
groups) and exocyclic (-NH2) amine groups of nucleotides, with the former at a faster rate 
than the latter (Prutz, 1998; Prutz, 1996). Reaction of HOCl with nucleotides is known to 
cause the formation of short-lived chloramine species (RNHCl and RR’NHCl) (Hawkins 
and Davies, 2001), which can lead to the dissociation of double-stranded DNA due to the 
disruption of hydrogen-bonding (Prutz, 1996). HOCl is also found to directly react with 
adenosine triphosphate (ATP) (Prutz, 1996). 
 
Unsaturated fatty acids and cholesterol are also susceptible to HOCl, causing the formation 
of chlorohydrin derivatives by addition of HOCl to double bonds. However, this reaction is 
relatively slow, with chlorohydrins only being detected in cells after exposure to cytotoxic 
HOCl concentrations (Carr et al., 1996; Vissers et al., 1998). Moreover, chlorohydrins 
were seen on LDL only at HOCl concentrations well above those required for protein 
modification (Hazell et al., 1994).  
 
HOCl also reacts with a range of low molecular weight biomolecules and antioxidants. 
HOCl reacts with GSH and ascorbate with rate constants > 107 M-1s-1 and approximately 
6×106 M-1s-1, respectively (Folkes et al., 1995). Phenols, hydroquinones (Pattison and 
Davies, 2001), taurine (Folkes et al., 1995), NADH, uric acid (Winterbourn, 1985), heme 
groups (Aruoma and Halliwell, 1987) and iron-sulfur centres (Rosen and Klebanoff, 1985) 
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are also oxidised by HOCl, though at much lower rates than GSH and ascorbate (Albrich et 
al., 1981; Winterbourn, 1985; Folkes et al., 1995).   
 
In addition to high reactivity with free thiols such as GSH, HOCl can also oxidise protein 
thiols, though their reactivity may vary based on their accessibility and pKa (Pullar et al., 
1999). HOCl can inactivate a range of thiol-containing enzymes, including glyceraldehyde 
3-phosphate dehydrogenase (GAPDH), creatine kinase, lactate dehydrogenase (Pullar et al., 
1999; Peskin and Winterbourn, 2006; Mckenzie et al., 1999), Na+-K+-ATPase (Kato et al., 
1998) and Ca2+-ATPase (Eley et al., 1991). HOCl can also induce the release of zinc from 
zinc finger proteins, in which the metal is bound to the sulfhydryl group of cysteine 
residues by thiolate bonds (Fliss and Menard, 1991).  
 
HOCl reacts with amino acid side chains of proteins with the following preference order: 
Met > Cys >> cystine~His~α amino acid > Trp > Lys >> Tyr~Arg > backbone amides > 
Gln~Asn (Winterbourn, 1985; Pattison and Davies; 2001). Amino acids, peptides and 
proteins are likely to be the major targets of HOCl due to their abundance in biological 
systems and their high reactivity with HOCl (Pattison and Davies, 2001), with the 
exception of reaction with GSH and possibly ascorbate. Such reaction results in side-chain 
modification, backbone fragmentation and cross-linking. For instance, irreversible protein 
crosslinks have been observed in cell membranes of red cells exposed to low doses of 
HOCl (Vissers et al., 1998). HOCl can react with free tyrosine or tyrosine residues of 
proteins, resulting in the formation of 3-chlorotyrosine and 3,5-dichlorotyrosine (Domigan 
et al., 1995; Hazen et al., 1996b; Kettle, 1996; Hazen et al., 1997; Fu et al., 2000).  
 
The amino groups of lysine and the N-terminal amines react with HOCl to form 
chloramines. These products can undergo secondary reactions with thiols and thiol-
containing proteins (Pullar et al., 2000), induce radical generation that may result in 
protein fragmentation or lipid peroxidation (Hawkins and Davies, 1999; Hazell et al., 1999) 
or break down to form protein carbonyls in proteins (Handelman et al., 1998; Hazen et al., 
1998a). Chloramine can also serve as a signalling molecule. Taurine chloramine, produced 
by HOCl reacting with taurine amino acid (Folkes et al., 1995), can activate extracellular 
signal-regulated kinase (ERK) (Midwinter et al., 2004). Glycine chloramine can oxidize 
the intracellular inhibitor (depicted as IκBα) of NF-κB (Midwinter et al., 2006), which is a 
major transcription factor that regulates expression of a large number of genes that code for 
cytokines, adhesion molecules and other components of the inflammatory response. 
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1.5.3 Cytotoxicity of HOCl towards mammalian cells 
HOCl has been implicated in exerting a cytotoxic effect on mammalian cells, as 
scavenging HOCl or inactivating MPO in stimulated neutrophils, monocytes or 
granulocytes prevented cytotoxicity to tumor cells and leukocytes (Clark and Klebanoff, 
1975; Clark and Klebanoff, 1977; Slivka et al., 1980; Weiss and Slivka, 1982). Similarly, 
neutrophils lacking MPO or membrane NADPH oxidase complex were not cytotoxic to 
tumor cells (Clark and Klebanoff, 1975).  
 
HOCl’s cytotoxicity to mammalian cells is further supported by it killing a range of cell 
types including red cells (Vissers et al., 1994), endothelial cells (Tatsumi and Fliss, 1994), 
epithelial cells (Abernathy and Pacht, 1995) fibroblasts (Vile et al., 2000), T-cell lines 
(Slivka et al., 1980) and tumor cells (Schraufstatter et al., 1990). These studies have 
demonstrated that HOCl caused necrotic cell death, as membrane integrity loss and cell 
lysis occurred. However, low concentrations of HOCl can also cause apoptotic cell death. 
Human hepatoma and fetal liver cells treated with HOCl showed mitochondrial 
permeability transition (MPT) -mediated mitochondrial membrane potential loss and 
caspase activation (see section 1.7.3), leading to apoptotic cell death (Whiteman et al., 
2005b). Human mesenchymal progenitor cells, upon HOCl treatment, showed Bax-
dependent MPT activation, which led to apoptosis inducing factor (AIF)/endonuclease G 
(EndoG) -dependent apoptotic cell death without the involvement of caspases (Whiteman 
et al., 2007). Vissers et al. (1999) demonstrated caspase-dependent apoptotic cell death in 
human endothelial cells upon HOCl treatment (see section 1.7 for apoptosis and necrosis).  
 
1.5.4 HOCl and atherosclerosis 
HOCl is suggested to contribute to the development of atherosclerosis via many pathways. 
One such pathway involves HOCl oxidatively modifying LDL, transforming it into a high 
uptake form for macrophages and eventually leads to foam cell formation. Indeed, 
exposing LDL to HOCl resulted in preferential oxidation of lysine residues of apo B-100 
(Hazell et al., 1994). The subsequent exposure of mouse peritoneal macrophages to this 
HOCl-oxidised LDL led to an increase in intracellular concentrations of cholesterol and 
cholesteryl esters (Hazell and Stocker, 1993).  
 
The detection of oxidative markers of HOCl, HOCl-modified epitopes and MPO in 
atherosclerotic lesions also implicates HOCl in the modification of LDL and general 
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plaque formation. The level of 3-chlorotyrosine, an oxidative marker of HOCl (Domigan et 
al., 1995; Kettle, 1996), was 6-fold higher in atherosclerotic tissue than in normal aortic 
intima and 30-fold higher in LDL isolated from atherosclerotic intima than in circulating 
LDL (Hazen and Heinecke, 1997). o,o’-Dityrosine levels, another oxidative marker of 
HOCl (Leeuwenburgh et al., 1997; Heinecke et al., 1993), were also detected to be 100-
fold higher in LDL isolated from human atherosclerotic lesions than those in the 
circulation. However, dityrosine can also form during OH•-mediated LDL oxidation via 
the Fenton reaction (Bruce et al., 1999). In addition, HOCl-modified apolipoprotein B-
100-containing lipoproteins have been identified in human lesions (Hazell et al., 1996). 
HOCl-modified epitopes, recognized by monoclonal antibodies that are raised against 
HOCl-modified LDL, are also found both inside and outside of macrophages in human 
lesions (Sugiyama et al., 2001). The immunoreactive MPO is found in human lesions as 
well, colocalizing with HOCl-modified epitopes (Daugherty et al., 1994; Malle et al., 2000; 
Sugiyama et al., 2001). These findings provide convincing evidence that MPO-derived 
HOCl oxidizes LDL under in vivo conditions.  
 
HOCl can also participate in the development of atherosclerosis via other pathways. HOCl 
can fragment components of ECM (Woods and Davies, 2003), which also occurs in 
atherosclerotic plaques (Woods et al., 2003). Moreover, HOCl can convert the pro-enzyme 
form of matrix metalloproteinases (MMPs) to the activated form (Weiss et al., 1985; 
Springman et al., 1990; Peppin and Weiss, 1986). MMPs will then degrade the ECM that 
strengthens the fibrous caps, accelerating plaque rupture (see section 1.3). HOCl can also 
indirectly activate MMPs by inhibiting the the activity of a class of proteins called 
“inhibitors of metalloproteinases” (TIMPs) (Shabani et al., 1998), which function by 
inhibiting MMP activity. HOCl itself can also solubilise collagen (Davies et al., 1993; 
Daumer et al., 2000) and degrade proteoglycan (Klebanoff et al., 1993), suggesting that 
HOCl may contribute to structural weakening of the fibrous cap and plaque rupture itself.  
 
Furthermore, HOCl can induce growth arrest, apoptosis or necrosis of endothelial cells 
(Sugiyama et al., 2004; Vissers et al., 1999), decrease adhesiveness of subendothelial 
matrix to endothelial cells (Vissers and Thomas, 1997) and increase endothelial cell 
permeability by causing rapid cytoskeletal shortening and cell retraction (Tatsumi and Fliss, 
1994). These data imply that the local production of HOCl by MPO-positive macrophages 
in the sub-endothelium of human coronary atheroma may promote local endothelial 
desquamation that produces superficial erosion of the intima and increase thrombogenicity. 
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MPO-derived HOCl is also suggested to promote the net accumulation of cholesterol 
within the artery wall by disturbing the cholesterol efflux from macrophages. Cholesterol 
can be exported from macrophages through the plasma membrane, via a high density 
lipoprotein (HDL) -dependent process called reverse cholesterol transport (Jessup & 
Kritharides, 2000), to the extracellular acceptor HDL. MPO-derived HOCl is found to 
oxidise HDL, hence impairing its ability to promote reverse cholesterol transport (Shao et 
al., 2006; Zheng et al., 2004; Zheng et al., 2005). 
 
1.5.5 HOCl as a signalling molecule 
HOCl has been speculated to regulate specific cell processes. Endothelial cells (Vissers et 
al., 1999) and human skin fibroblasts (Vile et al., 2000) exposed to low doses of HOCl 
initiate a transient growth arrest. The latter has shown that the growth arrest was associated 
with an increase in the levels of the transcription factor p53 and the p53-dependent wild-
type activating fragment-1/cyclin-dependent kinase inhibitory protein-1 (WAF1/CIP1). 
Furthermore, a sublethal dose of HOCl activated transcription of apurinic endonuclease, 
which reduced chromosomal aberrations caused by subsequent exposure to H2O2 (Grösch 
et al., 1998). Low doses of HOCl have also been found to activate mitogen-activated 
protein kinases (Midwinter et al., 2001).   
 
 
1.6 Antioxidant defenses 
While small amounts of oxidants may mediate cell-signalling cascades via alteration of the 
reducing environment in cells (Schafer and Buettner, 2001; Cross and Templeton, 2004), 
the excessive production of oxidants oxidises proteins, lipids, DNA and so on. These 
events result in cell proliferation, adaption of the cells by upregulation of defence systems, 
cell injury, senescence or cell death (Finkel, 1999; Sato et al., 1995; Halliwell and 
Gutteridge, 2007).  
 
Cells maintain the reducing environment and survive in the presence of oxidants by 
possessing a wide range of antioxidant defenses that prevent oxidant-induced cellular 
damage and maintain the redox-state of the cell. These antioxidant defenses include 1) 
antioxidant enzymes that remove reactive species (such as catalase, superoxide dismutase, 
superoxide reductase and peroxidise enzymes), 2) Repair systems that repair oxidised 
compounds or remove the damaged proteins (such as thioredoxin, methionine sulphoxide 
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reductase and ubiquitination), 3) Sequestration of pro-oxidants, such as iron ions, copper 
ions or haem, by proteins (such as transferrins, metalloproteins, albumin and haem 
oxygenases) to minimise their availability and 4) low molecular weight molecules that 
scavenge oxidants (such as GSH, ascorbate, α-tocopherol and urate). The next section will 
examine the antioxidant roles of GSH amd 7,8-dihydroneopterin (7,8-NP) in cellular 
protection.  
 
1.6.1 Glutathione (GSH) 
1.6.1.1 Functions of GSH  
GSH (Figure 1.4) is the predominant low molecular weight thiol in cells, with an 
intracellular concentration of 0.1-10 mM (Meister, 1988). More than 98% of the 
synthesized GSH exists in the thiol-reduced form. The most important function of GSH 
appears to be as an antioxidant defense removing oxidative stress and maintaining the 
thiol-redox status of the cell.  
 
 
 
Figure 1.4 Structure of GSH (adapted from Forman et al., 2009). 
 
 
GSH can act as an antioxidant by directly reacting with a range of oxidants such as OH•, 
HOCl, ONOO-, RO•, NO2
• and less efficiently with O2
•- (Halliwell and Gutteridge, 2007), 
resulting in the generation of GSSG. The GSH/GSSG couple is a major contributor to the 
redox state of the cell, with most cells having this couple at a ratio of 100:1 (Akerboom et 
al., 1982). Changes in this couple appear to correlate with cell proliferation, differentiation, 
or apoptosis (Boggs et al., 1998; Ballatori et al., 2009). Hence, intracellular GSH levels 
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must be maintained for cells to function properly. GSSG can be converted back to GSH by 
glutathione reductase (GR) in the presence of NADPH (reaction 1). 
 
     (reaction 1) 
 
However, GSH reacting with an excess amount of HOCl favours the formation of higher 
oxidation products such as sulfonamide and thiosulfonate (Pullar et al., 2001; Winterbourn 
and Brennan, 1997), which cannot be converted back to GSH by GR. This will be 
discussed in more details in sections 3.1 and 3.3. 
 
GSH can also react with exogenous xenobiotics or endogenous electrophilic molecules 
(both depicted as RX here), catalysed by glutathione S-transferase (GST) enzymes, to form 
GSH S-conjugates (RSG) (reaction 2).  
 
RX  +  GSH    RSG  +  HX                                          (reaction 2) 
GST
 
The above process can facilitate the detoxification of both exogenous xenobiotics and 
endogenous reactive intermediates and is critical for the formation of specific biological 
mediators (Wang and Ballatori, 1998). Some examples of xenobiotics that are metabolized 
by GSH in the presence of GST in animals are chloroform, adiamycin, DDT, naphthalene 
and paracetamol (Halliwell and Gutteridge, 2007). However, the presence of large amounts 
of such xenobiotics can decrease hepatic GSH concentrations, imparing the antioxidant 
defence capacity of the liver. Some examples of endogenous electrophilic molecules that 
form thioether conjugates with GSH are leukotrienes, prostaglandins, hepoxilin, nitric 
oxide, hydroxyalkenals, ascorbic acid, dopamine and maleic acid (Ballatori et al., 2009). 
 
GSH can also form mixed disulfides (by a process called protein-S-glutathionylation) with 
oxidized proteins (reactions 3-5).  
 
Protein-SH    Protein-S•                                   (reaction 3) 
R• 
 
Protein-S•  +  GSH    Protein-S-S•-G                             (reaction 4) 
 
Protein-S-S•-G  +  O2    Protein-SSG  +  O2
•-                (reaction 5) 
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S-glutathionylation is a reversible process, which helps in removing the oxidative stress 
and may protect protein thiol groups from further oxidations to irreversible sulphinic 
(RSO2H) and sulphonic (RSO3H) acids. Most importantly, this process has been 
increasingly recognized as an important mechanism for dynamic, post-translational 
regulation of a variety of regulatory, structural and metabolic proteins, and for the 
regulation of signaling and metabolic pathways in intact cell systems (Dalle-Donne et al., 
2007; Ghezzi and Simplicio, 2007; Mieyal et al., 2008; Halliwell and Gutteridge, 2007). 
 
GSH also serves as a cofactor for the glutathione peroxidase (GPX) or peroxiredoxins 
(PRXs) enzymes, which remove H2O2 and lipid hydroperoxides by coupling their 
reduction to H2O, with oxidation of GSH (reaction 6). Furthermore, GSH is involved in 
deglutathionylation (hence maintaining the reduced state of protein thiols) via the enzymes 
glutaredoxins (GRXs) and thioredoxins (TRXs) (Figure 1.5).  
 
 
GSH  +  oxidants    GSSG                                              (reaction 6) GPX
or PRX
 
 
 
 
 
Figure 1.5 Involvement of GSH in redox reactions.  
GSH is involved in maintaining the redox state of protein thiols via the enzymes 
glutaredoxins (GRXs) and thioredoxins (TRXs). The oxidized GSH (GSSG) and TRXs are 
converted back to the reduced state by the NADPH-dependent glutathione reductase and 
thioredoxin reductase, respectively. This scheme is adapted from Ballatori et al. (2009).  
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1.6.1.2 Biosynthesis, degradation and export of GSH  
The maintainence of GSH homeostasis is crucially important for cell function and is 
regulated by controlling its rate of synthesis, exportation from cells and degradation. GSH 
levels are also influenced by agents or conditions, which alter the thiol redox state, cause 
the formation of glutathione S-conjugates or complexes and disrupt the distribution of 
GSH among intracellular organelles. Nutritional status, hormonal/stress levels and 
physiological states (such as pregnancy and exercise) can also alter GSH levels (Ballatori 
et al., 2009).  
 
GSH is synthesized in every cell of higher eukaryotes. Yet, GSH synthesis, its turnover 
rates, and intracellular GSH levels differ among cell types and tissues (Uhlig and Wendel, 
1992). GSH is produced in the cytoplasm of cells from its precursor amino acids 
(glutamate, cysteine and glycine) in a series of reactions catalysed by ATP-dependent γ-
glutamylcysteine synthetase (γ-GCS) and GSH synthetase (reactions 7-8) (Forman et al., 
2009). The expression and catalytic activity of γ-GCS and the availability of cysteine 
largely control the rate of GSH biosynthesis. Cysteine can be made from methionine, taken 
up from the surrounding fluids or taken up in the form of cystine that is reduced to cysteine 
by cells. Although GSH is present in many foods, only small amounts are absorbed intact 
by the gut; most is hydrolysed to other amino acids before absorption (Halliwell and 
Gutteridge, 2007).  
 
 
L-glutamate  +  L-cysteine  +  ATP   
γ-GCS 
L-γ-glutamyl-L-cysteine  +  ADP  +  Pi            (reaction 7) 
 
 
L-γ-glutamyl-L-cysteine + glycine + ATP  GSH + ADP + Pi                   
(reaction 8) 
glutathione 
synthetase 
 
 
After its synthesis, GSH is delivered into intracellular compartments, including 
mitochondria, endoplasmic reticulum (ER), nucleus and the extracellular space (such as 
blood plasma and biles). GSH degradation occurs exclusively in the extracellular space, 
and in particular, on the surface of cells that express γ-glutamyl transpeptidase.   
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1.6.1.3 GSH deficiency and diseases  
Changes in GSH levels and oxidation state have been reported in numerous human 
diseases (Table 1.1). GSH deficiency leads to increased susceptibility to oxidative stress 
and the resulting damage is considered a key step in the onset and progression of many 
disease states. Conversely, elevated GSH levels generally increase antioxidant capacity and 
resistance to oxidative stress. Elevated GSH levels are observed in various types of 
cancerous cells and solid tumors, which render them more resistant to chemotherapy 
(Balendiran et al., 2004; Ballatori et al., 2009). Although in many cases these changes 
likely occur as a result of the underlying disease progression, in other cases these changes 
are closely linked to the onset and/or development of the disease.  
 
GSH levels, turnover rates and oxidation state may be determined by inherited or acquired 
defects in the enzymes, transporters, signalling molecules, transcription factors that are 
involved in GSH homeostasis or from exposure to reactive chemicals or metabolic 
intermediates (Ballatori et al., 2009; Njalsson and Norgren, 2005; Ristoff and Larsson, 
2007; Hirrlinger et al., 2002a and b).  
 
 
                                           
Table 1.1 Correlation between GSH levels and rate of apoptosis in human diseases. 
Adapted from Ballatori et al., 2009. 
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1.6.2 7,8-dihydroneopterin (7,8-NP) and neopterin 
1.6.2.1 Biosynthesis of 7,8-NP and neopterin  
The biosynthesis of 7,8-NP takes place in the pathway that leads to tetrahydrobiopterin 
(BH4) formation (Figure 1.6). BH4 serves as the electron donor in the hydroxylation of 
phenylalanine to tyrosine in the liver and of tyrosine to L-dopa and tryptophan in 
neuroendocrine tissue synthesising catecholamines or serotonin. It also serves as a cofactor 
for nitric oxide synthase (Walter et al., 2001). The pathway leading to BH4 starts with the 
conversion of GTP to 7,8-dihydroneopterin triphosphate. This step is catalysed by GTP-
cyclohydrolase I, with interferon-γ (IFN-γ) being the major trigger for this enzyme. In the 
presence of both Mg2+ ions and 6-pyrovoyltetrahydropterin synthase (PTPS), 7,8-dihydro-
neopterin triphosphate is converted to 6-pyrovoyl-tetrahydropterin, which is then reduced 
to BH4 in an NADPH-dependent reaction catalyzed by sepiapterin reductase (Hoffmann et 
al., 2003). The activity of PTPS in human and primate tissues and cell lines was found to 
be lower than that of other mammals, with lowest activities found in monocytes and 
macrophages (Werner-Felmayer et al., 1990; Werner et al., 1990). This results in an 
accumulation of 7,8-dihydroneopterin trisphosphate, which is subsequently cleaved by 
non-specific phosphatases to yield 7,8-NP. 7,8-NP diffuses out of the activated 
macrophages into the extracellular space and finally to the plasma.  
 
7,8-NP can be oxidised to form two products depending on the types of oxidant present 
(Figure 1.6). 7,8-NP is oxidised to the highly fluorescent neopterin through the loss of 
hydrogen at carbon-7 and nitrogen-8 of 7,8-NP after oxidation by hypohalous acids such as 
HOCl (Gieseg et al., 2001; Widner et al., 2000). The non-fluorescent 7,8-
dihydroxanthopterin can also be generated through the loss of the trihydroxylpropyl side 
chain at position 6 of 7,8-NP. This may occur by 7,8-NP reacting with O2
•-, RO2
• and H2O2 
(Gieseg et al., 2001; Murr et al., 1994; Widner et al., 2000).  
 
 
1.6.2.2 Interferon-γ (IFN-γ) 
The enzyme GTP-cyclohydrolase I can be activated upon IFN-γ induction to catalyse 7,8-
NP synthesis. IFN-γ is a dimeric molecule produced by monocytes, macrophages and T 
cells during the innate and acquired immune response. IFN-γ production is controlled by 
cytokines, particularly interleukin-12 (IL-12) and interlekin-18 (IL-18), which are secreted  
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Guanosine triphosphate (GTP) 
 
 
 
 
 
7,8-dihydronepterin triphosphate  
 
 
 
 
6-pyruvoyltetrahydropterin 
 
GTP-Cyclohydrolase l 
6-pyrovoyl-
tetrahydropterin synthase 
(PTPS) 
Sepiapterin 
reductase 
7,8-dihydroneopterin 
(7,8-NP) 
 
Neopterin 7,8-dihydroxanthopterin 
 
 
 
5,6,7,8-tetrahydrobiopterin (BH4)             
   
 
 
Figure 1.6 The biosynthesis and metabolism of 7,8-NP and neopterin.   
Human monocytes/macrophages lack the PTPS enzyme that converts 7,8-dihydro-
neopterin triphosphate to 6-pyrovoyltetrahydropterin, resulting in the accumulation of 7,8-
dihydronepterin tri-phosphate. This species is then hydrolysed by phosphatases to produce 
7,8-NP, which can be oxidised to neopterin or 7,8-dihydroxanthopterin depending on the 
types of oxidants present. This scheme is modified from Hoffmann et al., (2003). 
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by antigen presenting cells (such as macrophages, monocytes and dendritic cells). 
Macrophage recognition of many pathogens induces secretion of IL-12 and chemokines. 
The chemokines attract natural killer (NK) cells to the site of inflammation, whereas IL-12 
promotes IFN-γ synthesis in these cells. The combined stimulation of IL-12 and IL-18 
further increases IFN-γ production in macrophages, NK and T cells (Schroder et al., 2004). 
 
IFN-γ has shown both pro- and anti-atherogenic activities. The anti-atherogenic activities 
of IFN-γ include inhibiting the induction of E-selectin, P-selectin, platelet endothelial cell 
adhesion molecule-1 (PECAM-1), monocyte chemotactic protein (MCP-1) and its receptor 
monocyte chemotactic protein receptor (CCR2) (Leon & Zuckerman, 2005). These 
molecules assist in recruiting the circulating monocytes and T cells into the intima during 
the formation of a fatty streak lesion (see section 1.3). IFN-γ can also prevent human 
monocyte-mediated LDL oxidation by inhibiting 15-lipoxygenase synthesis (Folcik et al., 
1997). In addition, IFN-γ can decrease intracellular cholesteryl ester accumulation and 
foam cell formation possibly by down-regulating SR-A and CD36 receptors (Geng & 
Hansson, 1992; Grewal et al., 2001; Nakagawa et al., 1998).  
 
The pro-atherogenic activities of IFN-γ include up-regulation of antigen presenting 
components (like MHC), activation of macrophages, stimulation of respiratory burst 
(Hansson et al., 2006), induction of ceruloplasmin synthesis (Mazumder et al., 1997), 
promotion of T lymphocyte and monocyte recruitment by enhancing the release of 
endothelial-derived T cell α-chemoattractant (Cole et al., 1998) and increasing the 
expression of MCP-1 and the adhesion molecule vascular cell adhesion molecule-1 
(VCAM-1) (Leon & Zuckerman, 2005). IFN-γ can also increase expression of the 
scavenger receptor SR-PSOX in human monocytes and THP-1 cells, which would increase 
oxLDL uptake by the cells (Wuttge et al., 2004). On the other hand, IFN-γ can inhibit LDL 
receptor expression in murine and human macrophages (Garner et al., 1997; LaMarre et al., 
1993), very low density lipoprotein (VLDL) receptor expression in phorbol ester 
stimulated THP-1 and HL60 human macrophage cell (Kosaka et al., 2001) and reduces 
lipoprotein (a)/apoprotein (a) receptor expression (Skiba et al., 1994). IFN-γ also decreases 
cholesterol efflux and ATP binding cassette transporter-1 expression in murine and human 
macrophage-derived foam cells and cholesterol efflux in THP-1 cells (Panousis & 
Zuckerman, 2000; Reiss et al., 2004). Furthermore, IFN-γ decreases synthesis of 
lipoprotein lipase (LPL) (Garner et al., 1997; Jonasson et al., 1990), apolipoprotein E 
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(apoE) (Garner et al., 1997; Kalkan et al., 2005) and cholesterol 27-hydroxylase 
(Carpenter et al., 2001; Reiss et al., 2004). Decreases in LPL and apo E synthesis would 
reduce LDL and VLDL clearance from the circulation or lesion, whereas decreased 
synthesis of 27-hydroxylase would reduce clearance of cholesterol from foam cells as 27-
hydroxylation represents the first step in extrahepatic cholesterol metabolism. Finally, IFN-
γ increases acyl coenzyme A:cholesterol acyltransferase activity and expression in 
macrophages, which would be expected to promote cholesterol storage by increasing 
cholesterol ester synthesis thereby promoting foam cell formation (Panousis & Zuckerman, 
2000).   
 
1.6.2.3 Neopterin as a marker of inflammation 
Neopterin concentrations have been used as a marker of immune cell activation in a wide 
range of diseases. The highly fluorescent nature of neopterin makes it easily detectable by 
HPLC methods (Rippin, 1992; Werner et al., 1987), although many clinical laboratories 
also use immuno-based methods such as radioimmunoassay or enzyme-linked 
immunosorbant assay (ELISA) (Wachter et al., 1989; Westermann et al., 2000).  
 
For healthy individuals, mean neopterin concentrations in serum lie within 5.2 + 2.7 nM 
and in urine it ranges between 100 and 200 μmol/mol creatinine (Wachter et al., 1989). It 
is difficult to analyse neopterin concentrations in other body fluids such as synovial fluid, 
saliva and cerebrospinal fluid, due to the invasive techniques required. Therefore, only 
minimal data are available from healthy controls, with neopterin concentrations from 1.0 to 
9.0 nM (Hoffmann et al., 2003). The neopterin/7,8-NP ratio remains nearly constant at 1:2 
in urine, serum, or cerebrospinal fluid, suggesting that neopterin is not further metabolized 
after production (Hoffmann et al., 2003). 
 
Due to the stability of neopterin in biological fluids, with a half-life of approximately 90 
minutes within the circulatory system (Fuchs et al., 1994), neopterin has become a useful 
tool to assess the intensity of immune cell activation in a wide range of diseases. High 
neopterin concentrations are a reliable measure of the severity of infections such as viral, 
bacterial, protozoic, parasitic or fungi-induced infections, and chronic diseases such as 
rheumatoid arthritis, insulin-dependent diabetes mellitus, systemic lupus erythematosus, 
multiple sclerosis, coeliac disease, and rheumatic fever (Hoffmann et al., 2003). Plasma 
neopterin is not generally used in the management of cardiovascular diseases, however, 
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there is a growing amount of evidence on its value. Higher serum concentrations of C-
reative proteins and neopterin together with lower phospholipid concentrations are 
observed in patients with coronary heart disease (Rudzite et al., 2003). Serum neopterin 
concentration is also increased in patients with unstable angina and acute myocardial 
infarction (Schumacher et al., 1992; Schumacher et al., 1997; Tatzber et al., 1991). 
Moreover, neopterin concentrations in pus and plaque were found to be between 1 and 3 
µM (Gieseg et al., 2007).  
 
Neopterin production has also been shown to increase with increased production of ROS 
and in the presence of low serum concentrations of antioxidants like α-tocopherol 
(Schroecksnadel et al., 2004) and folic acid (Nathan, 1986). These results suggest that 
neopterin not only serves as a marker of the extent of cellular immune activation, but also a 
marker of the extent of tissue damage caused by ROS.   
 
1.6.2.4 Physiological role of 7,8-NP and neopterin  
The physiological role of 7,8-NP and neopterin during inflammation is controversial 
(Gieseg et al., 2007). Numerous in vitro studies suggested that these two species serve as 
pro-oxidants by enhancing oxidant production and cell death in combination with tumor 
necrosis factor (TNF). In contrast, 7,8-NP has also been shown to serve as an antioxidant 
by protecting macrophages from oxidants released during inflammation. In addition, 7,8-
NP and neopterin are also involved in apoptosis, signal transduction and gene expression.  
 
A) Antioxidant effect of 7,8-NP and neopterin  
7,8-NP can scavenge free radicals such as OH • (Heales et al., 1988) O2
•-, H2O2 (Shen, 
1994), aqueous peroxyl radicals (Oettl et al., 1997; Gieseg et al., 1995), lipid peroxyl 
radicals (Gieseg et al., 1995; Gieseg et al., 2003) and HOCl (Gieseg et al., 2001b). 7,8-NP 
is also an efficient scavenger of non-physiological radicals like 1,1-diphenyl-2-
picrylhydrazyl and 2,2’-azino-di-(3-ethylbenz-thaizoline sulphonate) (Oettl & Reibnegger, 
2002). 
 
On a larger scale, the radical scavenging activity of 7,8-NP explains the inhibition of 
radical-induced damages to a variety of cellular substrates and cells in the presence of 7,8-
NP. 7,8-NP inhibited metal ion- and aqueous peroxyl radical-mediated lipid peroxidation 
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on native LDL or linoleate by scavenging the propagating lipid peroxyl radicals (Gieseg et 
al., 1995; Gieseg and Cato, 2003; Gieseg et al., 2003). THP-1 and HMDM cell-mediated 
LDL oxidation was also prevented completely by micromolar concentrations of 7,8-NP 
(Gieseg and Cato, 2003). 7,8-NP was further found to inhibit ROS-mediated damage to a 
range of other substrates and cells, including bovine serum albumin (Duggan et al., 2001), 
erythrocytes (Gieseg et al., 2001b) and the U937 monocytic cell line (Gieseg et al., 2001a; 
Duggan et al., 2002). These studies noted protection against damage that ranged from 
dityrosine and protein hydroperoxide formation to haemolysis, cell death and thiol 
oxidation. Similarly, 7,8-NP appears to prevent copper- and AAPH-induced protein 
hydroperoxide formation on LDL by scavenging the lipid-derived radicals that are 
suggested to promote protein peroxidation (Gieseg et al., 2003). In addition to the above 
substrates, 7,8-NP has also been shown to prevent oxLDL-induced intracellular GSH loss 
in U937 cells by scavenging oxLDL-induced intracellular oxidants, which in turn 
maintained the intracellular redox environment and hence prevented cell viability loss 
(Baird et al., 2004; Baird et al., 2005). 7,8-NP also appears to efficiently scavenge reactive 
nitrogen species, inhibiting 3-nitrotyrosine formation in a simple system of 7,8-NP, 
tyrosine and peroxynitrite (Widner et al., 1998; Oettl et al., 2004). 7,8-NP has also been 
shown to protect Escherichia coli from chloramine T- and HOCl-induced growth 
inhibition and cytotoxicity (Weiss et al., 1993; Horejsi et al., 1996; Wede et al., 1999). 
  
7,8-NP and neopterin were also demonstrated to inhibit TNF-α-mediated apoptosis in the 
U937 cell line (Baier-Bitterlich et al., 1995). Furthermore, neopterin has been specifically 
confirmed to inhibit the activity of at least two other enzymes in vitro – the superoxide 
radical generators, NADPH oxidase and xanthine oxidase. Inhibition of the former occurs 
via neopterin competing with the NADPH substrate (Kojima et al., 1993), where inhibition 
of the latter involves a reversible, non-competitive mechanism (Oettl et al., 1997; Oettl & 
Reibnegger, 1999). Neopterin has also been found to inhibit MPO, leading to an increase 
in singlet oxygen but a decrease in all other ROS (Razumovitch et al., 2004).  
 
B) Pro-oxidant effect of 7,8-NP and neopterin and apoptosis  
Although 7,8-NP is clearly a potent radical scavenger, it mostly exhibits strong pro-oxidant 
activity at high concentrations. 7,8-NP, at 5 mM concentration, was found to induce 
oxidative stress resulting in apoptotic cell death in U937 cells (Baier-Bitterlich et al., 1995), 
neuronal NT2/ HNT cells (Spottl et al., 2000), Jurkat cells (Enzinger et al., 2002a; 
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Wirleitner et al., 1998; Wirleitner et al., 2001) and the rat pheochromocytoma cell line 
PC12 (Enzinger et al., 2002b). At this concentration, 7,8-NP also superinduced TNF-α-
mediated apoptosis in U937 cells (Baier-Bitterlich et al., 1995). Surprisingly, neopterin or 
7,8-NP with concentrations as low as 10 μM also induced apoptosis and augmented TNF-
α/IFN-γ-mediated apoptosis in rat alveolar epithelial cell line L2 cells (Schobersberger et 
al., 1996). The same study revealed that nitric oxide production was not involved in 
neopterin-mediated apoptosis in L2 cells. This was in contrast to neopterin- and 7,8-NP-
induced apoptosis in vascular smooth muscle cells (VSMCs), where inhibition of iNOS 
suppressed the pro-apoptotic effects of neopterin in VSMCs (Hoffmann et al., 1998; 
Hoffmann et al., 1996). 
 
One explanation for the observed pro-oxidant characteristic of 7,8-NP is related to its 
reducing nature (Gieseg et al., 2007). 7,8-NP may cause the reduction of redox-active 
metal ions within the buffers, which would increase the formation of various oxidants. For 
instance, 7,8-NP at high concentrations showed enhancement of copper-induced LDL 
oxidation, possibly due to the ability of 7,8-NP to reduce copper ion to its redox active 
state (Herpfer et al., 2002). 7,8-NP has also been shown to reduce another transition metal, 
iron, to the redox active ferrous ion state (Wirleitner et al., 2005). Moreover, it was 
reported that 7,8-NP enhanced the rate of OH • generation in phosphate buffered saline 
(PBS) containing low levels of iron (Oettl et al., 1999). However, this oxidant generation 
only becomes significant at extremely high 7,8-NP concentrations and in protein-free 
media, as proteins are very effective radical scavengers. Therefore, the high concentration 
of soluble proteins within plaque may make these reactions unlikely, although still possible 
(Gieseg et al., 2007).  
 
The pro-oxidant characteristic of 7,8-NP and neopterin can also be attributed to them 
enhancing ROS generation under certain conditions. For instance, neopterin and high 
concentrations of 7,8-NP intensify H2O2- and chloramine T-mediated luminol-dependent 
chemiluminescence assay, suggesting an enhancement of free radical formation (Murr et 
al., 1996; Weiss et al., 1993).  Unlike 7,8-NP, the effects of neopterin were generally pH-
dependent. For example, neopterin only promoted 3-nitrotyrosine formation at pH between 
4 and 5.5 (Widner et al., 1998), whereas its enhancement of chloramine T- and H2O2-
induced chemiluminiscence and cytotoxicity required a neutral or slightly alkaline pH 
(Weiss et al., 1993). In addition, the enhancement of neopterin on H2O2-induced 
chemiluminescence was found to be dependent on the presence of iron chelator complexes 
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(Murr et al., 1994). Antioxidants ranging form N-acetylcysteine to pyrrolidine 
dithiocarbamate, catalase and superoxide dismutase have been shown to significantly 
inhibit 7,8-NP-mediated apoptosis (Baier-Bitterlich et al., 1995; Baier-Bitterlich et al., 
1996; Enzinger et al., 2002b; Hoffmann et al., 2003; Spottl et al., 2000). It therefore 
appears that the presence of excess 7,8-NP results in ROS generation, disrupting the 
oxidant/antioxidant balance and ultimately leading to cell death.  
 
C) Gene expression and signal transduction  
Disruption of the cellular redox balance not only promotes apoptosis, but may also account 
for the neopterin- and 7,8-NP-mediated activation of various redox-sensitive transcription 
factors. For instance, the transcription factor activator protein 1 (AP-1) is known to sense 
the intracellular redox state and regulate the expression of multiple genes involved in stress 
response. It is composed of proteins from the Fos and Jun families and is usually a c-fos /c-
jun heterodimer. The activity of AP-1 is regulated by the amount of c-fos and c-jun made 
by cells and by phosphorylation of already-synthesised proteins (e.g. by mitogen-activated 
protein kinases (MAPKS)). Both processes can be altered by various ROS (Halliwell and 
Gutteridge, 2007).   
 
Along this line it was observed that incubation of cells with neopterin, and to a greater 
extent 7,8-NP, together with cyclic guanosine monophosphate (cGMP) induces c-fos gene 
expression in a c-fos-CAT reporter transactivation system of NIH3T3 mouse fibroblasts 
(Uberall et al., 1994). In addition, 7,8-NP activates the redox-sensitive transcription factor, 
activation protein-1 chloram-phenicol acetyltransferase (AP-1-CAT) and amplifies TNF-α 
induced NF-κB activation in Jurkat cells (Baier-Bitterlich et al., 1997b) and enhances 
apoptosis in rat PC12 cells by up-regulating signalling cascades associated with MAPKs 
(Enzinger et al., 2001).  Activation of p44/42 ERK was mediated by 7,8-NP alone, while 
strong activation of stress-activated protein kinase (SAPK) required co-incubation with 
TNF-α (Enzinger et al., 2002b).  These data suggests that neopterin and 7,8-NP may alter 
gene expression  by modulating the intracellular redox state. Interestingly, there is no 
documentation to date reporting on the specific pteridine receptor.    
 
Neopterin also enhances inducible nitric oxide synthase (iNOS) gene expression and nitric 
oxide release in rat vascular SMCs (Schobersberger et al., 1995) and amplifies the 
secretion of TNF-α in peripheral blood mononuclear cells induced by IFN-γ and IL-2 
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(Barak & Gruener, 1991). In VSMCs, neopterin is a potent stimulus of TNF-α gene 
expression and TNF-α protein release (Hoffmann et al., 1998). Furthermore, this 
laboratory has demonstrated that 7,8-NP down-regulated certain isoforms of CD36 protein, 
an oxLDL scavenger receptor (Amit, 2008, PhD thesis).  
 
In transfected Jurkat cells, 7,8-NP has been shown to induce trans-activation of IFN-γ, as 
well as the type I human T-cell leukaemia virus long terminal repeat sequence and HIV-1 
promoter (Baier-Bitterlich et al., 1996; Baier-Bitterlich et al., 1997a). Neopterin also 
induced inter-cellular adhesion molecule-1 (ICAM-1) gene expression and protein 
synthesis in type II-like alveolar epithelial cells (Hoffmann et al., 1999). As mentioned 
earlier, the increased production of ICAM-1 promotes the recruitment of immune cells into 
the intima. Infectious diseases of the lungs including sarcoidosis, lung tumours, fibrosis 
and adult respiratory distress syndrome are also associated with elevated neopterin 
concentrations in serum and an increased production of ICAM-1 (Wirleitner et al., 2005). 
 
The pteridines also influence secondary messengers.  For instance, both neopterin and 7,8-
NP were shown to induce an intracellular calcium influx in THP-1 cells (Woll et al., 1993) 
and inhibit ATP-induced calcium release from alveolar epithelial cells (Hsieh  et al., 2001). 
Neopterin was also shown to cause cardiac contractile dysfunction in isolated perfused rat 
hearts (Balogh et al., 2005).  These results imply the adverse clinical effect of neopterin, as 
calcium deposition represents a serious deterioration in patient prognosis due to the 
increasing complexity of the plaque tissue. 
 
 
1.7 Cell death mechanisms 
Cells die in response to a variety of stimuli and cell death can commonly occur by two 
mechanisms, necrosis and apoptosis. Yet, sometimes death with features of both pathways 
can occur (Halliwell & Gutteridge, 2007).  
 
Necrotic cell death is ATP-independent and is characterised by swelling of the cell and 
internal organelles, loss of cellular ion homeostasis, loss of integrity of mitochondrial, 
peroxisomal and lysosomal membranes, and eventual rupture of the plasma membrane 
releasing cell contents into the surroundings that may affect adjacent cells (Lelli et al., 
1998). The released contents can be antioxidants such as superoxide dismutase (SOD), 
catalase or GSH, pro-oxidants such as haem, iron and copper ions and other damaging 
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agents, such as activated calpains (Halliwell and Gutteridge, 2007). Another hallmark of 
necrosis is inflammation, where cells of the immune system ingest the necrotic cells to 
help limit infection and clear away debris. However, the activities and secretions of the 
phagocytes can also damage normal tissue in the vicinity, sometimes extensively (Duke et 
al., 1996). Severe damage to cytoskeletal proteins by calpain enzymes or cathepsins can 
cause irreversible membrane blebbing and eventually necrosis. This will be discussed in 
detail in Chapter 5. Dramatic intracellular ATP loss can also lead to necrosis, which will 
be discussed in Chapter 4.  
 
The earliest visible morphological changes in apoptotic cell death are cell shrinkage and 
bleb formation on the surface of the cell membrane without the membrane losing its 
integrity (Haunstetter & Izumo, 1998). Internal organelles retain their structure, but 
chromatin condensation and nuclear fragmentation occur (Yuan et al., 2000). Eventually, 
the cell breaks into small membrane-surrounded fragments (called apoptotic bodies), 
without rupture of organelle membranes (Haunstetter & Izumo, 1998). The apoptotic 
bodies are then cleared by phagocytosis without inciting an inflammatory response. The 
redistribution of phosphatidylserine (PS) to the outer surface of plasma membrane is also a 
hallmark of apoptosis, which enables the recognition of apoptotic bodies by phagocytic 
cells (van Engeland et al., 1998). If the apoptotic bodies are not phagocytosed, a process 
known as secondary necrosis will occur, in which the membranes of apoptotic bodies lyse 
and the contents of the bodies are released (Skepper et al., 1999; Tabas, 2005). 
 
1.7.1 Molecular mechanism of apoptosis  
Apoptosis is a tightly regulated cell death program involving a complex cascade of events.  
Apoptosis can be triggered by various stimuli from either outside or inside the cell, such as 
by ligation of cell surface receptors, DNA damage as a cause of defects in DNA repair 
mechanisms, treatment with cytotoxic drugs or irradiation, contradictory cell cycle 
signalling or by developmental death signals. Two major pathways, the extrinsic and 
intrinsic pathways, leading to apoptotic cell death have been described, and caspases are 
heavily involved in both pathways.  
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1.7.1.1 Caspases  
Caspases are a family of at least 14 cysteine proteases that have been described as ‘the 
central executioners’ of apoptosis. Their full name ‘cysteine-aspartyl-specific proteases’ 
reflects their active cysteine group and the characteristic cleavage of protein substrates at 
aspartate residues (Chandra & Orennius, 2002; Hampton & Orennius, 1997).  Caspases can 
be functionally classified into two classes; (i) the initiator caspases that are involved in 
recruitment and activation, and are characterised by long prodomains containing either 
death-effector domain (DED) (caspase-8 and caspase-10) or a caspase recruitment domain 
(CARD) (caspase-2, and caspase –9); and (ii) the executioner or effector caspases 
containing short prodomains (caspase-3, caspase-6 and caspase-7) (Grutter, 2000). Not all 
caspases are involved in cell death. For instance, caspases-1, -4 and -5 (possessing large 
terminal domains) in humans are involved in the processing of pro-inflammatory cytokines 
such as pro-IL-1β and -18 (Kroemer and Martin, 2005).  
 
In resting cells, caspases are present as inactive zymogens, the so called pro-caspases. 
Activation requires that the N-terminal domain of a pro-caspase be removed by proteolytic 
cleavage, leaving proteolytic active ~20 kDa and ~10 kDa subunits. The effector caspases 
are proteolytically activated by the initiator caspases. The hypothesized mechanism of 
initiator caspase activation is described in section 1.7.1.2. The active enzyme consists of 
heterotetramers composed of two large and two small subunits, with two active sites per 
molecule (Thornberry and Lazebnik, 1998). The cysteine and histidine residues at the 
active site are harbored within the large subunit.  
 
1.7.1.2 The extrinsic, intrinsic and other apoptotic pathways  
In the extrinsic pathway, apoptotic signal can be initiated by direct interaction of specific 
ligands with their respective receptors on cell membranes (Figure 1.7). These receptors are 
called death receptors, which belong to the tumour necrosis factor receptor (TNFR) gene 
superfamily, including TNFR-1, Fas/CD95 (fibroblast associated cell surface) and the 
TNF-related apoptosis-inducing ligand (TRAIL) receptors DR-4 and DR-5 (Ashkenazi, 
2002). All members of the TNFR family consist of cysteine-rich extracellular subdomains 
that allow them to recognise specific ligands, resulting in the trimerisation and activation 
of the respective death receptor. The activated death receptors on the cytoplasmic side then 
recruit adapter proteins, such as Fas-associated death domain (FADD) and TNF receptor-
associated death domain (TRADD), to their cytosolic death domains (DDs). TRADD and 
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FADD contain both DDs and death effector domains (DEDs). While their DDs bind to 
cytosolic DDs of TNFR, their DEDs bind to DED-containing pro-caspases, particularly 
pro-caspase-8 (or pro-caspase-10). This results in recruitment of pro-caspase-8 to liganded 
death receptor complexes and activation of caspase-8 through the induced proximity 
mechanism (Ashkenazi, 2002). This mechanism suggests that the zymogen forms of 
unprocessed caspases are not entirely inactive but rather possess weak protease activity 
(measured in some cases at ~1% of the fully active enzymes). When brought into close 
proximity during recruitment, the zymogens can trans-process each other, producing the 
fully active proteases (Reed, 2000). The activated caspase-8 in turn cleaves and activates 
the downstream effector caspases-3, -6 and -7.  
 
Activation of effector caspases put in motion the cellular events characteristic of apoptosis. 
These include modification of the function of the target proteins, which results in the 
disabling of homeostatic and repair processes (such as activation of the caspase-activated 
DNAse that fragments DNA), the stopping of cell cycle progression, the inactivation of 
apoptotic inhibitors, the disassembly of the cell (such as activation of enzymes that 
remodel the cytoskeleton and cause blebbing) and the marking of the dying cell for 
disposal (Reed, 2000; Grutter, 2000). Caspase-3 is also responsible for cleaving poly-ADP 
ribose polymerase specifically at Asp-Glu-Val-Asp (DEVD) sequence (Nicholson et al., 
1995).  
 
The intrinsic apoptosis pathway is activated by a variety of extracellular and intracellular 
stresses, such as oxidative stress and treatment with cytotoxic drugs. Generally, the signal 
derived from the activated death receptor is not sufficient to stimulate the direct activation 
of apoptotic effector caspases and subsequently to execute cell death. Hence, the signal 
needs to be amplified via the mitochondria-dependent apoptotic pathway (Figure 1.7). 
This occurs when activated caspase-8 cleaves the pro-apoptotic protein Bid of the Bcl-2 
family into its truncated form (tBid) (see also section 1.7.2), which translocates to the 
mitochondria. tBid then acts in concert with Bax and Bak of the pro-apoptotic Bcl-2 family 
to facilitate the mitochondrial outer membrane permeabilisation (MOMP) and release of 
factors from the inter-membrane space to the cytosol, such as cytochrome c (Luo et al., 
1998; Halliwell and Gutteridge, 2007). Earlier data suggested that loss of mitochondrial 
membrane potential and opening of the mitochondrial membrane permeability (MPT) pore 
are necessary for cytochrome c release (Kluck et al., 1999; Liu et al., 1996). However, 
recent data suggested that both events are not needed (Ly et al., 2003; Stridth et al., 1998; 
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Waterhouse et al., 2002). MOMP may also release SMAC (alternatively called DIABLO) 
(Luo et al., 1998; Halliwell and Gutteridge, 2007). SMAC is a protein that binds and 
inhibits endogenous caspase blockers (IAP) (Adam et al., 2000; Verhagen et al., 2000).  
 
Cytochrome c is a 14 kDa soluble protein attached to the inner membrane of the 
mitochondria and its traditional role is to shuttle electrons between complexes III and IV of 
the electron transport chain (ETC) on the inner mitochondrial membrane. The release of 
cytochrome c may result in breakdown in electron flow, generating ROS such as O2
•- and 
reduces the supply of adenosine triphosphate (ATP) (Cai & Jones, 1998; Stridth et al., 
1998). Once in the cytosol cytochrome c, as well as ATP/ deoxyadenosine triphosphate 
(dATP), binds to the cytosolic caspase adaptor Apaf-1 (apoptotic proteinase activating 
factor 1) to form the apoptosome. This complex binds pro-caspase-9 and facilitates trans-
processing of caspase-9 zymogens via the induced proximity mechanism (Reed, 2000) (see 
above). The activated caspase-9 in turn activates caspases-3 and -6 (Halliwell and 
Gutteridge, 2007).  
 
Another way of triggering apoptosis is to introduce an agent that directly activates caspases 
and/or mitochondrial pro-apoptotic proteins. For example, tributylin targets mitochondria, 
causing swelling and cytochrome c release. The cytotoxic T lymphocytes can deliver a 
pore-forming protein (perforin) and a set of proteolytic enzymes (granzymes) into their 
target cells. Granzyme B can directly activate the target cell’s caspases and by doing so, 
induce apoptosis. Granzyme B can also bypass caspases by directly cleaving inhibitors of 
caspase-3-activated DNase (ICAD), Bid and caspase-3. The ER stress response can also 
lead to apoptosis (Halliwell & Gutteridge, 2007).  
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Figure 1.7 Some major caspase-dependent apoptotic pathways (simplified scheme).  
Refer to the text in section 1.7.1.2 for the description of the pathways.  
 
1.7.1.3 Caspase-independent apoptotic pathways  
Some of the mitochondrial proteins released as a result of MOMP, such as apoptosis 
inducing factor (AIF) and HtrA2/Omi (a mitochondrial serine protease), can also promote 
caspase-independent apoptotic death by causing chromatin condensation, ROS generation 
and DNA damage (Kroemer and Martin, 2005). oxLDL was previously found to activate a 
caspase-independent apoptotic pathway mediated by the release of AIF (Zhang et al., 2004; 
Vindis et al., 2005). Moreover, microinjection of AIF-specific antibodies can prevent 
caspase-independent neuronal death induced by DNA damage or excitotoxins (Cregan et 
al., 2002; Wang et al., 2004). HtrA2/Omi-specific inhibitor ucf-101 inhibits the 
nephrotoxic and the pro-apoptotic effect of cisplatin in vivo (Cilenti et al., 2005).  
 
Caspase-independent apoptotic death can also result from stimuli that cause calpain 
enzyme activation and lysosomal membrane permeabilization with the consequent release 
of cathepsin proteases (Kroemer and Martin, 2005). This will be discussed in more detail 
in Chapter 5.  
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1.7.2 Bcl-2, ROS and redox regulation of apoptosis  
The Bcl-2 family of proteins serve as either anti- or pro-apoptotic factors regulating the 
mitochondrial membrane potential, outer membrane permeability and hence the release of 
pro-apoptotic factors (Reed, 1997; Reed, 1998). There are over 30 protein members in the 
Bcl-2 family, which can be characterised by the presence of particular conserved sequence 
motifs, known as Bcl-2 homology domains (BH1 to BH4). The anti-apoptotic proteins 
including Bcl-2, Bcl-XL, Bcl-w and Bcl-B posses the domains BH1, BH2, BH3 and BH4. 
The pro-apoptotic proteins can be divided into two subgroups: the Bax-subfamily (consists 
of Bax, Bak and Bok) that all possess the domains BH1, BH2 and BH3; the BH3 only 
proteins (Bid, Bim, Bik, Bad, Bmf, Hrk, Noxa, Puma, Blk, BNIP3 and Spike) have only 
the short BH3 motif (Cory & Adams, 2005). The relative ratios of these pro- and anti-
apoptotic members are more important to the survival of a cell than the expression of any 
member in particular (Carmody & Cotter, 2001). 
 
The Bcl-2 family proteins regulate apoptosis via many pathways. Bax, Bcl-Xs, Bid, Bim 
and Bak occur as dimers or oligomers in the cytosol and form ion-conducting channels in 
the mitochondrial outer membrane (Kroemer & Reed, 2000). They also form pores in the 
membranes of the ER and nucleus. These channels/pores probably induce mitochondrial 
membrane permeability and cytochrome c release from the mitochondria, intervene in 
calcium ion (Ca2+) signalling by inducing Ca2+ release from the ER and modulate nuclear 
membrane. The pro-apoptotic effect to some extent also depends on caspases. For example, 
caspases-1 and -3 degrade Bcl-XL and Bcl-2, respectively, converting anti-apoptotic 
proteins into pro-apoptotic mediators (Kirsch et al., 1999). 
 
Bcl-2 also appears to function as an antioxidant. For instance, Bcl-2 was previously shown 
to prevent lipid peroxidation associated with apoptosis, suggesting that Bcl-2 may 
indirectly regulate antioxidant defences to prevent cell death (Hockenbery et al., 1993). 
There is also a strong link between Bcl-2 and the endogenous antioxidant GSH, as the 
analysis of multiple lymphoid systems showed that increased Bcl-2 protein levels were 
related to increased intracellular GSH levels. Moreover, the resistance of cells to apoptosis-
inducing stimuli conferred by elevated Bcl-2 expression was significantly decreased 
following depletion of intracellular GSH (Mirkovic et al., 1997). Bcl-2 has also been found 
to prevent mitochondrial permeability transition and cytochrome c release via maintenance 
of reduced pyridine nucleotides (Kowaltowski et al., 2000). 
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The role of ROS and redox in apoptosis is not clearly defined since it is difficult to 
distinguish whether oxidative events are a consequence of damage or cause of cell death. 
The ability of antioxidants to prevent apoptosis provides evidence for a role of ROS in 
apoptotic signal transduction (Carmody & Cotter, 2001). Oxidative stress can lead to 
apoptosis, often by inducing the MPT and causing release of pro-apoptotic factors. 
However, caspases have exposed sulfhydryl (–SH) groups, which can be readily 
inactivated by H2O2, HOCl, OH•, ONOO- and other reactive species (RS) (Hampton et al., 
2002; Hampton & Orennius, 1997). Thus, high levels of RS can delay or halt apoptosis, 
but often cell death continues by a necrotic or intermediate pathway. Alternatively, 
apoptosis triggered by other mechanisms (such as ligand binding to death receptors) is 
accompanied by oxidative stress. For example, release of cytochrome c and caspase-
dependent cleavage of complex I of the mitochondrial ETC disrupt the ETC, causing more 
O2
•- formation (Halliwell and Gutteridge, 2007).   
 
1.7.3 Mitochondrial membrane permeability transition (MPT)   
Mitochondrial membrane potential loss is considered a common pathway leading to both 
apoptotic and necrotic cell death (Kim et al., 2003a; Lemasters, 1999). The level of its loss 
affects cellular ATP levels, which determine whether cells undergo necrosis or caspase-
dependent apoptosis (Eguchi et al., 1997), since caspase activation requires ATP.  
 
The mitochondrion is encompassed by two membranes, and the electron transport chain 
(ETC) at the inner mitochondrial membrane (IMM) is where oxidative phosphorylation 
and hence most of the cellular ATP generation take place (Figure 1.8). The mitochondria 
of healthy cells maintain an electrochemical gradient across the IMM, which is created by 
pumping protons (H+) from the matrix to the inter-membrane space (IMS) of the 
mitochondria in conjunction with electron transport through the ETC at the IMM. Influx of 
H+ back into the matrix through the F0F1-ATPase/H+ pump at the IMM drives the 
conversion of adenosine diphosphate (ADP) and PO43- (Pi) to ATP (Matsuyama and Reed, 
2000).  
 
In order to maintain this crucial gradient, transport across the IMM is tightly regulated by 
many specific transporters for the metabolites that need to cross the IMM, such as the 
H+/K+ antiporter, Na+/H+ exchanger, Cl-/HCO3- antiporter, uncoupling proteins and the 
Pi/OH- exchanger. The IMM also contains protein import channels, as well as the adenine 
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nucleotide translocator (ANT) that exchanges ADP and ATP between the mitochondrial 
matrix and the IMS.  
 
In contrast to the IMM, the outer mitochondrial membrane (OMM) is completely porous to 
H+, presumably due to the presence of the voltage-dependent anion channel (VDAC). 
VDAC is a β-sheet-type transmembrane channel protein involved in transporting 
metabolites, including ADP and ATP, between mitochondria and cytosol (Figure 1.8). It is 
permeable to molecules of up to 5000 daltons in its open configuration (Mannella, 1992; 
Harris and Thompson 2000). Even in its “closed” configuration, it creates a pore of 
approximately 1.8 angstroms in diameter, which is adequate for passage of H+ and other 
biologically relevant ions (Matsuyama and Reed, 2000). The IMS is where many of the 
characterized apoptosis-inducing proteins reside, including cytochrome c, apoptosis 
inducing factor (AIF) and some pro-caspases.  
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Figure 1.8 ATP generation and transport in mitochondria. 
Oxidative phosphorylation occurs across the inner mitochondrial membrane (IMM) via the 
electron transport chain, including cytochrome c (C), and the F1F0-ATPase (F1F0). 
Protons (H+) are pumped into the inter-membrane space (IMS) of mitochondria and flow 
back into the matrix through the the F1F0-ATPase. ATP produced in the matrix is 
exchanged for cytosolic ADP through the adenine nucleotide translocator (ANT) in the 
IMM and the voltage dependent anion channel (VDAC) in the outer mitochondrial 
membrane (OMM). 
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Many models for the mitochondrial membrane potential loss have been proposed, which 
may occur either before or after caspase activation, depending on the stimuli (Matsuyama 
and Reed, 2000; Harris and Thompson 2000). One of the popular models involves the 
opening of the high conductance membrane permeability transition (MPT) pore in the 
IMM (Kroemer, 1998), which is proposed to be a large multi-protein complex composed 
of VDAC, the ANT, creatine kinase, hexokinase, the benzodiazapine receptor and 
cyclophilin D (Zoratti and Szabo, 1995; Crompton, 1999). This multi-protein complex 
forms a large channel (2.0 ± 2.6 nm diameter) between the cytosol and the mitochondrial 
matrix, allowing passage of proteins up to 1.5 kD, in response to a number of 
mitochondrial stresses including Ca2+ (Zoratti and Szabo, 1995).  
 
Mitochondria are known to import Ca2+ from the cytosol to the electronegative matrix via 
the Ca2+ uniporter in the IMM, in response to elevations of cytosolic Ca2+. This creates 
transient depolarizations of the IMM, followed by efflux of H+ and restoration of 
mitochondrial membrane potential (Loew et al., 1994). Typically, mitochondria can 
tolerate a few to several pulses of Ca2+, but eventually their capacity to adapt to Ca2+ loads 
is overwhelmed and the mitochondria depolarize irreversibly due to a profound change in 
the inner membrane permeability representing the so-called “permeability transition” 
(Bernardi et al., 1998). This phenomenon leads to the MPT pore opening, allowing free 
passage of protons and ions across the IMM, osmotic disequilibrium and eventually 
swelling of the matrix. Since the IMM is folded into cristae that have a larger surface area 
than the surrounding OMM, matrix swelling would eventually exceed the surface area of 
the OMM and cause OMM to rupture, thereby spilling the contents of the IMS into the 
cytosol. This Ca2+-based mechanism for cell death may be particularly relevant to 
ischemia-reperfusion injury and neuroexcito-toxicity involving NMDA-family receptors, a 
family of plasma membrane Ca2+ channels that open in response to glutamate and related 
neurotransmitters and that have been implicated in cell death during stroke and several 
other neurological diseases (Matsuyama and Reed, 2000). MPT opening is also regulated 
by the intracellular redox environment, mitochondrial calpain activation and cathepsin 
proteases, which will be discussed in detail in Chapter 5.  
 
Whether depolarization is the initial event leading to apoptosis is under debate, as many 
reports suggest that mitochondrial hyperpolarization and subsequent matrix alkalinization 
are earlier events in apoptosis (Harris and Thompson, 2000), though depolarization 
eventually occurs in apoptosing cells.  
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1.8 Calpain enzymes 
Calpains are Ca2+-dependent cysteine proteinases, which form a family consisting of at 
least six distinct members (Sorimachi et al., 1989; Sorimachi et al., 1993; Sorimachi et al., 
1994). The family can be divided into two groups on the basis of distribution- ubiquitous 
and tissue specific. Within mammals, calpains 1, 2, 4, 5, 7, 10, 12 and 13 are ubiquitously 
expressed, whereas calpains 3, 6, 8, 9 and 11 have more tissue-specific distributions 
(Huang and Wang, 2001), implicating a diverse set of roles for calpain family members. 
However, the current knowledge about the enzymological and biological properties of 
calpains applies mainly to the ubiquitous isozymes, μ- and m-calpains (or calpains I and II, 
respectively). μ-Calpain is activated in the presence of μM levels of Ca2+, whereas m-
calpain requires mM levels of Ca2+ (Croall and DeMartino, 1991; Saido et al., 1994a). 
They localize mainly in cytoplasm, but are also found in mitochondria, Golgi and ER 
membranes (Arrington et al., 2006; Tavares and Duque-Magalhaes, 1991).   
 
All the ubiquitous calpain isozymes are heterodimers consisting of one large subunit and 
one small subunit (Saido et al., 1994b). It is suggested that calpain is activated via 
autolysis of the subunits in the presence of sufficient Ca2+ (Saido et al., 1992). Autolysis 
removes the amino-terminal pro-peptide portion that presumably suppresses the protease 
activity or may cause a conformational change in the molecule, leading to the enzyme 
activation (Saido et al., 1994b). However, Brown and Crawford (1993) suggested that 
autolysis might be a post-activation process. Phosphatidylserine and phosphatidylinositol 
were found to lower the Ca2+ concentration required for calpain autolysis (Coolican and 
Hathaway, 1984), leading to the hypothesis that the enzyme is activated at cell membranes 
where these phospholipids are localized (Suzuki et al., 1987). 
 
Calpains are linked to the pathogenesis of Alzheimer’s disease, cataracts, limb girdle 
muscular dystrophy, gastric carcinoma and Type II diabetes (Goll et al., 2003; Saito et al., 
1993). Unlike caspases that require specific amino acid sequences for the cleavage, 
calpains show no obvious sequence preferences (Sorimachi et al., 1997). The substrates of 
calpains are diverse such as cytoskeletal proteins (Liu and Schnellmann, 2003; Muguruma 
et al., 1995; Ringger et al., 2004; Taylor et al., 1995), receptors (Gregoriou et al., 1994), 
ion channels (Bi et al., 1996; Hell et al., 1996), proteases (Bizat et al., 2003; Blomgren et 
al., 2001; Chua et al., 2000), oncogenic proteins (Pariat et al., 1997), cell signalling 
molecules (Sato and Kawashima, 2001; Tremper-Wells and Vallano, 2005), lens proteins 
(Fukiage et al., 1997) and extracellular matrix components such as proteoglycans and 
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fibronectin (Goll et al., 2003). Calpains are also thought to participate in the induction of 
cellular necrosis in various cell types (Inserte et al., 2004; Shi et al., 2000; Wang et al., 
2004) and in the regulation of apoptosis through interactions with p53, Bid and caspase 3 
(Bizat et al., 2003; Chen et al., 2001; Pariat et al., 1997). Furthermore, calpains induce 
morphological changes in thrombocytes (Wolf et al., 1999) and neuronal cells (Yap et al., 
2006), resembling a caspase-mediated apoptotic cell death. Unfortunately, in many cases, 
the specific calpain responsible for these cellular actions and disease processes has not 
been identified. Consistent with the observation that calpain activation takes place at cell 
membranes (see above), a large portion of the substrates are proteins that are closely 
associated with membranes (Saido et al., 1994b).  
 
The nature of calpain-catalyzed proteolysis usually proceeds in a limited manner and 
results in alteration, rather than simple destruction, of the substrate proteins. For example, 
limited proteolysis, by both μ- and m-calpains, at the hinge region between the regulatory 
(inhibitory) and catalytic domains of protein kinase C produces an active fragment. The 
activity of this active fragment is independent of cofactors such as phospholipids and 
phorbolester that are normally required for activation of the intact molecule (Kishimoto et 
al., 1989). In addition, limited proteolysis of a given protein by calpains is likely to cause 
destabilization of its structural rigidity as well, making it more sensitive to attack by 
various cellular proteases.  
 
 
1.9 Research programme 
There are two major aims of this PhD project: 
1) To examine the antioxidative effect of intracellular GSH and 7,8-NP on HOCl-induced 
damage to HMDM cells; 
2) To investigate the cell death mechanisms of HMDM cells upon HOCl exposure.  
 
Chapter 3 will discuss the cytotoxic effect of HOCl on HMDM cells and the protective 
effects of intracellular GSH and 7,8-NP on HMDM cells against HOCl. The cytotoxic 
effect of HOCl on HMDM cells will be determined by examining cell viability loss, cell 
morphological changes and intracellular GSH loss in HOCl-treated HMDM cells. The 
protective effect of intracellular GSH on HMDM cells upon HOCl insult will be studied by 
examining the HOCl-induced cell viability loss in HMDM cells depleted of intracellular 
GSH and examining HOCl LD50 levels of different HMDM cell preparations against their 
Chapter 1 
_____________________________________________________________________________________________________________ 
40
GSH levels. The effect of 7,8-NP in protecting HMDM cells against HOCl will be 
investigated by examining cell viability and intracellular GSH loss in HOCl-treated 
HMDM cells in the presence of extracellular 7,8-NP, or 7,8-NP produced by HMDM cells 
upon IFN-γ stimulation.  
 
Chapter 4 will discuss the mode of cell death that HMDM cells undergo upon HOCl 
treatment and the effects of HOCl on proteins and metabolic energies in HMDM cells. 
Caspase-3 enzyme activation and cellular membrane integrity will be investigated to 
determine whether HMDM cells undergo apoptotic or necrotic cell death upon HOCl 
exposure. Effects of HOCl on tyrosine residues, intracellular ATP, GAPDH enzyme 
activity, mitochondrial membrane potential and O2
•- generation will also be examined. The 
role of MPT activation in HOCl-mediated death will be examined using the MPT inhibitor, 
cyclosporin A.  
 
Chapter 5 will discuss the role Ca2+ plays in HOCl-induced HMDM cell death. The effect 
of HOCl on cytosolic Ca2+ levels and the sources of these changes will be studied using 
fluorescent dyes and a range of Ca2+ channel blockers and a Ca2+ chelator. The effect of 
HOCl-induced cytosolic [Ca2+] rise on HMDM cell viability will also be examined. 
Calcium ions are known to cause calpain and MPT activation. Calpain activation and its 
association with cell death will be studied using calpain inhibitors in HOCl-treated HMDM 
cells. The effect of HOCl-induced cytosolic Ca2+ level increase on MPT-mediated 
mitochondrial membrane potential loss will also be examined by reducing the cytosolic 
Ca2+ level increase and by preventing cytosolic Ca2+ uptake by mitochondria.  
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2.   MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Reagents 
All reagents used were of analytical grade or better. All solutions were prepared using ion-
exchanged ultra filtered water, produced using a NANOpure ultrapure water system from 
Barnstead/Thermolyne (IA/USA). 
 
Sigma-Aldrich Chemical Co., Missouri, USA β-mercaptoethanol  
Boehringer, Mannheim, Germany 1,4-Dithiothreitol (DTT) 
Sigma-Aldrich Chemical Co., Missouri, USA 3-[(3-Cholamidopropyl)dimethylammonio]-1 
 -propanesulfonate (CHAPS) 
Sigma Chemical Co., Missouri, USA 3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyl- 
 tetrazolium bromide (MTT) 
Sigma Chemical Co., Missouri, USA 4-bromo-calcium ionophore A23187 (Br-A) 
Sigma Chemical Co., Missouri, USA 4-(2-hydroxyethyl)-1-piperazineethane- 
 sulfonic acid (HEPES) 
Aldrich Chemical Co., Wisconsin, USA 4’6-diamidino-2-phenylindole (DAPI) 
Sigma Chemical Co., Missouri, USA 4-morpholine-propanesulfonic acid (MOPS) 
Sigma Chemical Co., Missouri, USA 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) 
Sigma-Aldrich Chemical Co., Missouri, USA 7-amino-4-methyl-coumarin (AMC) 
Schircks Laboratory, Switzerland 7,8-Dihydroneopterin (7,8-NP) 
Merck Ltd, Poole, England Acetic acid 
Merck Ltd, Poole, England  Acetone 
J.T.Baker (USA) Acetonitrile 
Sigma-Aldrich Chemical Co., Missouri, USA Acetyl-Asp-Glu-Val-Asp-7-amido-4- 
 methylcoumarin (Ac-DEVD-AMC) 
Invitrogen, California, USA Acridine orange (AO) 
Sigma-Aldrich Chemical Co., Missouri, USA Adenosine diphosphate (ADP) 
Sigma-Aldrich Chemical Co., Missouri, USA Adenosine monophosphate (AMP) 
Sigma-Aldrich Chemical Co., Missouri, USA Adenosine triphosphate (ATP) 
Sigma Chemical Co., Missouri, USA Ammonium phosphate dibasic 
Fonterra Brand New Zealand, Ltd, N Anchor non fat milk powder 
Santa Cruz Biotechnology Inc., (USA) Annexin V Apoptosis Kit 
BOC Gasses; Auckland, NZ Argon gas 
Ascorbic acid Sigma Chemical Co., St. Louis, USA 
Pierce, Illinois, USA Bicinchoninic acid (BCA) protein 
determination kit  
Bovine serum albumin (BSA) Sigma Chemical Co., Missouri, USA 
Bromophenol blue Sigma Chemical Co., Missouri, USA 
Butylated hydroxytoluene (BHT) Sigma Chemical Co., Missouri, USA 
Calcium chloride (CaCl2) BDH lab supplies Ltd., Poole, England 
Calpeptin  Merck, Darmstadt, Germany 
Chelex 100 resin Bio-Rad Laboratories, California, USA 
Coumassie blue Bio-Rad Laboratories, California, USA 
Cyclosporin A (CSA) Merck, Darmstadt, Germany 
Sigma Chemical Co., Missouri, USA Dantrolene 
Diethyl ether Merck, Darmstadt, Germany 
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Diehtyl maleate Sigma Chemical Co., Missouri, USA 
Dihydroethidium (DHE) Merck, Darmstadt, Germany 
BDH lab supplies Ltd., Poole, England Dimethyl sulphoxide (DMSO) 
DL-Buthionine-[S,R]-Sulfoximine (BSO) Sigma Chemical Co., Missouri, USA 
Sigma Chemical Co., Missouri, USA DL-O-tyrosine 
Ethanol BDH lab supplies Ltd., Poole, England 
Ethylenediaminetetraacetic acid (EDTA) BDH lab supplies Ltd., Poole, England 
Ethlylene glycol-bis(2-aminoethylether)- Sigma Chemical Co., Missouri, USA 
N,N,N’,N’-tetracetic acid (EGTA)  
Sigma Chemical Co., Missouri, USA Flunarizine dihydrochloride 
Merck Darmstadt, Germany Fluo-3-acetoxymethyl (AM) ester 
Sigma Chemical Co., Missouri, USA Glyceraldehyde-3-phosphate (GAP) 
Sigma Chemical Co., Missouri, USA Glycerol 
Bio-Rad Laboratories, California, USA Glycine 
Sigma Chemical Co., Missouri, USA Glutathione (reduced form) 
Sigma Chemical Co., Missouri, USA Guanabenz acetate salt 
BDH lab supplies Ltd., Poole, England Hydrochloric acid (HCl) 
Sigma Chemical Co., Missouri, USA Idazoxan hydrochloride 
BDH lab supplies Ltd., Poole, England Iodine 
Imukin®; Boehringer Ingelheim Pty Ltd, Interferon-γ (IFN-γ) 
New South Wales, Australia  
Axis-Shield PoC AS, Oslo, Norway Lymphoprep 
Merck Darmstadt, Germany Methanol 
Fermentas International Inc, Ontario, Canada Molecular Weight Marker 
Sigma-Aldrich, Steinheim, Switzerland Monobromobimane 
Schircks Laboratory, Switzerland Neopterin 
Sigma Chemical Co., Missouri, USA Nicotinamide adenine dinucleotide (NAD+) 
Sigma Chemical Co., Missouri, USA Nicotinamide adenine dinucleotide phosphate 
(NADP+)  
Sigma Chemical Co., Missouri, USA Nifedipine 
Nitrogen gas BOC Gasses, Auckland, NZ 
Sigma Chemical Co., Missouri, USA NP-40 
BDH lab supplies Ltd., Poole, England Perchloric acid 
Phenol Sigma Chemical Co., Missouri, USA 
BDH lab supplies Ltd., Poole, England Phosphoric acid 
Ponceau S Sigma Chemical Co., Missouri, USA 
Merck Darmstadt, Germany Potassium carbonate (K2CO3) 
Merck Darmstadt, Germany Potassium chloride (KCl) 
Potassium iodide (KI) May & Barker Ltd, Dagenham, England 
Sigma Chemical Co., Missouri, USA Ruthenium red 
Merck Darmstadt, Germany SJA6017 
BDH lab supplies Ltd., Poole, England Sodium arsenate 
Sodium chloride (NaCl) BDH lab supplies Ltd., Poole, England 
Sodium dihydrogen orthophosphate Merck Darmstadt, Germany 
Sodium dodecyl sulphate (SDS) Sigma-Aldrich Chemical Co., Missouri, USA 
Sodium hydrogen carbonate (NaHCO3) Merck, Darmstadt, Germany 
Sodium hydroxide (NaOH) Merck, Darmstadt, Germany 
Sodium hypochlorite (NaOCl) Clorogene Supplies, Petone, NZ 
Chelsea Sugar Refinery, Auckland, NZ Sucrose 
Supersignal West Dura chemiluminescence Pierce Biotechnology Inc., Illinois, USA 
Merck Darmstadt, Germany Tetrabutylammonium bisulfate 
Tetramethylrhodamine methyl ester (TMRM) Merck Darmstadt, Germany 
Thimerosal Sigma Chemical Co., Missouri, USA 
Trichloroacetic acid (TCA) Sigma Chemical Co., Missouri, USA 
Trifluoroacetic acid (TFA) Sigma Chemical Co., Missouri, USA 
Tris(hydroxymethyl)aminomethane (Tris) Roche Diagnostics GmbH, Mannheim, 
Germany  
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Triton X-100 
Trypan blue solution (0.4%) 
Tween-20 
Verapamil hydrochloride 
 
Sigma Chemical Co., Missouri, USA 
Sigma Chemical Co., Missouri, USA 
Sigma Chemical Co., Missouri, USA 
Sigma Chemical Co., Missouri, USA 
 
2.1.2 Antibodies 
Goat anti-mouse IgM HRP-conjugated 
Mouse monoclonal against β-Actin 
Mouse monoclonal IgG2a caspase-3 (E-8) 
Sheep Anti-mouse IgG HRP-conjugated 
 
 
2.1.3 Media and buffer 
Earle’s balanced salt solution (EBSS) 
Heat-inactivated foetal calf serum  
Penicillin/streptomycin liquid (containing 
5000 units of penicillin and 5000μg of 
streptomycin/ml) 
Roswell Park Memorial Institute (RPMI)- 
1640 media, with phenol red 
RPMI-1640 media, without phenol red 
Santa Cruz Biotechnology Inc., USA 
Sigma-Aldrich Chemical Co., USA 
Santa Cruz Biotechnology Inc., USA 
Amersham Biosciences, England 
 
 
 
 
 
Invitrogen, California, USA 
Invitrogen, California, USA 
Invitrogen, California, USA 
 
 
Sigma-Aldrich Chemical Co., Missouri, USA 
 
Sigma-Aldrich Chemical Co., Missouri, USA 
 
 
2.1.4 General Solutions, Buffers and Media 
2.1.4.1 Phosphate Buffered Saline (PBS) 
Phosphate buffered saline (PBS; 150 mM NaCl and 10 mM sodium dihydrogen 
orthophosphate, pH 7.4) was stirred with 1 g of washed Chelex 100 resin for at least 4 
hours to remove metal ions, followed by vacuum filtration using a 0.45 µm Phenex filter 
membrane (Phenomenex). 
 
2.1.4.2 RPMI-1640 media (with or without phenol red) 
The media was prepared as per manufacturer’s instructions. Powdered RPMI-1640 (with or 
without phenol red) was dissolved in nanopure water, followed by addition of sodium 
bicarbonate and pH adjustment to 7.4 with 1 M NaOH. The media was filter-sterilised 
using a peristaltic pump (CP-600, Life Technologies) and a 0.22 µm Millex®-GP50 filter 
(Molsheim, SA). Once transferred into sterile bottles, media was stored at 4°C but warmed 
to 37°C before use.  
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2.1.4.3 7,8-Dihydroneopterin (7,8-NP) and interferon-γ (IFN-γ) solutions 
A 2 mM stock of 7,8-dihydroneopterin (7,8-NP) was prepared fresh prior to each 
experiment. It was dissolved in degassed ice cold RPMI-1640 medium or EBSS buffer 
with 0.68 mM CaCl2 during a 5-minute sonication. 7,8-NP was then filtered through a 0.20 
µm membrane filter (Sartorius AG, Goettingen, Germany), and diluted to working 
concentrations in warm HMDM culture medium or EBSS with 0.68 mM CaCl2. A 10,000 
unit/ml IFN-γ stock solution was diluted to working concentrations (0-750 unit/ml) in 
warm HMDM culture medium. 
 
2.1.4.4 Diethyl maleate (DEM) solution 
A 100 mM diethyl maleate (DEM) stock solution was prepared in DMSO, which was then 
diluted to 2 mM in RPMI-1640 medium and filtered using a 0.20 µm membrane filter. The 
2 mM stock was diluted to working concentrations (0-500 μM) in HMDM culture medium.   
 
 
2.2 Methods 
2.2.1 Cell culture 
All cell experiments and preparation were carried out under aseptic conditions in a Class II 
biological safety cabinet (Clyde-Apex BH 200). Sterile plastic wares were supplied by 
Bector Dickinson & Co., Falcon, Nunc, Terumo, Unomedical, and Greiner Bio-one. Media 
and solutions were sterilised either by autoclaving or by filtration through a sterile 0.22 µm 
membrane filter. Any equipments and tissue culture products were sprayed with 70% (v/v) 
ethanol before being transferred into the Class II biological safety cabinet.   
 
Experiments were conducted on both the THP-1 monocyte-like cell line and primary 
HMDM cells. Those cells were incubated at 37°C in a humidified incubator, with an 
atmosphere calibrated to 5% carbon dioxide: 95% air (Nuaire™ IR Autoflow).    
 
2.2.1.1 Cell culture media   
RPMI-1640 medium (with phenol red) containing 100 units/ml penicillin G and 100 µg/ml 
streptomycin was supplemented with either 10% (v/v) heat-inactivated human serum (HIHS) 
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(see section 2.2.1.2) or 5% (v/v) heat-inactivated foetal calf serum for culturing HMDMs or 
THP-1 cells, respectively. These two growth media for HMDM and THP-1 cells are 
referred to in the thesis as HMDM culture medium and THP-1 culture medium, 
respectively.  
 
2.2.1.2 Preparing Human Monocyte-Derived Macrophages (HMDMs) 
Ethics approval for the use of human blood was granted by the Canterbury Ethics 
Committee (protocol number 98/07/069). The isolation procedure for HMDMs was 
adapted from Firth (2006; PhD thesis) and carried out at room temperature. All the media 
and solutions were warmed up to room temperature prior to use, except for the HMDM 
culture medium, which was warmed up to 37°C.  
 
Unlinked blood was collected from consenting haemochromatosis patients into 600 ml 
autologous bags containing the anticoagulant citrate-phosphate-dextrose-adenine (CPDA-1) 
by the NZ Blood Bank (Riccarton Road, Christchurch). Upon arrival at the Free Radical 
Biochemistry Laboratory, the blood was centrifuged  (Multifuge 1 S-R, Heraeus) for 20 
minutes in 50 ml Falcon tubes at 3000 g, with slow deceleration. The resulting buffy coat 
was collected using a mixing cannula attached to a 10 ml syringe, transferred into new 
Falcon tubes at 15 ml per tube, and mixed well with PBS at 20 ml per tube. The mixture 
was then underlaid with 15 ml of Lymphoprep, and centrifuged at 1000 g for 20 minutes 
with the brake on.  
 
After centrifugation, a white layer of monocytes/lymphocytes appearing about half-way 
down the Falcon tube was transferred to new centrifuge tubes (50 ml/tube). Each tube was 
topped up to 45 ml with sterile PBS and centrifuged at 500 g for 15 minutes. The resulting 
cell pellet was washed in 45 ml of PBS (at 500 g for 10 minutes) 3 times. The cell pellet 
was subsequently re-suspended in serum-free RPMI-1640 media (at 5×106 cells/ml) (see 
section 2.2.5.2 for monocytic cell density determination), followed by incubation in 6-well 
Falcon suspension culture plates for approximately 40 hours. Under these conditions, any 
T cells contaminating the cell suspension are unable to survive and platelets adhere to the 
surface of the plates, while monocytes remain viable in suspension.  
 
After 40 hours, the viable monocytes were centrifuged at 500 g for 15 minutes and re-
suspended in HMDM culture medium supplemented with approximately 150 ng/ml 
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granulocyte macrophage colony-stimulating factor (GMCSF), at a concentration of 5×106 
cells/ml. The cells were then plated at 5×106 cells/well in 12-well adherent plates. GMCSF 
was a gift from the Haemotology Research lab at the Christchurch School of Medicine, 
University of Otago. 
 
The cells were also plated on coverslips using the method adapted from Amit (2008; PhD 
thesis). Coverslips (22×22mm; Marienfeld) were sterilised by immersing in 96% ethanol 
under aseptic conditions. This was followed by UV sterilisation for 15 minutes, during 
which they were left to dry. The sterilised coverslips were then placed into 6-well 
suspension culture plates (1 coverslip/well) and the cells were plated on top of the 
coverslip at 5×106 cells/coverslip. The plate was left undisturbed at room temperature for 1 
hour, allowing the cells to attach to the coverslip, before adding 1 ml of HMDM culture 
medium into each well. Both 6-well and 12-well plates were then incubated at 37°C.  
 
The HMDM culture medium was replaced every three to four days. Experiments were 
conducted once more than 70% of monocytes had matured to macrophages, which usually 
took 14 days after plating.  
 
2.2.1.3 Preparation of heat-inactivated human serum (HIHS) 
Unlinked blood from consenting haemochromatosis patients was collected into 600 ml dry 
bags by the NZ Blood Bank (Riccarton Road, Christchurch). The blood bag was incubated 
in an upright position at room temperature for 1 hour and then at 4°C overnight. This 
treatment allowed the blood to clot and the serum to separate from the blood clot. The 
serum was subsequently collected into 50 ml centrifuge tubes and centrifuged at 1500 rpm 
for 15 minutes to pellet any remaining blood cells. The resulting serum was transferred 
into new 50 ml centrifuge tubes, heat inactivated in a water bath at 56°C for 30 minutes, 
and then stored at –80 ºC.   
 
2.2.1.4 Preparation of THP-1 cell line 
The THP-1 cell line was originally obtained from a patient with acute monocytic 
leukaemia and has been confirmed to possess monocytic properties (Tsuchiya et al., 1980). 
Our THP-1 cells were obtained from the Haemotology Research lab at the Christchurch 
School of Medicine, University of Otago.  
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Two vials of 20×106 cells/mL THP-1 cells, at 1 mL per vial, were removed from the liquid 
nitrogen storage and defrosted in a 37°C water bath until only a small piece of frozen 
liquid remained in the vials. The liquid in both vials was then poured into 30 ml of THP-1 
culture medium in a 50 ml centrifuge tube, followed by centrifugation at 500 g for 5 
minutes to remove the DMSO freezing medium. The resulting cell pellet was re-suspended 
in 10 ml of THP-1 culture medium in a 25 cm2 tissue culture flask. Cell density was 
determined by Trypan blue assay (see section 2.2.5.2) and maintained at 0.3-1×106 
cells/ml by passaging in 75cm2 tissue culture flasks every 3 days.  
 
 
2.2.2 Measurement of HOCl concentration 
The concentration of sodium hypochlorite (NaOCl), stored at 4°C, was measured using the 
method described by van den Berg and Winterbourn (1994). A pH 12 buffer containing 25 
ml of 0.2 M KCl and 6 ml of 0.2 M NaOH diluted to 100 ml with nanopure water was 
prepared. The buffer was then used to dilute the stock NaOCl 500-fold, and the absorbance 
at 292 nm measured on a Shimadzu UV-1601PC UV-visible spectrophotometer (Shimadzu 
Corporation, Japan). The concentration was determined using the extinction coefficient 
(350 M-1cm-1) of HOCl at pH 12 (Gazda and Margerum, 1994).  
 
 
2.2.3 HOCl experimental setup  
NaOCl was diluted to working concentrations in Earle’s balanced salt solution (EBSS) 
containing 0.68 mM CaCl2, unless otherwise stated. At pH 7.4, the HOCl solution 
contained about equimolar concentrations of HOCl and OCl
- (pka = 7.5) (Morris, 1966); 
however we have referred to it in the thesis as HOCl for simplicity. All the media and 
solutions were warmed up to 37°C prior to experiments.  
 
HMDMs (5×106 cells/ml) were washed three times in PBS, followed by incubation with 0-
500 μM HOCl (at 1ml/well) at 37°C for 10 minutes, unless otherwise stated. After 
treatment, the HOCl medium was removed and the cells were washed twice with PBS. Any 
cells dislodged during the HOCl treatment and washing steps were collected in 1.7 ml 
microtubes (Axygen, Scientific, USA) and the solutions were centrifuged for 7 minutes at 
500 g. The resulting pellet was mixed with the corresponding adherent cells in each well. 
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The above processes were carried out before any analyses mentioned below, unless 
otherwise stated.  
 
2.2.4 Incubation of THP-1 cells with 6% ethanol 
Two millilitres of 1×106 cells/ml THP-1 cells were transferred to each well of a 12-well 
suspension culture plate. Cells were subsequently treated with or without 6% ethanol for 5 
hours before transferring the cells to 15 ml centrifuge tubes and centrifugation at 400 g for 
5 minutes at room temperature. The cell pellet was washed twice more with cold PBS at 
2600 g for 5 minutes at 4°C, followed by storage at -80°C until analysis.  
 
 
2.2.5 Cell viability assays 
2.2.5.1 MTT reduction assay 
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay provides 
an indirect measure of cell viability. Metabolically active cells can endocytose and 
metabolise the yellow MTT compound, via the action of cellular NAD(P)H 
dehydrogenases, into a purple insoluble MTT-formazan product that can be quantified 
spectrophotometrically (Mosmann, 1983). The colour intensity provides an indication of 
the concentration of cells and their metabolic activity. 
 
MTT was dissolved in RPMI-1640 medium (without phenol red), at a concentration of 5 
mg/ml. The mixture was then sterilised through a 0.2 μm membrane filter (Sartorius AG, 
Germany) and stored at –20°C in the dark. 10% (w/v) sodium dodecyl sulphate (SDS) in 
0.01 M hydrochloric acid (HCl) was stored at room temperature. 
 
After treatment (see section 2.2.3), HMDMs in each well  were incubated at 37°C with 1 
ml of RPMI-1640 without phenol red containing 0.5 mg/ml MTT for 1 hour. The insoluble 
purple crystals developed in each well were then dissolved by mixing with 1 ml of 10% 
(w/v) SDS. The absorbance was read at 570 nm, against a blank lacking cells but containing 
all other reagents.  
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2.2.5.2 Trypan Blue Exclusion Staining 
Trypan blue exclusion staining measures cell viability by analysing cell membrane 
integrity (Moldeus et al., 1978). Viable cells have intact membranes that are impermeable 
to the dye and, as a consequence, appear opaque when viewed under a microscope. Dead 
cells have compromised membrane integrity and stain a deep blue colour due to trypan 
blue uptake.  
 
Trypan blue stain (200 µl) was added directly to HMDMs in each well. After 1 minute, the 
dye in each well was replaced with 1 ml of PBS buffer. An inverted microscope was 
subsequently used to randomly examine five fields of view across each well. The 
proportion of viable cells in that well was calculated by dividing the number of viable cells 
from all five fields of view by the total number of cells (both alive and dead) from all five 
fields of view. 
 
This method is also used to count monocytes and THP-1 cells on a haemocytometer 
(Marienfeld, Germany). Monocytes and THP-1 cells were mixed with the stain at 1:10 and 
1:1 ratios, respectively. Subsequently, a light microscope was used to count the number of 
opaque (alive) cells in defined regions of a haemocytometer.  
 
 
2.2.6 Total thiol determination by the DTNB assay 
Cellular free thiol concentrations were measured using an assay described by Ando and 
Steiner (1973) and modified by Soszynski et al. (1997). 5,5'-Dithiobis-2-nitrobenzoic acid 
(DTNB or called Ellman's reagent) reacts with free thiols at 1:1 stoichiometry. The 
resulting product, 3-carboxylato-4-nitrothiophenolate (CNTP), is a coloured anion with a 
peak absorbance at 412 nm. DTNB (MW 396.3 g/mol) was dissolved in PBS to give a 
stock concentration of 3 mM, which was stored at 4°C in the dark for up to 1 month. 1% 
(w/v) SDS was made up by dissolving SDS in PBS and stored at room temperature.  
 
HMDMs in each well were solubilised by adding 1 ml of 1% (w/v) SDS to each well. The 
resulting cell lysate was transferred to 1.7 ml microtube and sonicated for 15 seconds. Cell 
lysate (50 μl) was taken for protein assay (see section 2.2.10) before adding 500 μl of cold 
3 mM DTNB solution to each sample (final concentration 1 mM). The samples were 
subsequently incubated at room temperature in a heated shaking block (Eppendorf 
Thermomixer 5436) for 30 minutes. The absorbance was then measured at 412 nm, against 
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blanks containing 1% (w/v) SDS with DTNB and also cell lysate lacking DTNB. 
Absorbance values were converted into thiol concentrations using an extinction coefficient 
of 13,600 M-1cm-1 (Boyne & Ellman, 1972). 
 
 
2.2.7 HPLC analyses 
High Performance Liquid Chromatography (HPLC) is a widely used system for separating, 
identifying and quantifying compounds. The HPLC system (Shimadzu Corporation, Japan) 
used in this research consisted of a controller (LC-20AD), a fluorescence detector (RF-
10AXL), a UV-Vis detector (SPD-M20A), an auto sampler (SIL-20AC HT), a column 
oven (CTO-20A), inline vacuum degasser (DGU-20A5), and a communication bus module 
(CBM-20A). Peak areas were quantified using the Shimadzu CLASS-VP software package.  
 
All the mobile phases used were sonicated (Alphatech Systems Ltd & Co., Auckland) for 
10 minutes prior to pumping through the HPLC system. Analytes in samples were 
standardised against particular standards with known concentrations to determine their 
concentrations. 
 
2.2.7.1 Intracellular GSH analysis  
Monobromobimane (MBB) is a cell-permeable fluorescent dye that binds thiol groups, 
specifically those of GSH. The GSH-MBB adducts can then be detected by the HPLC 
system after protein precipitation (Cotgreave and Moldeus, 1986). The procedures were 
carried out under minimum exposure of light, as MBB is light sensitive.  
 
MBB (MW 271.1) was dissolved in acetonitrile to give a 40 mM stock, which was stored 
in darkness at 4°C for up to 2 weeks. Reduced GSH (MW 307.3 g/mol), at 5 and 10 μM 
concentrations, was prepared in cold PBS immediately before HPLC analysis to serve as 
standards.  
 
For analysis, the media was removed and 400 μl of PBS, 9 μl of 0.1 M NaOH (to bring up 
the pH to 8), and 10 μl of 40 mM MBB were added to each well of HMDM cells, in this 
order. After 20 minutes of incubation in the dark at room temperature, 20 μl of 100% (w/v) 
trichloroacetic acid (TCA) was added to lyse the cells and precipitate cellular proteins. The 
cell lysate was collected and centrifuged in 1.7 ml microtubes at 900 g for 5 minutes. Five 
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µl of the resulting supernatant was injected onto the Phenosphere reverse phase C-18, 
150×4.6 mm, 5 µm column (Phenomenex, Auckland, NZ), heated to 35°C. GSH-MBB 
adducts were detected by the fluorescence detector with excitation and emission 
wavelengths set at 394 nm and 480 nm, respectively. Mobile phase A (consisting of 0.25% 
acetic acid in nanopure water) and mobile phase B (consisting of 100% acetonitrile) were 
pumped through the column at a flow rate of 1.5 ml/minute with the following gradient 
program: 
 
       Time 
(minutes) 
Mobile phase A   
(0.25% acetic acid) 
Mobile phase B   
(100% acetonitrile) 
0 90 % 10 % 
10 90 % 10 % 
11 0 % 100 % 
15 0 % 100 % 
16 95 % 5 % 
20 95 % 5 % 
 
 
 
 
 
 
 
 
2.2.7.2 Pterin analysis  
This method was adapted from Flavall (2007; master thesis) and can measure pterin level 
in the cell-conditioned medium, cell-free medium, and in cells. 7,8-dihydroneopterin (7,8-
NP) does not fluoresces, whereas neopterin (the oxidised form of 7,8-NP) can be detected 
by its native fluorescence. Total pterins (neopterin plus 7,8-NP) can therefore be detected 
by oxidising 7,8-NP to neopterin, and the initial 7,8-NP concentration can be calculated by 
subtracting neopterin level from total pterin level.  
 
The acidic iodide solution (5.4% (w/v) iodine and 10.8% (w/v) potassium iodide in 1 M HCl) 
was prepared by dissolving 5.4 g of potassium iodide and 2.7 g of solid iodine in 35 ml of 
nanopure water, followed by adding 4.37 ml of 100% HCl. The solution was then made up 
to a final volume of 50 ml. Ascorbic acid (MW 176) at a concentration of 0.6 M in 
nanopure water was made fresh on the day of analysis.  
 
HMDMs in each well were scraped off the wells and lysed in 300 µl of cold nanopure 
water and acetonitrile (1:1 ratio). One hundred µl of cell lysate was aliquoted to two sets of 
1.7 ml microtubes; one for neopterin measurement and the other one for total pterin 
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measurement. As for cell-conditioned or cell-free medium, 100 µl of the medium was 
transferred to two sets of 1.7 ml microtubes and mixed well with 100 µl of acetonitrile.  
 
The 100 µl samples prepared for neopterin measurement were vortexed thoroughly and 
centrifuged at 20,800 g for 10 minutes at 4°C. To 100 µl samples for total pterin 
measurement, 40 µl of the acidic iodide solution was added before vortexing for a few 
seconds. The reaction mixture was then incubated at room temperature for 15 minutes in 
the dark. Forty µl of 0.6 M ascorbic acid in water was subsequently added and mixed by 
vortexing briefly to oxidise the remaining iodine. The reaction mixture was then 
centrifuged at 20,800g for 10 minutes at 4°C. As a result, the reaction mixture for total 
pterin measurement contained only 40% acetonitrile, which was different from the 50% 
acetonitrile present in the neopterin standard (see below). However, the preliminary test 
showed that the elution times of neopterin peaks for the total pterin samples and the 
neopterin standard were very similar, indicating that this acetonitrile percentage 
differences did not affect the elution time of neopterin peak.  
 
Ten µl of the supernatant from both neopterin and pterin samples was injected onto a 
reverse phase Synergi Hydro-RP 80A, 250 × 4.6 mm, 4 µm column (Phenomenex, 
Auckland, NZ), maintained at 35°C. The column was developed with a mobile phase of 
95% (v/v) of 20 mM ammonium phosphate (pH 6) and 5% (v/v) methanol, pumped at a flow 
rate of 1 ml/minute. Twenty mM ammonium phosphate (MW 132.06) in nanopure water 
was adjusted to pH 6 by adding 10 M phosphoric acid. Neopterin was detected by a 
fluorescence detector using excitation and emission wavelengths set at 353 nm and 438 nm, 
respectively. A neopterin (MW 253) standard of 25 nM to 2 μM concentrations, made up 
in acetonitrile and 20 mM ammonium phosphate (pH 6) (1:1 ratio), was used to quantify 
the elution time and peak size of neopterin.  
 
2.2.7.3 Protein tyrosine residue oxidation  
Tyrosine residue oxidation serves as an indicator of protein damage by free radical 
exposure (Gieseg et al., 1993; Gieseg et al., 2003). In this research, cellular tyrosine 
residue loss upon HOCl insult was examined by measuring cellular tyrosine residue levels 
via acid hydrolysis of cellular proteins and HPLC analysis.  
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To each well of HMDMs, 1 ml of cold nanopure water, 50 µl of 100 mg/ml ethylene-
diaminetetraacetic acid (EDTA), and 50 µl of 20 mg/ml butylated hydroxytoluene (BHT) 
in methanol were added in this order. The cells were then scraped off the wells, transferred 
to 1.7 ml microtubes, and sonicated for 5 minutes. The cell lysate (200 μl) was then 
transferred to a glass durham tube with a diameter of 7.5 mm and mixed with 10 μl of 100 
mg/ml EDTA and 10 μl of 20 mg/ml BHT. The protein was then precipitated by adding 
800 μl of ice cold acetone and incubating on ice for 10 minutes before centrifugation at 
7000 g at 4ºC for 15 minutes. After removing the supernatant, the pellet was washed with 
500 μl of ice cold diethyl ether with centrifugation to remove any remaining lipids.  
 
For the acid hydrolysis of proteins, the resulting pellet was dried under vacuum for 1 hour 
and then placed into a Pico-Tag vial (Millipore, USA) containing 1 ml of 6M HCl with 1% 
(w/v) phenol and 50 μl of β-mercaptoethanol. Argon gas was flushed through the Pico-Tag 
vial for 5 minutes to remove oxygen. The vial was then evacuated by connecting to a high 
vacuum line for 2 seconds (the Vac. gauge pressure was maintained below 200mm Torr). 
Subsequently, the vial was incubated in a 110ºC oven for 16 hours, followed by gradual 
cooling down to 4ºC. Next, the sample was centrifuged under vacuum using the Speed Vac 
for 2 hours before re-solubilising the pellet with 200 μl of 0.1% trifluoroacetic anhydride 
(TFA) (pH 2.5). The sample was then centrifuged at 20,800 g for 5 minutes at 4ºC before 
transferring 100μl of the resulting supernatant to an auto sampling vial. Ten μl was injected 
onto a reverse phase Aqua C18, 250 x 4.6 mm, 5μm column (Phenomenex). The column 
was developed with mobile phase A (0.1% (v/v) TFA at pH 2.5) and mobile phase B (100% 
acetonitrile), pumped at a flow rate of 1 ml/minute using the following gradient program. 
TFA with a concentration of 0.1% (v/v) at pH 2.5 was prepared by adding 1 ml of TFA to 
800 ml of nanopure water, adjusting the pH to 2.5 with 10 M NaOH, and making up to a 
final volume of 1 L. Tyrosine was detected by a fluorescence detector using excitation and 
emission wavelengths set at 280 nm and 320 nm, respectively. A tyrosine (MW 181.2) 
standard of 1 µM concentration, made up in 0.1% (v/v) TFA (pH 2.5), was used to quantify 
the elution time and peak size of tyrosine residue.  
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 Time 
(minutes) 
Mobile phase A   
(0.1% TFA, pH 2.5) 
Mobile phase B   
(100% acetonitrile) 
0 99 % 1 % 
10 95 % 5 % 
14 90 % 10 % 
16 50 % 50 % 
21 50 % 50 % 
30 99 % 1 % 
 
 
 
 
 
 
 
 
2.2.7.4 Measurement of intracellular ATP  
The effect of HOCl on ATP in HMDMs was examined by measuring intracellular ATP 
levels upon HOCl exposure via HPLC analysis. For sufficient signal to be detected by the 
HPLC system, 3 wells of 5×106 cells/ml HMDMs were combined together by scraping 
using a total of 125 µl cold 0.07 M perchloric acid (PCA) in nanopure water. The cell 
lysate was then sonicated for 1 minute, left on ice for 30 minutes, and centrifuged at 
20,800 g for 5 minutes at 4°C to remove proteins. The supernatant was neutralised with 
12.5 µl of 2 M potassium carbonate (MW 138.21) in nanopure water (the ratio between 
0.07 M PCA and 2 M potassium carbonate was 10:1) and centrifuged as above. The 
supernatant (40 µl) was injected onto a reverse phase 5 μm ODS (C18), 250 x 4.6 mm, 5 
μm column (Phenomenex). This column was developed with mobile phase A (consisting of 
6.9 g/L of sodium phosphate (MW 137.99) and 2 g/L of tetrabutylammonium bisulfate 
(MW 339.54) in nanopure water, pH adjusted to 5.5 using 10 M NaOH) and mobile phase 
B (consisting of mobile phase A and acetonitrile at a ratio of 75:25), pumped at a flow rate 
of 1 mL/minute using the following gradient program;  
 
 Time 
(minutes) Mobile phase A (pH 5.5) Mobile phase B   
0 100 % 0 % 
5 100 % 0 % 
25 30 % 70 % 
28 30 % 70 % 
30 100 % 0 % 
50 100 % 0 % 
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ATP was quantified by reverse phase ion pair-HPLC UV/Vis detection at 254 nm (Tuckey, 
2008; PhD thesis). An ATP stock of 1 mM concentration was prepared in 50 mM 
NaH2PO4 (pH 7.2) and stored at -20°C. The stock was diluted to 25 µM in cold nanopure 
water immediately before use to serve as a standard for quantifying the elution time and 
peak size of ATP.  
 
 
2.2.8 GAPDH activity measurement  
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a glycolytic enzyme that 
catalyses the oxidative phosphorylation of glyceraldehyde-3-phosphate (GAP) to 
1,3-diphospho-glycerate (1,3-PGA). In the process, the NAD+ cofactor is reduced to 
NADH, which has a strong absorbance at 340nm. The activity of GAPDH can hence be 
monitored spectrophotometrically by measuring the rate of NADH formation using an 
assay modified from Steck and Kant (1974).  
 
Thirty mM NaH2PO4 (pH adjusted to 8 with 10 M NaOH) in nanopure water, 0.2M sodium 
arsenate (MW 312.01) in nanopure water, and 0.2% (v/v) Triton X-100 in 30 mM NaH2PO4 
(pH 8) were all stored at room temperature. A 294 mM GAP (MW 170.6) stock in 
nanopure water was stored at -80°C, which was diluted to the 15 mM working 
concentration in nanopure water. 20 mM NAD+ (MW 663.43) was made up fresh on the 
day of analysis in cold nanopure water. Both substrates were stored on ice during use.  
 
HMDM cells in each well were scraped off using cell scrapers (Greiner bio-one, Germany) 
and 1 ml of cold PBS. The resulting cell mixture was transferred to a 1.7 ml microtube and 
stored on ice. One hundred μl of cell lysate and 100 μl of 0.2% (v/v) Triton X-100 were 
mixed in a semi-micro cuvette, which was then incubated for 1 minute in the 
spectrophotometer at 37°C. To this was added 600 μl of 30 mM NaH2PO4 (pH 8) that had 
already been equilibrated to 37°C, 50 μl of 0.2 M sodium arsenate, 50 μl of 20 mM NAD+, 
and 100 μl of 15 mM GAP in this order, followed by mixing. The absorbance was recorded 
at 0.1-minute intervals over 3 minutes at 294 mM. The molar extinction coefficient of 
NADH (6220 M-1cm-1) was used to calculate the rate of NADH release in μM/minute.  
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2.2.9 SDS-PAGE and Western blot analysis 
2.2.9.1 Solutions for SDS-PAGE and Western blot analysis 
The cracker buffer was prepared by dissolving SDS (MW 288.38), glycerol (MW 92.10), 
bromophenol blue (MW 670.02) in 0.5 M tris-HCl in nanopure water (pH adjusted to 6.8 
using 11.4 M HCl) and making up to a final volume of 50 ml. Prior to use, 1 ml of the 
above solution was mixed with 20 μl of β-mercaptoethanol and 2 ul of 100 mg/ml 
ethylenediaminetetraacetic acid (EDTA). The final cracker buffer hence consisted of 0.125 
M Tris-HCl (pH 6.8), 1% (w/v) SDS, 20% (w/v) glycerol, 0.1% (w/v) bromophenol blue, 2% 
(v/v) β-mercaptoethanol, and 0.5 mM EDTA.  
 
Lysis buffer consisted of 40 mM of HEPES (MW 238.31), 50 mM of NaCl (MW 58.44), 1 
mM EDTA (MW 372.24), and 1 mM EGTA (MW 380.4) in nanopure water, with pH 
adjusted to 7.4 using 10 M NaOH and stored at 4°C. Prior to use, Complete, Mini protease 
inhibitor stock (7×) was added to lysis buffer. The 7× stock protease inhibitor solution was 
prepared as per manufacturer’s instructions. One Complete, Mini protease inhibitor 
cocktail tablet (Roche, Germany) was dissolved in 1.5 ml of nanopure water to give a 7× 
stock solution. The completed lysis buffer was stored on ice until use.  
 
MOPS (4-morpholine-propanesulfonic acid) buffer consisted of 50 mM MOPS, 50 mM tris 
base, 0.1% (w/v) SDS, and 1 mM EDTA in nanopure water, with the pH adjusted to 7.7 by 
adding concentrated HCl.  
 
Transfer buffer for Western blot analysis consisted of 25 mM tris, 192 mM glycine (MW 
75.07), and 20% (v/v) methanol in nanopure water, which was stored at 4°C until use. 
Ponceau S stain consisted of 0.01% (w/v) Ponceau S and 5% (v/v) acetic acid.  
 
The TBS washing solution consisted of 40 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.05% 
Tween-20 (w/v), and 0.01% (w/v) thimerosal (contains Hg) in nanopure water. The 5% (w/v) 
blocking solution (TBSM) was prepared by dissolving 10 g of Anchor non-fat milk powder 
in 200 ml of TBS and was stored at 4°C. 1 and 2% TBSM, were made up by diluting the 
5% TBSM with TBS.  
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2.2.9.2 Cell processing for HMDM and THP-1 cells 
One hundred and fifty µL of ice cold complete lysis buffer was used to scrape HMDMs off 
the plate or lyse THP-1 cell pellet (see section 2.2.4). The cell lysate was then transferred 
into a 1.7 ml microtube and incubated on ice to properly lyse the cells. After 30 minutes, 
the cell lysate was vortexed briefly and 5 µl was taken for protein assay (see section 
2.2.10), while the rest was stored at -80°C until use. 
 
After protein analysis, the volume of cell lysate containing 90 µg of protein was transferred 
to a new 1.7ml microtube. Ice cold acetone was then added to precipitate the proteins (the 
ratio of cell lysate to acetone was 1:10). After incubation on ice for 5 minutes, the sample 
was centrifuged at 20,800 g for 5 minutes at 4°C. The resulting protein pellet was 
dissolved in “cracker” buffer for SDS-PAGE analysis (see section 2.2.9.3).  
 
2.2.9.3 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
analysis 
Cracker buffer (90 µl) was used to dissolve the acetone-precipitated protein pellet 
described above to give a final protein concentration of 1 µg/µl. The sample was then 
heated in a heating block at 95ºC for 3 minutes and centrifuged for 5 minutes at 20,800 g at 
room temperature to remove any cell debris.  
 
A gradient polyacrylamide gel, 4-12% (Bis-Tris Gel, Invitrogen, Carslband, CA, USA), 
was placed in the XCell SureLock™ Mini-Cell system (Invitrogen, US) and the MOPS 
running buffer added to the buffer reservoir. Five µl of Fermentas pre-stained molecular 
weight marker mix (Fermentas International Inc, Canada) and 15 µL of samples 
(containing 15 µg proteins) were loaded into the wells of the gel, before electrophoresis at 
200 V for approximately 1 hour until the loading buffer dye reached the bottom of the gel.  
 
2.2.9.4 Western blot analysis 
After SDS-PAGE, the separated proteins on the SDS-PAGE gel were electrophoretically 
transferred onto a nitrocellulose membrane with 0.45 µm pore size (Invitrogen, USA) 
using a HoeferTM TE22 tank transfer unit (USA) filled with cold transfer buffer, with 
voltage set at 70 V using the PowerPac 300 power supply (BioRad). After approximately 
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15 hours, the nitrocellulose membrane was stained with Ponceau S stain for 1 minute to 
ensure that the transfer was successful.  
 
The following membrane washing and incubation took place on a rocking platform mixer 
(Ratex Instruments, Australia). After briefly rinsing with water, the membrane was blocked 
using 5% TBSM for 2 hours, followed by three consecutive 5-minute washes in TBS. The 
membrane was then probed with the primary mouse monoclonal IgG2a antibodies against 
caspase-3 (E-8) (Santa Cruz Biotechnology Inc, USA) in 1:1000 dilution using 1% TBSM. 
After 1.5 hours, the membrane was washed 5 times in TBS 5 minutes each, followed by 1 
hour incubation in the secondary antibody goat anti-mouse IgM-HRP (Santa Cruz 
Biotechnology Inc, USA) diluted to 1:1000 with 1% TBSM. The membrane was then 
washed as above, followed by brief washing in nanopure water twice to remove any 
residual TBS. TBS contains Tween-20, which inhibits the peroxidase from reacting with 
the chemiluminescence substrates, and hence interferes with visualisation (see section 
2.2.9.5). The membrane was then left in nanopure water and taken for visualisation 
immediately.  
 
2.2.9.5 Visualisation 
Detection of the secondary HRP-coupled antibody was conducted using “Supersignal West 
Dura chemiluminescence” substrates (Pierce, USA), which consist of the luminol solution 
and the peroxide solution. These two solutions were mixed at 1:1 ratio to give the working 
solution immediately before use. When applied to the membrane, the luminol in the 
working solution reacts with the horseradish peroxidase (HRP) on the secondary antibody 
on the membrane and hydrogen peroxide in the working solution to generate 3-
aminophthalate plus the emission of light at 425 nm.  
 
The working solution (0.5 ml) was evenly applied to the membrane and the image was 
recorded for 12 minutes on a Syngene Chemigenius-2 bioimaging system using Genesnap 
software (Global, NZ). The membrane was then stored in TBS at 4ºC for β-actin detection 
(see section 2.2.9.6). 
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2.2.9.6 β-actin detection 
The membrane (see section 2.2.9.5) was re-probed for β-actin as an internal control to 
confirm equal loading of proteins. The membrane was incubated for 1.5 hours with the 
primary mouse monoclonal antibodies against β-actin (Sigma-Aldrich Chemical Co., USA) 
diluted to 1:10000 in 1% TBSM. The procedures and visualisation were the same as those 
mentioned in sections 2.2.9.4 and 2.2.9.5. The two exceptions were that the secondary 
antibody used was peroxidase-conjugated sheep anti-mouse IgG (Amersham Biosciences, 
England) diluted to 1:10000 in 1% TBSM, and the exposure time for visualisation was 2 
minutes.  
 
 
2.2.10 Determination of protein concentration  
Protein concentration was determined using the bicinchoninic acid (BCA) protein 
determination kit from Pierce (supplied by Global Scientific). The working reagent was 
prepared by mixing Reagent A (sodium carbonate, sodium bicarbonate, BCA and sodium 
tartrate in 0.1 M sodium hydroxide) and Reagent B (4% CuSO4.5H2O) at a 50:1 ratio 
immediately before use.   
 
Fifty µl of sample and/or 0-250 µg/ml bovine serum albumin (BSA) were mixed with 1 ml 
of working reagent and incubated at 60°C for 30 minutes with gentle shaking in a heated 
shaking block before measuring the absorbance at 562 nm against water blank. Protein 
concentration was determined using the BSA standard curve.  
 
 
2.2.11 Measurement of cellular caspase-3 activity 
2.2.11.1 Solutions required for caspase-3 activity measurement  
Caspase-3 binds to the synthetic substrate, acetyl-Asp-Glu-Val-Asp-7-Amido-4-
methylcoumarin (Ac-DEVD-AMC), and enzymatically cleaves the substrate to release the 
fluorescent AMC, which can be detected by the fluorometer. 
 
A buffer consisting of 100 mM of HEPES, 10% (w/v) sucrose, 0.1% (w/v) CHAPS, and 10-4 
% (w/v) NP-40 was prepared in nanopure water, with the pH adjusted to 7.25 with 10 M 
NaOH and stored at -20°C.  
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Ac-DEVD-AMC (50 mM) in 100% DMSO was stored at -20°C. Dithiothreitol (DTT) (1 
M) was prepared in nanopure water and kept on ice in the dark for no more than 24 hours. 
AMC (0-1000 nM) was prepared in dimethyl sulphoxide (DMSO) as standards. Working 
solution was made up of 1 ml of buffer, 5 μl of 1 M DTT, and 1 μl of 50 mM Ac-DEVD-
AMC. It was kept at room temperature in the dark and only the required volume was 
prepared.   
 
2.2.11.2 Measurement of caspase-3 activity in THP-1 cells  
THP-1 cell pellet (see section 2.2.4) was mixed well with 200 μl of working solution and 
immediately measured for the rate of AMC release using the fluorescence 
spectrophotometer (Cary Eclipse), with the excitation and emission wavelengths set at 370 
and 440 nm, respectively. The kinetics were measured at 0.1-minute intervals for 2 minutes 
using the Kinetics software (Cary Eclipse). The rate of AMC release was expressed as 
pmol/min by comparing the fluorescence (unit/min) to the standard curve. The 
fluorescence unit of the standard curve was monitored using the Advanced Reads software 
(Cary Eclipse). The cell lysate was then used for protein determination.  
 
2.2.11.3 Measurement of caspase-3 activity in HMDM cells 
HMDMs were scraped off each well using 70 μl of ice cold lysis buffer without the 
protease inhibitors (see section 2.2.9.1), transferred to a 1.7 ml microtube, and left on ice 
for 30 minutes to lyse cells. Five μl of the resulting cell lysate was taken for protein assay, 
while 60 μl of the cell lysate was mixed well with 200 μl working solution. The rate of 
AMC release was immediately measured as described in section 2.2.11.2.  
 
 
2.2.12 Fluorescence microscopy   
Cytosolic calcium ion (Ca2+) level, intracellular superoxide production, mitochondrial 
membrane potential and lysosomal stability in HMDMs were monitored by probing the 
cells with particular fluorescent dyes followed by examination by fluorescence microscopy.  
 
HMDMs on coverslips (see section 2.2.1.2) were incubated with fluorescence dyes either 
before or after HOCl treatment depending on the type of fluorescence dye used, but always 
at 37ºC in the dark. The cells were then washed twice with warm PBS, placed onto a 
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microscope slide (25.4×76.2 mm, 1mm-1.2mm thick, Sail brand) containing about 50 μl of 
EBSS with 0.68 mM CaCl2 with cells facing down.  
 
The cells were viewed using a Zeiss AxioImager.M1 epifluorescent microscope (Carl Zeiss 
(NZ) Ltd, Auckland, New Zealand), equipped with a Differential Interference Contrast 
(DIC) condenser and fitted with an HBO 100 W mercury vapour lamp. Cells were viewed 
using 40× Plan-NEOFLUAR objective. Different fluorescent filters were used depending 
on the fluorescent dyes employed. The images were captured using a Zeiss AxioCam HRc 
CCD camera with AxioVision Rel. 4.5 software (1300 × 1030 pixel resolution) and 
processed with Adobe Photoshop 8.0. To ensure accuracy within experimental treatments 
and to avoid fluorescent dye quenching, the time for sample irradiation and image capture 
was kept constant. The concentration and volume applied, incubation period, excitation 
and emission wavelengths, and fluorescent filters used for each fluorescent dye are 
described in sections 2.2.12.1 to 2.2.12.5.  
 
The resulting fluorescence intensities for the detection of mitochondrial membrane 
potential and cytosolic calcium were converted to numerical values using the online 
software Image J. The fluorescence intensities of 20 cells per treatment were converted and 
averaged using Microsoft Excel software.  
 
2.2.12.1 Dihydroethidium (DHE)  
Dihydroethidium (DHE) has been widely used for detecting intracellular superoxide anions. 
This cell permeable dye reacts with superoxide resulting in the formation of a two-electron 
oxidised product, ethidium (E+), which binds to DNA and leads to enhancement of red 
fluorescence (λex/λem = 510/605 nm) (Budd et al., 1997; Zhao et al., 2003). DHE (MW 
315.4) stock was prepared in DMSO and stored at -20ºC.  
 
After HOCl treatment and PBS washing, HMDMs were incubated with 200 μl of 10 μM 
DHE in EBSS with 0.68 mM CaCl2 for 20 minutes. The fluorescent filter used for DHE 
was Zeiss filter set 00 (excitation: band path 530-585; beam-splitter: FT600; emission: 
LP615).   
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2.2.12.2 Acridine orange (AO)  
Acridine orange (AO) can accumulate in acidic compartments, such as lysosomes. Upon 
excitation by blue light (λex 487 nm), the highly concentrated AO in lysosomes emits a red 
fluorescence, whereas less concentrated AO in cytosol emits a green fluorescence. It hence 
can be used to monitor lysosomal stability (Yap et al., 2006). AO (MW 301.8) stock in 
nanopure water was stored at 4ºC.  
 
After HOCl treatment and PBS washing, HMDMs on coverslips were incubated with 250 
μl of 10 μg/ml AO in EBSS with 0.68 mM CaCl2 for 20 minutes. The fluorescence filter 
used for AO was the Chroma multiband filter set 82000, using the single band blue exciter 
for FITC.  
 
2.2.12.3 Fluo-3-acetoxymethyl (AM) ester 
Fluo-3-acetoxymethyl (AM) ester is used to detect cytosolic free calcium and it is cell 
permeable due to its AM ester structure. After entering the cells, it is cleaved by 
intracellular esterases to form Fluo-3 and AM. Upon excitation by blue light (λex 488 nm), 
Fluo-3 emits a green fluorescence (λem 530 nm) when bound to free calcium ions in the 
cytosol (Minta et al., 1989; Kao et al., 1989). Fluo-3-AM ester (MW 1129.9) stock was 
prepared in DMSO and stored at -20ºC.  
 
HMDMs on coverslips were pre-incubated with 200 μl of 10 μM fluo-3-AM in EBSS with 
0.68 mM CaCl2 for 40 minutes, followed by PBS washing and HOCl treatment. The 
fluorescence filter used for fluo-3 was the Zeiss filter 38HE (FITC).  
 
2.2.12.4  Tetramethylrhodamine methyl ester (TMRM) 
Tetramethylrhodamine methyl ester (TMRM) is used to monitor mitochondrial membrane 
potential. It is a lipophilic cation, which accumulates in mitochondria in proportion to the 
mitochondrial membrane potential. The cationic nature of TMRM will cause intense 
fluorescence at more negative membrane potentials, losing its fluorescence as the 
membrane potential becomes more positive (Russell et al., 1999). TMRM (MW 500.9) 
stock in methanol was stored at -20ºC.  
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HMDMs on coverslips were pre-incubated with 300 μl of 100 nM TMRM in EBSS with 
0.68 mM CaCl2 for 30 minutes, followed by PBS washing and HOCl treatment. The 
fluorescence was immediately observed (λex/λem = 548/574 nm) using the Chroma 
multiband filter set 82000, with the single band green exciter for TRITC/Cy3. 
 
2.2.12.5 Propidium iodide (PI)  
The use of propidium iodide (PI) allows detection of necrotic cells. The cell membrane 
integrity excludes PI in viable and apoptotic cells, whereas necrotic cells are permeable to 
PI. The cells were processed following manufacturer’s instructions (BD Biosciences 
Clontech, USA) and under minimal exposure of light. HMDM cells on coverslips, after 
HOCl treatment, were washed twice in warm RPMI-1640 media and left in 0.5 ml of 
binding buffer (10 mM HEPES adjusted to pH 7.4 with NaOH, 140 mM NaCl and 2.5 mM 
CaCl2) for 1 minute. Next, the cells were incubated with 200 µl of binding buffer 
containing 4 µg/ml PI at room temperature in the dark for 30 minutes. The cells were then 
washed twice in binding buffer, followed by placing the coverslip, with cells facing down, 
on a microscope slide containing 50 µl of binding buffer. The fluorescent filter used for PI 
was a Zeiss filter set 00.  
 
 
2.2.13 Statistical analysis   
Data was graphed and statistically analysed using the Prism software program (version 4.0; 
GraphPad Software, USA). Significance was confirmed by a one-way analysis of variance 
(ANOVA), followed by Tukey’s multiple comparison test to provide a more quantitative 
indication of significance between treatments and/or time points. Where appropriate, linear 
regression and correlation analyses were also applied with r2 values calculated assuming a 
Gaussian distribution. Significance levels are indicated in the following manner: * p < 0.05; 
** p < 0.01; *** p< 0.001.  
 
Results displayed in this thesis are taken from one experiment, which is representative of at 
least three separate experiments. The means and standard errors of the mean (SEM) shown 
within each experiment were calculated from triplicate samples.……….……………….
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3. HOCL-INDUCED HMDM CELL DEATH 
AND DEFENSE MECHANISMS BY GSH 
AND 7,8-NP 
 
3.1 Introduction 
Hypochlorous acid (HOCl) is a powerful oxidant generated by neutrophils, monocytes, and 
certain types of macrophages at sites of chronic inflammation via the myeloperoxidase 
(MPO) enzyme-catalysed oxidation of Cl- ions by H2O2. Previous studies have shown that 
20-400 μM HOCl can be generated through the MPO/H2O2/Cl- system per hour (Weiss et 
al., 1982; Foote et al., 1983).  
 
HOCl plays a central role in the killing of microorganisms at sites of inflammation 
(Albrich et al., 1981; Barrette et al., 1987; McKenna and Davies, 1988; Albrich and Hurst, 
1982). However, its high reactivity with a range of biomolecules (Pullar et al., 2000) 
suggests that it can also cause injury to the surrounding tissues. Exposing a variety of cell 
types to HOCl results in cell death either by necrosis (Vissers et al., 1994; Vissers et al., 
1998; Hawkins et al., 2001; Tatsumi and Fliss, 1994; Abernathy and Pacht, 1995; Vile et 
al., 2000; Slivka et al., 1980; Schraufstatter et al., 1990) or apoptosis (Vissers et al., 1999; 
Wagner et al., 2000; Yap et al., 2006; Salunga et al., 2007; Whiteman et al., 2007; 
Whiteman et al., 2005b). HOCl can induce cytotoxicity either by reacting with cell 
membrane components (Schraufstatter et al., 1990; Barrette et al., 1989; Albrich et al., 
1986), or by passing through cell membranes to react with intracellular components (Carr 
and Winterbourn, 1997; Vissers and Winterbourn, 1995; Pullar et al., 1999).  
 
The necrotic core of advanced atherosclerotic plaques is rich in cell debris of macrophages 
(Ball et al., 1995; Berberian et al., 1990; Stary et al., 1995). These findings imply that 
macrophages within plaques undergo cell lysis, contributing to advanced plaque formation. 
HOCl may be responsible for the killing of macrophages during the progression of plaque 
formation, since macrophages, MPO enzyme and 3-chlorotyrosine (a biomarker of HOCl) 
were found colocalizing in advanced lesions (Daugherty et al., 1994; Malle et al., 2000; 
Sugiyama et al., 2001). The abundance of macrophage cells and the absence of neutrophils 
in the lesions (Sugiyama et al., 2001) indicate that macrophages may be the primary cells 
producing HOCl in the lesions, and may be under threat of HOCl insult. Moreover, the 
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same study documents increased numbers of MPO-expressing macrophages in eroded or 
ruptured plaques, causing acute coronary syndromes. Human macrophages are therefore 
chosen in this thesis to study the cytotoxic effect of HOCl to better understand the roles 
HOCl and macrophages play in the progression of atherosclerotic disease.   
 
For macrophages to function properly at inflammation sites, including in atherosclerotic 
lesions, they need to possess antioxidative mechanisms defending themselves against 
HOCl insult. Glutathione (GSH) is the major intracellular antioxidant and its deficiency 
has been implicated in a number of diseases; possibly due to the increased susceptibility of 
cells/tissues to oxidative stress (Ballatori et al., 2009). Moreover, GSH is significantly lost 
in red cells (Vissers and Winterbourn, 1995) and neutrophils (Carr and Winterbourn, 1997) 
before cell lysis occurs, indicative of its role in defending cells against HOCl.    
 
Winterbourn and Brennan (1997) have proposed a reaction scheme of GSH with HOCl 
(Figure 3.1). GSH reacts with OCl- (reaction 1) to produce sulphenyl chloride (GSCl), 
which will readily react with more GSH (reaction 2) to form disulfides (GSSG). Reaction 3 
will occur by HOCl competing for GSCl to produce sulphonyl chloride (GSO2Cl). GSO2Cl 
can react with more GSH to give thiolsulphonate (GSO2SG) (reaction 4), which is more 
favourable at high GSH concentrations. GSO2Cl can also undergo an internal HCl 
elimination to give the putative sulphonamide (reaction 5). Amines (RNH2) can also 
compete for GSCl (reaction 6) giving chloramines (RNHCl), which then oxidize GSH to 
generate GSSG (reaction 7). As the products of reaction 7 react rapidly with each other, the 
chloramine is likely to be formed only as a transient species. 
 
Human macrophages can synthesize and release neopterin and its reduced form, 7,8-
dihydroneopterin (7,8-NP), upon induction by interferon-γ (IFN-γ) (Wachter et al., 1989; 
Wachter et al., 1992). 7,8-NP may be produced and play a role within the lesions, since 
IFN-γ (both mRNA and protein) has been detected in atherosclerotic lesions of humans and 
mice (Hansson et al., 1989a; Libby, 1995; Zhou et al., 1998). In addition, the neopterin 
levels are found to be significantly elevated in patients with vascular disease (Schumacher 
et al., 1992; Tatzber et al., 1991; Rudzite et al., 2005). 
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Figure 3.1 Proposed reaction of GSH with HOCl. 
This reaction scheme is adapted and modified from Winterbourn and Brennan, 1997.   
 
 
The purpose of γ-IFN-stimulated 7,8-NP production by macrophages is not yet fully 
understood. It has been found to act as either a pro-oxidant or antioxidant depending on its 
concentration (see also sections 3.3 and 1.6.2). Gieseg et al. (2007) have hypothesized that 
7,8-NP is synthesised by γ-interferon-stimulated macrophages to protect cells against the 
oxidants encountered within an inflammatory site such as atherosclerotic lesion. This 
laboratory has previously shown that low μM concentrations of 7,8-NP is a very potent 
antioxidant. It protects erythrocytes from lysis induced by peroxyl radicals, hydrogen 
peroxide and HOCl (Gieseg et al., 2001b). Moreover, 7,8-NP has been demonstrated to 
protect free proteins, cellular proteins and protein thiols from oxidant damage (Duggan et 
al., 2001; Duggan et al., 2002). 7,8-NP was also shown to dramatically increase the lag 
time of LDL oxidation mediated by copper and peroxyl radical (Gieseg et al., 1995). In 
addition, 7,8-NP prevented cell-mediated LDL oxidation (Firth, 2006, PhD thesis; Gieseg 
& Cato, 2003) and effectively protected U937 cells from oxLDL-induced death at μM 
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concentrations (Baird et al., 2005). In contrast, neopterin and high concentrations of 7,8-
NP could result in ROS generation, disrupt the oxidant/antioxidant balance and ultimately 
lead to cell death (Weiss et al., 1993; Murr et al., 1994; Baier-Bitterlich et al., 1995; Baier-
Bitterlich et al., 1996a; Spottl et al., 2000; Enzinger et al., 2002a and b; Hoffmann et al., 
2003). 7,8-NP was also found to upregulate the production of IFN-γ, thereby establishing 
an autocrine feed-back loop (Baier-Bitterlich et al., 1996b). 
 
This first part of the chapter examines the cytotoxicity of HOCl on HMDM cells by 
examining the HOCl-mediated cell viability loss and morphological changes. The second 
part of the chapter studies the efficiency of intracellular GSH in protecting HMDM cells 
against HOCl insult. This is carried out by examining the degree of HOCl-induced cell 
viability loss in HMDM cells with intact or depleted intracellular GSH. The correlation 
between initial intracellular GSH level and the HOCl concentration required to kill 50% of 
a cell population will also be examined. The third part of the chapter studies the efficiency 
of 7,8-NP in preventing HOCl-mediated cytotoxicity to HMDM cells. This is carried out 
by examining the effect of extracellular and IFN-γ-induced 7,8-NP in preventing HOCl-
mediated intracellular GSH and cell viability losses.  
 
 
3.2 Results 
3.2.1 Effect of HOCl on HMDM cell viability    
The cytotoxicity of HOCl on HMDM cells was examined by exposing HMDM cells to 
HOCl for 10 minutes, followed by incubation in the RPMI-1640 medium containing 10% 
HIHS (referred to as HMDM culture medium in this thesis for simplicity) for 20 hours. 
The cell viability was measured by the MTT reduction assay (Figure 3.2a). No statistically 
significant cell viability loss was observed at 50 μM HOCl. In contrast, 100, 150, 200, and 
300 μM HOCl reduced cell viability by approximately 10, 40, 55 and 81% of the control, 
respectively. The degree of cell viability loss measured by the trypan blue exclusion assay 
was similar to that measured by MTT assay (r2 = 0.9760) (Figure 3.2b).  
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Figure 3.2 HMDM cell viability loss occurred after HOCl treatment.  
HMDM cells (5×106 cells/ml) were treated with increasing HOCl concentrations for 10 
minutes, followed by incubation in HMDM culture medium for 20 hours. The cells were 
subsequently analysed for cell viability using a) the MTT reduction assay and b) the trypan 
blue exclusion assay. The data are expressed as a percentage of the respective control 
values with no HOCl added. Significance is indicated from control with 0 μM HOCl. 
Results are displayed as mean ± SEM of triplicates from a single experiment, 
representative of three separate experiments.  
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To examine how fast HOCl exerted its cytotoxic effect on HMDM cells, the cells were 
incubated with increasing concentrations of HOCl for 10, 30, or 60 minutes and cell 
viability was determined after 20 hours (Figure 3.3). An HOCl concentration of 50 μM did 
not induce significant cell viability loss regardless of the length of the incubation. HMDM 
cells treated with 100, 150, 200, and 500 μM HOCl for 10 minutes showed cell viability 
loss of approximately 50, 70, 80, and 75% of the control, respectively. HMDM cells 
treated with the respective HOCl concentrations for 30 or 60 minutes showed similar 
degrees of cell viability loss. This suggests that the cytotoxic effect of HOCl on HMDM 
cells was rapid and completed within 10 minutes. Hence, HMDM cells were treated with 
HOCl for 10 minutes for all the future experiments.   
 
A time course of HOCl-induced HMDM cell viability loss was examined by measuring 
cell viability at time intervals up to 24 hours in HMDM cells initially treated with HOCl 
for 10 minutes (Figure 3.4). Initially (0 hr post HOCl treatment), HMDM cells treated 
with 100, 150, and 200 μM HOCl showed viability loss of approximately 35%, 50%, and 
75% of the control, respectively. No further significant cell viability loss were observed 
over time at 100 and 200 μM HOCl. At 150 μM HOCl, HMDM cells showed further 
decrease in viability at 6 hr and 12 hr by approximately 13% and 22%, respectively 
(compared to the respective 0 hr cell viability loss). However, the cell viability loss 
observed at 24 hr was similar to that at 0 hr. These results showed that HOCl caused rapid 
HMDM cell death and had no latent effect on the cells if they were not killed in the initial 
treatment. 
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Figure 3.3 HMDM cell viability loss occurs after 10-minute exposure to HOCl.  
HMDM cells (5×106 cells/ml) were treated with varying HOCl concentrations for 10 
minutes ( △ ), 30 minutes ( ? ), or 60 minutes ( ? ), followed by incubation in HMDM 
culture medium for 20 hours. The cells were subsequently analysed for cell viability using 
the MTT reduction assay, with data expressed as a percentage of the respective controls 
with no HOCl added. Each data point was subtracted from blank controls. Significance is 
indicated from the respective controls with 0 μM HOCl.  
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Figure 3.4 Time course of HMDM cell viability loss after HOCl treatment. 
HMDM cells (5×106 cells/ml) were incubated with 100 ( ? ), 150 ( ? ) and 200 μM (△) 
HOCl for 10 minutes, followed by incubation in HMDM culture medium. Cell viability 
was determined at time intervals using the MTT reduction assay. Each data point is 
expressed as a percentage of the respective controls with 0 μM HOCl. Significance is 
indicated from the respective 0-hour values. 
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3.2.2 Effect of HOCl on HMDM cell morphology   
Morphological changes of HMDM cells after HOCl treatment were also examined (Figure 
3.5). The control cells showed a poached egg-like appearance, which is the classic 
morphology of macrophage cells. HMDM cells treated with 50 μM HOCl did not show 
significant morphological changes, while HMDM cells treated with 100 μM HOCl 
appeared rounder, more disk-like, and marginally enlarged compared to the control cells. 
HOCl at concentrations of 150 and 200 μM caused the cells to enlarge with bleb formation, 
which was detectable straight after the HOCl treatment and did not disappear 1 hour after 
treatment. The cellular membranes looked distorted and disrupted, and cell debris was 
detected. A number of cells were also found detached and floating in the medium. These 
morphological changes appeared to be characteristics of necrotic cell death.  
 
 
3.2.3 Effect of HOCl on intracellular GSH    
Intracellular GSH is a very potent antioxidant and can efficiently scavenge a range of 
oxidants and radicals including HOCl (Halliwell and Gutteridge, 2007). Hence, the 
antioxidative effect of intracellular GSH in scavenging HOCl and protecting HMDM cells 
from HOCl insult was examined. HMDM cells were treated with HOCl, followed by 
incubation in HMDM culture media for 3 hours (Figure 3.6). At 50 μM HOCl, HMDM 
cells showed a 15% decline in intracellular GSH level compared to the control (34.6 ± 0.4 
nmol/mg protein), though this decrease was statistically insignificant (p > 0.05). At 100, 
150, 200 and 300 μM HOCl, HMDM cells showed dramatic loss of 60, 70, 72 and 100% 
intracellular GSH compared to the control, respectively.  
 
Cell viability was also measured concurrently with the intracellular GSH (Figure 3.6). At 
50 and 100 μM HOCl, there were approximately 8% and 15% loss of cell viability, 
respectively. However, these decreases were statistically insignificant compared to the 
control. At 150, 200 and 500 μM HOCl, the cell viability decreased by approximately 50, 
60 and 84% of the control, respectively. Taken together, there was significant intracellular 
GSH loss (i.e. at 100 μM HOCl) before significant cell viability loss occurred (i.e. at 150 
μM HOCl).  
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Figure 3.5 Morphological changes of HMDMs after HOCl treatment.  
HMDM cells (5×106 cells/ml) grown on coverslips were treated with a) 0, b) 50, c) 100, d) 
150 and e) 200 μM HOCl for 10 minutes, followed by incubation in HMDM culture 
medium for 1 hour. The cells were subsequently viewed in situ on microscope slides using 
an inverted microscope (40× magnification). Differential interference contrast (DIC) 
photos were taken using a digital camera. Cells with distorted cellular membranes are 
marked with white arrows.  
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Figure 3.6 Intracellular GSH loss occurred before cell viability loss in HMDM cells 
upon HOCl treatment.  
HMDM cells (5×106 cells/ml) were treated with increasing HOCl concentrations for 10 
minutes, followed by incubation in HMDM culture medium for 3 hours. The cells were 
then analysed for cell viability ( ? ) and intracellular GSH level ( ? ) using the MTT 
reduction assay and HPLC analysis, respectively. Cell viability is presented as a percentage 
of the respective controls with no HOCl. Significance is indicated from the respective 
controls with 0 μM HOCl.  
 
 
3.2.4 Effect of intracellular GSH in protecting HMDM cells against 
HOCl damage   
The observation that intracellular GSH level declined significantly before significant cell 
viability loss occurred (Figure 3.6) implied that intracellular GSH might have played an 
important role in protecting HMDM cells from HOCl cytotoxicity. This hypothesis was 
investigated by depleting HMDM cells of intracellular GSH prior to HOCl treatment, 
followed by cell viability measurement. Diethyl maleate (DEM) has been commonly used 
as an intracellular GSH depleting agent, which binds to GSH either directly or via S-
transferase (Mitchell et al., 1983; Bizzozero et al., 2006; Yamamoto et al., 2005; Chen et 
al., 2005; Yang et al., 2004).  
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Prior to this study, a suitable concentration of DEM and the optimal time period for DEM 
incubation needed to be determined. HMDM cells incubated with increasing 
concentrations of DEM for 4 hours showed a concentration-dependent decrease in 
intracellular GSH level (Figure 3.7). The control cells had an intracellular GSH level of 
28.8 ± 1.2 nmol/mg protein. At 50 and 100 μM DEM, the intracellular GSH levels were 
reduced to 8.2 ± 1.6 (70% decrease) and 2.5 ± 0.4 nmol/mg protein (90% decrease), 
respectively. There was no statistically significant decrease in cell viability with increasing 
DEM concentrations (Figure 3.7). 
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Figure 3.7 Diethyl maleate (DEM) blocked intracellular GSH without affecting 
HMDM cell viability. 
HMDMs (5×106 cells/ml) were incubated with increasing concentrations of DEM at 37°C 
in the dark for 4 hours. The cells were subsequently analysed for cell viability (gray bars) 
and intracellular GSH (white bars) using the MTT reduction assay and HPLC analysis, 
respectively. Cell viability and GSH level are presented as percentage of the respective 
controls with no DEM added. Significance is indicated from the respective controls with 0 
μM DEM.  
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To confirm that DEM did not react with cellular protein thiols, concurrent measurement of 
intracellular GSH and cellular protein thiols were carried out in HMDM cells treated with 
DEM for 4 hours (Figure 3.8). The protein thiol and intracellular GSH levels of the control 
were 703.7 ± 19.7 and 98.3 ± 3.2 nmol/mg protein, respectively. At 100, 200, and 300 μM 
DEM, the intracellular GSH levels were reduced to 19.5 ± 1.7 (80% decrease), 7.1 ± 1.7 
(93% decrease), and 2.7 ± 0.1 nmol/mg protein (97% decrease), respectively. In contrast, 
there were no statistically significant decreases in protein thiol levels with the increasing 
DEM concentrations. DEM at a concentration of 100 μM was chosen for further 
experiments, as this concentration caused about 80-90% depletion of GSH in HMDM cells 
(Figures 3.7 and 3.8).  
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Figure 3.8 Diethyl maleate (DEM) did not remove protein thiols.  
HMDM cells (5×106 cells/ml) were incubated with increasing concentrations of DEM at 
37°C in the dark for 4 hours. Protein thiol levels (gray bars) and intracellular GSH levels 
(white bars) were then determined using the DTNB assay and HPLC analysis, respectively. 
Protein thiol and GSH levels are presented as percentage of the respective controls with 0 
μM DEM. Significance is indicated from the respective controls.  
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The shortest incubation time period with DEM for maximal GSH depletion in HMDM 
cells was determined. HMDM cells incubated with 100 μM DEM were analysed for 
intracellular GSH at time intervals of up to 4 hours (Figure 3.9). The control HMDM cells 
showed an intracellular GSH level of 33.5 ± 2.8 nmol/mg protein. There was no observable 
decline in intracellular GSH level straight after DEM addition (i.e. 0 hr post DEM 
incubation) compared to the control. After 1, 2, 3 and 4 hours of incubation with DEM, 
HMDM cells showed decreased intracellular GSH levels by approximately 30, 38, 60 and 
70% of the control, respectively. The decrease in intracellular GSH level was statistically 
significant (p < 0.05) between 2 and 3 hours, while statistically insignificant between 3 and 
4 hours (p > 0.05). Based on this data, HMDM cells were incubated with 100 μM DEM for 
3 hours for the future related experiments.  
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Figure 3.9 Time course of GSH depletion in HMDMs incubated with DEM.  
HMDM cells (5×106 cells/ml) were incubated with or without 100 μM DEM at 37°C in the 
dark, followed by measuring intracellular GSH levels at time intervals by HPLC analysis. 
GSH levels are presented as percentage of the non-DEM-treated control. Significance is 
indicated from the same control.   
 
 
To study the effect of intracellular GSH in protecting HMDM cells against HOCl 
cytotoxicity, HMDM cells were pre-incubated with 100 μM DEM for 3 hours prior to 
HOCl treatment and cell viability measurement (Figure 3.10). HMDM cells with intact 
intracellular GSH (i.e. without DEM treatment) showed approximately 20% (p < 0.05), 
38% (p < 0.001) and 70% (p < 0.001) decreases in cell viability compared to the control 
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after treatment with 100, 150 and 200 μM HOCl, respectively. In contrast, HMDM cells 
depleted of approximately 90% of intracellular GSH showed a 20% decrease in cell 
viability after treatment with 50 μM HOCl (p < 0.001), while treatment with 100, 150 and 
200 μM HOCl caused 59%, 64% and 47% of cell viability loss, respectively. At HOCl 
concentrations below 200 μM, the HOCl-induced viability loss in HMDM cells with 
depleted intracellular GSH was significantly greater than those in the respective HMDM 
cells with intact intracellular GSH. This suggests intracellular GSH played an important 
role in protecting HMDM cells against HOCl insult. However, there were no significant 
differences in cell viability loss between HMDM cells with intact or depleted intracellular 
GSH when HOCl concentrations were above 200 μM HOCl.     
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Figure 3.10 HMDM cells depleted of intracellular GSH are more sensitive to HOCl 
exposure.  
HMDM cells (5×106 cells/ml) were pre-treated with (gray bars) or without (white bars) 
100 μM DEM for 3 hours, followed by exposing the cells to increasing HOCl 
concentrations for 10 minutes. The cells were then incubated in HMDM culture medium 
for 1 hour prior to cell viability analysis using the MTT reduction assay. Cell viability is 
presented as a percentage of the DEM- and HOCl-non-treated control. * indicates the 
significance between HMDM cells treated with and without DEM.  
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3.2.5 Correlation between intracellular GSH levels of different HMDM 
cell preparations and the cells’ resistance to HOCl exposure 
A confounding factor in this research was that different HMDM cell batches showed 
varying levels of resistance towards HOCl cytotoxicity. HMDM cells prepared from 
different blood donors had similar initial MTT absorbance values (p > 0.05), i.e. they had 
similar initial metabolic activities. Yet, they had different levels of cell viability loss after 
treatment with increasing HOCl concentrations (Figure 3.11). The different levels of cell 
viability loss might be caused by varying experimental conditions on different days. To 
examine whether this was the case, two different HMDM cell preparations were exposed to 
the same HOCl preparation simultaneously (Figure 3.12). They showed statistically the 
same initial MTT absorbance values of approximately 1.0 (p > 0.05), but significantly 
different values after treatment with 150 μM HOCl (p < 0.001). These results indicate that 
the varying resistance of each HMDM preparation towards HOCl cytotoxicity was likely 
not caused by variation in experimental conditions. The similar initial metabolic activities 
within different cell preparations indicated that they could not have been a contributing 
factor either.  
 
Based on earlier result (Figure 3.10), the varying level of resistance of HMDM cells 
towards HOCl insult might be attributed to the varying intracellular GSH level in each cell 
batch. To investigate this, each different HMDM cell batch was measured for its initial 
intracellular GSH value, initial protein concentration (in mg/5×106 cells), and cell viability 
after HOCl treatment. The HOCl concentration required to kill 50% of cell population in 
each cell preparation was directly related to their intracellular GSH level, as shown by the 
correlation analysis (Figure 3.13a). An r2 value of 0.6808 suggests that 68% of the variant 
in LD50 (i.e. HOCl concentration required for killing 50% cell population in each cell batch) 
was predicted by the initial GSH level in each cell batch. This indicates that intracellular 
GSH provides approximately 70% protection against HOCl insult.  
 
Furthermore, the correlation analysis between the initial protein concentration and the 
HOCl concentration required to kill 50% of cell population in each cell preparation showed 
an r2 value of 0.063 (Figure 3.13b). Assuming the initial protein level of each cell 
preparation is directly proportional to the cell number, this result suggests that cell number 
was relatively consistent in each cell batch and was not responsible for the varying level of 
resistance in different cell preparations against HOCl insult.  
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Figure 3.11 Different HMDM cell preparations showed varying resistance towards 
HOCl insult.  
HMDM cells (5×106 cells/ml) prepared from different blood donors were treated with 
increasing HOCl concentrations for 10 minutes, followed by incubation in HMDM culture 
medium for 20 hours. The cells were then analysed for cell viability using the MTT 
reduction assay. Cell viability is presented in MTT absorbance units. Each line represents a 
different cell preparation from a different donor.  
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Figure 3.12 Two different HMDM cell preparations showed varying resistance 
towards the same HOCl insult.  
HMDM cells (5×106 cells/ml) prepared from blood donors A (white bar) and B (gray bars) 
were treated with or without 150 μM HOCl for 10 minutes, followed by incubation in 
HMDM culture medium for 20 hours. The cells were then analysed for cell viability using 
the MTT reduction assay. Cell viability is presented in MTT absorbance units. Significance 
is indicated from the respective controls with 0 μM HOCl.  
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Figure 3.13 Intracellular GSH levels, not cellular protein levels, are the primary 
cause of varying resistance of different HMDM batches against HOCl damage.  
The HOCl concentration required to kill 50% of the cell population in each HMDM cell 
batch was compared with a) the initial intracellular GSH and b) the initial cellular protein 
concentrations using a trend line to illustrate the correlation.  
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3.2.6 HOCl-mediated GSH loss in HMDM cells over time  
Whether HOCl-treated HMDM cells were able to replenish their oxidised GSH pool was 
also studied. After the 10-minute exposure to HOCl, the intracellular GSH levels in 
HMDM cells were measured up to 24 hours (Figure 3.14). The intracellular GSH level of 
control cells (with no HOCl addition) was approximately 60.9 ± 5.3 nmol/mg protein. At 
50 μM HOCl, the intracellular GSH level remained statistically similar to the control value 
over time (p > 0.05). At 100 μM HOCl, the intracellular GSH level decreased initially to 
40.5 ± 3.3 nmol/mg protein (25% decrease), which remained at this level for the next 10 
hours and recovered to the control value at 24 hours. At 200 μM HOCl, the intracellular 
GSH level decreased initially to 29.9 ± 2.1 nmol/mg protein (50% decrease). There was a 
further progressive decrease in intracellular GSH level over the next 10 hours, which was 
not recovered at 24 hours. At 500 μM HOCl, the intracellular GSH level was completely 
depleted initially and was not recovered over time. The significance of this time course 
study will be discussed in section 3.3.  
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Figure 3.14 Time course of HOCl-induced GSH loss in HMDM cells. 
HMDM cells (5×106 cells/ml) were treated with 0 ( ? ), 50 ( ? ), 100 (△) , 200 (▽), and 
500 μM (○) HOCl for 10 minutes, followed by incubation in HMDM culture medium. The 
cells were subsequently collected at time intervals and analysed for GSH using HPLC 
analysis. Significance is indicated from the respective 0 hr controls.  
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3.2.7 Effect of extracellular 7,8-NP in preventing HOCl-mediated 
HMDM cell damage 
7,8-NP has previously been shown to prevent loss of U937 viability (Gieseg et al., 2001a) 
and erythrocyte lysis (Gieseg et al., 2001b). This protection by 7,8-NP was possibly due to 
its scavenging of HOCl, as Widner et al. (2000) demonstrated that 7,8-NP scavenges HOCl 
efficiently to form neopterin. To study whether 7,8-NP is an effective cellular antioxidant 
against HOCl insult to HMDM cells, cells were treated wtih 400 μM HOCl in the presence 
of 7,8-NP in the reaction medium. The degree of protection extracellular 7,8-NP gives to 
the cells was then quantified by measuring cell viability and intracellular GSH loss 
concurrently (Figure 3.15). HOCl at 400 μM alone caused intracellular GSH to decrease 
by 90% (it decreased from a control value of 41.2 ± 2.7 to 3.7 ± 0.04 nmol/mg protein) and 
cell viability by 60%. In the presence of 100 μM 7,8-NP, the intracellular GSH level 
decreased by approximately 50% (the GSH level measured was 20.0 ± 2.5 nmol/mg 
protein) and cell viability by 10%, compared to the respective controls. In the presence of 
200 μM 7,8-NP, the intracellular GSH level decreased by approximately 10% (the GSH 
level measured was 31.3 ± 2.3 nmol/mg protein) and no significant cell viability loss was 
observed, compared to the respective controls. At 300 μM 7,8-NP, there were no 
significant loss in either intracellular GSH level or cell viability. These results suggest that 
7,8-NP in the medium efficiently prevented HOCl-induced intracellular GSH and HMDM 
cell viability loss. 
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Figure 3.15 7,8-dihydroneopterin (7,8-NP) added to the reaction medium prevented 
GSH and cell viability losses in HMDM cells upon HOCl insult.  
HMDM cells (5×106 cells/ml), pre-incubated in the presence or absence of increasing 7,8-
NP concentrations in the dark at 37°C for 5 minutes, were treated with or without 400 μM 
HOCl for 10 minutes. The cells were then incubated in HMDM culture medium for 1 hour, 
followed by measuring cell viability (gray bars) and intracellular GSH (white bars) using 
the MTT reduction assay and HPLC analysis, respectively. Significance is indicated from 
the respective 0 μM HOCl controls.  
 
 
3.2.8 Effect of IFN-γ-stimulated production of 7,8-NP in preventing 
HOCl-mediated HMDM cell damage 
7,8-NP is synthesized in human macrophages in response to IFN-γ production (Wachter et 
al., 1989; Wachter et al., 1992). This section aims to study whether IFN-γ-induced 7,8-NP 
production in HMDM cells was enough to protect the cells from HOCl insult. This was 
carried out by synthesizing 7,8-NP de novo by incubating HMDM cells with IFN-γ, 
followed by exposing the cells to HOCl. 7,8-NP is non-fluorescent, while its oxidized form 
neopterin fluoresces and can be detected via HPLC analysis (λex/λem = 353/438 nm) with 
an elution time of approximately 4.1 min (Figure 3.16). The initial 7,8-NP level was 
calculated by subtracting the initial neopterin level (Figure 3.16a) from the total pterin 
level (the initial neopterin plus the initial 7,8-NP that had been oxidized to neopterin using 
the acidic iodide solution) (Figure 3.16b) (Flavall, 2007, Masters thesis).  
  
 Chapter 3 84 
0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 min
0
25
50
75
100
125
150
175
200
mV
3.
01
7
3.
22
4 4.
10
4
4.
36
7
 
a) 
Neopterin  Retention time: 4.104 
Area: 175271 
0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 min
0
25
50
75
100
125
150
175
200mV
3.
09
5
4.
16
2
4.
50
4
 
b) Total pterin  Retention time: 4.162 
Area: 1524542 
 
Figure 3.16 HPLC neopterin and total pterin traces of HMDM cells. 
HMDM cells (5×106 cells/ml) were lysed in cold water and acetonitrile (1:1 ratio). a) Half 
of the cell lysate was centrifuged to precipitate down proteins and the resulting supernatant 
was analysed for neopterin by HPLC analysis. b) The other half of the cell lysate was 
mixed with the acidic iodide solution to oxidise all 7,8-NP to neopterin, followed by 
reducing the excess iodine using 0.6 M ascorbic acid. After centrifugation, the resulting 
supernatant was analysed for total pterin (neopterin and 7,8-NP that has been oxidised to 
neopterin) by HPLC analysis.  
 
 
Prior to carrying out the above study, a suitable IFN-γ concentration and incubation period 
needed to be decided. HMDM cells were incubated with increasing IFN-γ concentrations 
in RPMI culture medium for 24 or 48 hours. The total 7,8-NP synthesised was calculated 
by measuring 7,8-NP levels in both cells and media, as 7,8-NP can diffuse out of the 
activated macrophages into the extracellular spaces (Gieseg et al., 2007). The control cells 
at 24- and 48-hour showed total 7,8-NP levels of approximately 38.3 ± 3.2 and 39.3 ± 3.5 
pmol/5×106 cells, respectively. At 24 hour, 250, 500 and 750 U/ml IFN-γ induced 7,8-NP 
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production in HMDM cells by 1.6, 2.0 and 1.6 fold, respectively. There was no further 
significant increase in 7,8-NP levels after 48 hours of incubation compared to those after 
24 hours of treatment (Figure 3.17).  
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Figure 3.17 7,8-NP synthesis in IFN-γ activated HMDM cells. 
HMDM cells (5×106 cells/ml) were treated with increasing IFN-γ concentrations in 
HMDM culture medium for 24 (white bars) or 48 hours (gray bars), followed by 
measuring and combining 7,8-NP levels in both cells and the respective media by HPLC 
analyses. Significance is indicated from the respective 0 U/ml γ-IFN data.  
 
 
The same experimental setup was performed to examine the effect of IFN-γ treatment on 
HMDM cell viability (Figure 3.18). HMDM cells incubated with 250, 500 and 750 U/ml 
IFN-γ for 24 hours did not cause significant cell viability loss, although 750 U/ml IFN-γ 
caused the cell viability to vary greatly. HMDM cells incubated with 250, 500 and 750 
U/ml IFN-γ for 48 hours showed cell viability loss of approximately 16, 18 and 54% of the 
control, respectively. Taken together, incubation with 500 U/ml IFN-γ for 24 hours showed 
maximum 7,8-NP synthesis in HMDM cells without affecting cell viability. This 
experimental condition was used for the later related experiments. The cell viability loss 
observed after IFN-γ treatment was possibly due to either IFN-γ or the 7,8-NP produced, 
which will be discussed in details in section 3.3.6.  
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Figure 3.18 Effect of IFN-γ on HMDM cell viability.  
HMDM cells (5×106 cells/ml) were treated with increasing IFN-γ concentrations in 
HMDM culture media for 24 (white bars) or 48 hours (gray bars), followed by cell 
viability determination with the MTT reduction assay. Significance is indicated from the 
respective 0 U/ml IFN-γ data. 
 
 
7,8-NP added to the reaction medium significantly prevented HOCl-induced intracellular 
GSH and cell viability loss (Figure 3.15). 7,8-NP is produced in vivo by IFN-γ-stimulated 
macrophages (Gieseg et al., 2007), which leads to the hypothesis that IFN-γ-induced 7,8-
NP can also prevent HOCl-induced intracellular GSH and HMDM cell viability loss. To 
prove this hypothesis, HMDM cells were pre-incubated with or without 500 U/ml IFN-γ 
for 24 hours for 7,8-NP synthesis. These IFN-γ-treated cells were then exposed to 
increasing concentrations of HOCl and analysed for cell viability (Figure 3.19). The 
amount of 7,8-NP released into the culture media was added back to the reaction media 
during HOCl treatment. There was no significant cell viability loss below 150 μM HOCl in 
HMDM cells pre-treated either with or without IFN-γ (p > 0.05). At 150, 200, 300 and 400 
μM HOCl, HMDM cells treated without IFN-γ showed approximately 6, 12, 61 and 73% 
cell viability loss, respectively, whereas HMDM cells treated with IFN-γ showed 
approximately 18, 15, 62 and 66% cell viability loss, respectively. The percentages of cell 
viability loss between the corresponding IFN-γ-treated and non-treated cells were not 
statistically different. Taken together, de novo 7,8-NP synthesis did not prevent HOCl-
mediated cell viability loss in HMDM cells.  
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Figure 3.19 Effect of IFN-γ-induced 7,8-NP production in preventing HOCl-mediated 
HMDM cell viability loss.  
HMDM cells (5×106 cells/ml) were treated with (gray bars) or without (open bars) 500 
U/ml IFN-γ in HMDM culture media for 24 hours. The net 7,8-NP levels in media were 
measured by HPLC analysis (47.025 ± 28.846 nM). Subsequently, the IFN-γ-treated and 
non-treated cells were incubated in EBSS media, with 47.025 ± 28.846 nM 7,8-NP added 
back to the EBSS media of IFN-γ-treated cells. The cells were then exposed to increasing 
HOCl concentrations for 10 minutes and incubated in HMDM culture media for 1 hour. 
Cell viability was measured using the MTT reduction assay and presented as percentage of 
the respective 0 μM HOCl controls. Significance is indicated from the respective 0 μM 
HOCl controls.  
 
 
The same experimental setup was carried out for examining the effect of IFN-γ-induced 
7,8-NP in preventing HOCl-mediated intracellular GSH loss (Figure 3.20). The 
intracellular GSH levels of control cells (without HOCl treatment) treated with or without 
IFN-γ were measured 36.7 ± 1.4 or 46.7 ± 1.2 nmol/mg protein, respectively. A HOCl 
concentration of 50 μM did not cause statistically significant intracellular GSH losses in 
both HMDM cells with and without IFN-γ treatment. At 100, 150, 200, 250 and 300 μM 
HOCl, the GSH levels in IFN-γ-non-treated HMDM cells were decreased by 20, 40, 56, 76 
and 85%, respectively, while the GSH levels in IFN-γ-treated HMDM cells were decreased 
by 22, 55, 77, 86 and 91%, respectively, compared to their controls. The GSH levels in 
IFN-γ-treated HMDM cells were significantly lower than those in the corresponding IFN-
γ-non-treated cells either with or without HOCl treatment. The only exception was at 300 
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μM HOCl, where there was no difference in intracellular GSH levels between IFN-γ-
treated and non-treated HMDM cells. Overall, IFN-γ treatment induced intracellular GSH 
loss and IFN-γ-induced 7,8-NP synthesis did not prevent HOCl-mediated intracellular 
GSH loss.  
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Figure 3.20 Effect of IFN-γ-induced 7,8-NP production in preventing HOCl-mediated 
intracellular GSH loss in HMDM cells.  
HMDM cells (5×106 cells/ml) were treated with (gray bars) or without (open bars) 500 
U/ml IFN-γ in HMDM culture media for 24 hours. The net 7,8-NP levels in media were 
measured by HPLC analysis (47.025 ± 28.846 nM). Subsequently, the IFN-γ-treated and 
non-treated cells were incubated in EBSS media, with 47.025 ± 28.846 nM 7,8-NP added 
back to the media of IFN-γ treated-cells. The cells were then exposed to increasing HOCl 
concentrations for 10 minutes and incubated in HMDM culture media for 1 hour. 
Intracellular GSH levels were then measured by HPLC analysis. Significance is indicated 
from the respective 0 μM HOCl controls. Significance between IFN-γ-treated and non-
treated HMDM cells at each HOCl concentration are shown on top of the bars.  
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3.2.9 The effect of 7,8-NP, taken up by HMDM cells from culture media, 
on HMDM cell viability and in preventing loss of HOCl-mediated 
intracellular GSH and cell viability 
7,8-NP produced by IFN-γ-treated HMDM cells could not prevent HOCl-induced 
intracellular GSH (Figure 3.20) and cell viability loss (Figure 3.19). This was possibly 
because the amount of 7,8-NP produced was too little compared to the intracellular GSH 
level (section 3.3.6). This section aims to study whether incubating HMDM cells with 7,8-
NP would lead to 7,8-NP accumulating in HMDM cells to a level that is more comparable 
to intracellular GSH level, hence became more efficient in preventing HOCl-induced 
intracellular GSH and cell viability loss. This was carried out by pre-incubating HMDM 
cells with increasing concentrations of 7,8-NP in HMDM culture medium for 24 hours, 
followed by removal of the 7,8-NP-rich medium and measurement of the 7,8-NP levels 
accumulated in HMDM cells by HPLC analysis. The same experimental setup was also 
carried out for the examination of cell viability to study the effect of 7,8-NP accumulation 
in HMDM cells on the HMDM cell viability. 
 
After 24 hours, the control cells without 7,8-NP treatment showed an intracellular 7,8-NP 
level of 3.4 ± 3.6 pmol/5×106 cells. Pre-incubation of cells with 100, 200 and 300 μM 7,8-
NP had their intracellular 7,8-NP levels increased to 89.3 ± 0.3, 167.3 ± 1.4, 240.1 ± 6.8 
pmol/5×106 cells, respectively (Figure 3.21a). Incubating HMDM cells with up to 300 μM 
7,8-NP for 24 hours did not cause cell viability loss (Figure 3.21b). Taken together, 
incubating HMDM cells with extracellular 7,8-NP up to 300 μM for 24 hours caused 
intracellular 7,8-NP increase without affecting cell viability.  
 
The next question was whether the intracellular 7,8-NP increase, resulting from incubation 
of HMDM cells with extracellular 7,8-NP (Figure 3.21), would prevent loss of HOCl-
mediated cell viability and intracellular GSH. HMDM cells were incubated with 300 μM 
7,8-NP for 24 hours, followed by removal of the 7,8-NP-rich medium and exposure to 
increasing HOCl concentrations. HMDM cell viability and intracellular GSH in cells were 
subsequently determined. At 100, 150 and 200 μM HOCl, the 7,8-NP-treated and the 
respective non-treated HMDM cells showed statistically the same loss of cell viability (P > 
0.05) (Figure 3.22) and intracellular GSH (P > 0.05) (Figure 3.23). Taken together, the 
7,8-NP accumulated in cells (resulting from pre-incubation of HMDM cells with 300 μM 
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7,8-NP in the medium for 24 hours) could not prevent the subsequent HOCl-mediated cell 
viability and intracellular GSH loss.   
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Figure 3.21 Uptake of 7,8-NP by HMDM cells from the medium supplemented with 
increasing concentrations of 7,8-NP and the effect on HMDM cell viability.  
HMDM cells (5×106 cells/ml) were exposed to increasing 7,8-NP concentrations in 
HMDM culture media for 24 hours, followed by determination of a) 7,8-NP levels in cells 
by HPLC analyses and b) cell viability by the MTT reduction assay. Significance is 
indicated from the respective 0 μM 7,8-NP controls.  
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Figure 3.22 Intracellular 7,8-NP increase resulting from treatment of HMDM cells 
with extracellular 7,8-NP did not prevent HOCl-induced HMDM cell viability loss. 
HMDM cells (5×106 cells/ml) were incubated with (gray bars) or without (white bars) 300 
μM 7,8-NP in HMDM culture media for 24 hours, followed by treatment with or without 
increasing HOCl concentrations in EBSS media. The cells were subsequently analysed for 
cell viability using the MTT reduction assay. Cell viability is presented as a percentage of 
the non-7,8-NP-treated and 0 μM HOCl control. There was no statistical difference in cell 
viability loss between 7,8-NP-treated and the respective non-treated HMDM cells (P > 
0.05). 
 
0 20 50 100 150 200
0
10
20
30
40
[HOCl] (μM)
In
tra
ce
llu
la
r G
SH
(n
m
ol
/m
g 
pr
ot
ei
n)
 
Figure 3.23 Intracellular 7,8-NP increase resulting from treatment of HMDM cells 
with extracellular 7,8-NP did not prevent HOCl-induced GSH loss in HMDM cells.  
HMDM cells (5×106 cells/ml) were incubated in the presence (gray bars) or absence (white 
bars) of 300 μM 7,8-NP in HMDM culture media for 24 hours, followed by treatment with 
or without increasing HOCl concentrations in EBSS media. The cells were subsequently 
analysed for intracellular GSH by HPLC analysis. There was no statistical difference in 
intracellular GSH loss between 7,8-NP-treated and the respective non-treated HMDM cells 
(P > 0.05). 
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3.3 Discussion 
3.3.1 Effect of HOCl on HMDM cell viability and intracellular GSH 
HOCl caused a concentration-dependent loss of HMDM cell viability above a critical 
HOCl concentration threshold (i.e. above 50 μM) (Figure 3.2). This is in agreement with a 
number of studies using different cell types, including endothelial cells (Vissers et al., 
1999; Pullar et al., 1999), red blood cells (Vissers et al., 1994), human skin fibroblasts 
cells (Vile et al., 2000), cultured cortical neurons (Yap et al., 2006) and THP-1 monocyte 
and J774 macrophage cells (Hawkins et al., 2001). Activated neutrophils have been 
demonstrated to produce 20-400 μM HOCl through the MPO/H2O2/Cl- system (Weiss et 
al., 1982; Foote et al., 1983). Hence, the HOCl concentrations used that caused HMDM 
cell viability loss were well within the physiological range of HOCl production. 
 
Cell viability was measured by both MTT reduction assay (Figure 3.2a) and trypan blue 
exclusion assay (Figure 3.2b). The MTT reduction assay measures metabolic activity of 
cells; MTT compound is reduced by mitochondrial NADH dehydrogenases to formazan 
only in living, metabolically active cells and formazan production is directly proportional 
to cell number (Mosmann, 1983). Yet, stimulated cells can produce more formazan than 
resting cells, suggesting that the observed HMDM cell viability loss could be attributed to 
either an increased ratio of dead to viable cells or decreased metabolic activity in the viable 
cells. Cell viability measured by the trypan blue exclusion assay (monitors cell membrane 
integrity) agrees with that obtained by the MTT assay. This indicates the observed cell 
viability loss was indeed due to cell death. Irrespective of their different mechanisms for 
detecting cell death, these two assays provided strong corroboration of all viability results 
obtained.  
 
The MTT reduction assay was chosen over the trypan blue assay as the general cell 
viability assay in this thesis, because it gives a quantitative result, which is more accurate 
than the more biased result obtained by the trypan blue assay due to the cell counting errors 
under inverted microscope. For the trypan blue assay, PI dye tend to enter HMDM cells 
and formed tiny blue spots rather than an obvious blue patch, which made it very hard to 
distinguish between dead and live HMDM cells. As a result, more HMDM cells than 
needed were possibly assigned as dead cells. This explains why the HOCl-induced cell 
viability loss measured by the trypan blue assay was slightly greater than that measured by 
the MTT reduction assay.  
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The loss of MTT reduction in HOCl-treated HMDM cells implicated mitochondria toxicity. 
In agreement with the current result, HOCl has been previously shown to cause 
mitochondria swelling in mitochondria isolated from rat liver, indicating that HOCl caused 
impairment of isolated mitochondrial function (Whiteman et al., 2005). This HOCl-
mediated mitochondria toxicity was unlikely a result of cell membrane lysis, since it was 
shown in Chapter 4 that preventing MPT-mediated mitochondrial membrane potential 
loss inhibited HOCl-induced HMDM cell viability loss.  
 
HMDM cells exposed to the same HOCl concentration for 10 to 60 minutes, followed by 
incubation in RPMI culture media for 20 hours, showed similar percentages of viability 
loss (Figure 3.3). This indicates that HOCl was completely consumed and caused rapid 
cell viability loss within 10 minutes. It was less likely that any HOCl remained for more 
than 10 minutes, since HOCl is a highly oxidising agent and rapidly react with a range of 
biomolecules (see section 1.5.2). HOCl (60 μM) was completely consumed by 0.2 x 106 
human hepatoma cells within 20 minutes, indicating rapid consumption of HOCl when in 
contact with these cells (Whiteman et al., 2005). The time course of HOCl-mediated cell 
viability loss showed that the cell viability decreased most significantly during the initial 
10-minute HOCl treatment and did not decrease further after the initial treatment (Figure 
3.4). Taken together, HOCl caused rapid (i.e. within 10 minutes), not gradual cell viability 
loss (i.e. over 24-hour period), irrespective of the concentrations applied. 
  
The rapid metabolic energy loss (measured by MTT assay) and perturbation of cellular 
membranes (measured by trypan blue assay) implied that HOCl induced necrotic cell death 
in HMDM cells. This is consistent with the HOCl-induced morphological changes. HOCl 
concentrations at or less than 50 μM did not cause significant morphological changes, 
while concentrations above 100 μM caused the cells to enlarge significantly with the cell 
membranes deformed or ruptured (Figure 3.5). HOCl causes necrotic cell death in many 
other cell types (Vissers et al., 1994; Tatsumi and Fliss, 1994; Abernathy and Pacht, 1995; 
Vile et al., 2000; Slivka et al., 1980; Schraufstatter et al. 1990). Yet, it is also suggested 
that low HOCl doses induced apoptosis while high doses induced necrosis (Vissers et al., 
1999). The mechanism(s) of HOCl-induced HMDM cell death will be discussed in detail 
in Chapters 4 and 5.  
 
It was found that HMDM cells treated with HOCl only showed significant cell viability 
loss after the intracellular GSH level was significantly decreased (Figure 3.6). This implies 
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that HOCl did not react with cell membranes first causing membrane integrity loss, but 
penetrated the plasma membrane to react with intracellular GSH rapidly, within 10 minutes. 
This agrees with Vissers and Winterbourn (1995), who suggested that HOCl penetrated the 
red cell membranes to oxidise GSH rapidly, within 2 minutes. It is possible that HOCl 
penetrates cell membranes, as HOCl is an uncharged free acid, which can pass through the 
hydrophobic lipid bilayer while undergoing minimum reaction with membrane 
components (Pullar et al., 2000).  
 
The above results also imply that once GSH was no longer abundant enough in cells to 
effectively scavenge HOCl, the remaining HOCl then reacted with other biomolecules, 
causing metabolic energy and membrane integrity loss. This hypothesis is consistent with 
some previous studies, which showed significant HOCl-induced intracellular GSH loss 
before cell lysis or cell swelling were observed (Vissers and Winterbourn., 1995; Carr and 
Winterbourn, 1997). In contrast to this hypothesis, Schraufstatter et al. (1990) have argued 
that cell membrane in tumor cells was the prime target of HOCl and would provide a 
protective barrier for cytoplasmic components (Schraufsttater et al., 1990). This difference 
from the current result suggests that this particular cell type allows more restricted access 
to HOCl than HMDM cells.  
 
Interestingly, there were no statistically significant intracellular GSH loss at HOCl 
concentrations at or less than 50 μM (Figures 3.6 and 3.10). One possible explanation is 
that HOCl also reacted with some other biomolecules, which showed greater or similar 
reactivity with HOCl and/or abundance as GSH, either before or at the same time as 
intracellular GSH. As a result, the effect of HOCl at low concentrations on intracellular 
GSH was less profound. For example, GAPDH enzyme, which possesses thiol groups at its 
active site, showed decreased activity at the same rate as intracellular GSH loss in HOCl-
treated HMDM cells (see Chapter 4). Moreover, though GSH shows extremely high 
reactivity with HOCl with a rate constant above 107 M-1s-1, ascorbate can also react rapidly 
with HOCl with a rate constant approximately 6×106 M-1s-1 (Folkes et al., 1995). Amine 
groups are oxidized by HOCl at a rate about 100 times less than thiol groups and thioethers 
such as Met residues, but they would compete favourably for HOCl as they are generally 
present in considerable excess over sulfur compounds (Winterbourn, 1985). 
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3.3.2 Effect of intracellular GSH in preventing HOCl-induced cell 
viability loss 
Intracellular GSH loss occurring before HMDM cell viability loss during HOCl exposure 
(see Figure 3.6) implies that intracellular GSH plays an important role in protecting 
HMDM cells from HOCl insult. The time course of GSH loss in HMDM cells treated with 
increasing HOCl concentrations showed that there was no GSH recovery when the initial 
GSH loss was 50% of the control GSH value or when the GSH concentration has 
decreased to approximately 30 nmol/mg protein (Figure 3.14). This result implies that the 
initial GSH loss in HMDM cells treated with 100 μM HOCl in Figure 3.6 should not be 
recovered with time, because the initial GSH loss was approximately 50% of the control 
GSH value and the GSH concentration has decreased to less than 20 nmol/mg protein. The 
lack of GSH recovery was possibly due to HOCl inactivating the GSH synthesis and repair 
enzymes, depleting NADPH (required for glutathione reductase), ATP and cysteine 
(substrates required for GSH biosynthesis), and causing the irreversible formation of 
higher oxidation products (such as sulphonamide and thiolsulfonate) when the initial 
intracellular GSH concentration is relatively low (Figure 3.1). The above possibilities are 
discussed in further details in section 3.3.4.  
 
The cell viability curve in Figure 3.6 is different from that in Figure 3.3. This was 
possibly because the HMDM cell batches used in these two studies contained significantly 
different initial intracellular GSH level, which led to their different resistance towards 
HOCl insult. The correlation study (Figure 3.13a) has shown that the initial intracellular 
GSH level in a particular cell batch was significantly correlated with the HOCl 
concentration required to kill 50% cell population of that cell batch.  
 
This hypothesis was further confirmed by the finding that HMDM cells depleted of 
approximately 90% of intracellular GSH (using DEM) showed significantly lower cell 
viability after HOCl treatment compared to HMDM cells with intact GSH (Figure 3.10). 
The result is similar to Gotoh et al. (1993), who demonstrated that GSH depletion renders 
oxLDL cytotoxic to both THP-1 cells and PMA-derived macrophage cells at a 
concentration well tolerated by cells with intact GSH. However, this theory does not apply 
to HMDM cells exposed to high HOCl concentrations. At 200 or 500 μM HOCl, the 
percentage of cell viability loss was the same between HMDM cells with or without intact 
intracellular GSH. This was possibly because intracellular GSH could not protect HMDM 
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cells from high concentrations of HOCl. High HOCl concentrations caused extremely rapid 
loss of intracellular GSH and the huge excess of HOCl reacted overwhelmingly with other 
intracellular components of HMDM cells within the 10-minute incubation.  
 
The lower sensitivity of DEM-treated HMDM cells towards HOCl exposure was not 
caused by DEM reacting with cellular protein thiols. This was demonstrated by the finding 
that incubation of HMDM cells with up to 300 μM DEM did not affect protein thiol levels, 
while 100 μM DEM caused approximately 80% decrease in intracellular GSH (Figure 3.8). 
It was previously shown that incubation of rat brain slices with 10 mM DEM for 2 hours 
decreased protein thiol level by 13% of control (Bizzozero et al., 2006). This difference 
from the current result was possibly due to the much higher DEM concentration used by 
the investigators compared to the concentration used in this study.  
 
Incubation with 100 μM DEM for 3 hours was the chosen experimental condition for 
depleting intracellular GSH, as this condition caused intracellular GSH to decrease by 
approximately 60-90% (Figures 3.7-3.9). Interestingly, cell viability was not affected by 
the absence of intracellular GSH (Figure 3.7). This agrees with a previous study, which 
demonstrated that monocytic THP-1 cells and phorbol-12-myristate-13-acetate (PMA)-
derived macrophage cells depleted of intracellular GSH using L-buthionine-S-sulfoxomine 
(a selective inhibitor of γ-glutamyl cysteine synthase) showed no decrease in cell viability 
(Gotoh et al., 1993). The result from this study suggests that either other antioxidants were 
protecting the cells from oxidative stress in the absence of GSH or there was little or no 
oxidative stress within the incubation period.  
 
DEM (100 μM) caused intracellular GSH to deplete by approximately 75% and 60% in 
figures 3.8 and 3.9, respectively. This percentage difference was due to the different initial 
GSH levels in the HMDM cell batches used. The initial intracellular GSH levels in 
Figures 3.8 and 3.9 were measured 28 and 35 nmol/mg protein, respectively. However, the 
GSH levels in both HMDM cell batches decreased by approximately 21 nmol/mg protein 
after 100 μM DEM treatment.  
 
Keeping in mind that intracellular GSH plays a crucial role in protecting HMDM cells 
from HOCl insult, the next question was how exactly intracellular GSH prevented HOCl-
induced cell viability loss. The data in Chapter 5 will show that HOCl-induced cytosolic 
Ca2+ increase was the major cause of necrotic cell death in HMDM cells. This cytosolic 
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Ca2+ increase was attributed to both Ca2+ influx from the media via Ca2+ channels on cell 
membranes and Ca2+ release from ER via Ca2+ channels on ER membranes (see section 
5.2). Since these Ca2+ channels (on both cell and ER membranes) can be activated by 
HOCl interacting with the essential thiol groups within them (see section 5.3), it was 
possible that intracellular GSH scavenged HOCl from inside the cells, preventing HOCl 
from interacting with cell membrane Ca2+ channels (from cytoplasmic side) and ER Ca2+ 
channels. This could then prevent cytosolic Ca2+ increase and subsequently cell death.  
 
3.3.3 Effect of intracellular GSH concentration in protecting HMDM 
cells from HOCl insult 
HMDM cell preparations from different donors showed different sensitivity towards the 
same HOCl concentration (Figure 3.11). This varying level of resistance to HOCl in each 
cell preparation was not caused by differences in experimental conditions (Figure 3.12), 
nor by cell number differences in each cell batch (the cell number in each cell batch was 
relatively constant) (Figure 3.13b). The correlation study suggested that the level of 
resistance to HOCl in a cell preparation increased with their intracellular GSH level 
(Figure 3.13a). This is possibly due to the fact that elevated GSH levels generally increase 
antioxidant capacity and resistance to oxidative stress. The current result agrees with 
Rosenblat et al. (2007), who showed that intracellular GSH elevation by administering 
liposomal GSH to a mouse model of atherosclerosis diminished blood plasma and 
macrophage oxidative stress levels and macrophage cholesterol mass. Moreover, low 
intracellular GSH levels have been implicated in a number of diseases, such as Parkinson’s 
disease, Alzheimer’s disease, myocardial infarction, multiple sclerosis, and rheumatoid 
arthritis (Fadeel et al., 1999; Pastore et al., 2003). This is possibly attributed to low GSH 
levels increasing susceptibility of cells towards oxidative stress, resulting in damages that 
lead to onset and/or progression of the diseases (Ballatori et al., 2009).  
 
Varying GSH levels in HMDM cells of different donors are possibly attributed to the 
varying expression levels and activity of GSH-related enzymes such as y-glutamylcysteine 
ligase, glutathione synthetase and glutathione reductase, and/or availability of ATP, 
NADPH and the substrate L-cysteine (Ballatori et al., 2009).  
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3.3.4 Intracellular GSH recovery/loss over time in response to HOCl 
insult   
For intracellular GSH to be an effective antioxidant against HOCl, it should scavenge 
HOCl rapidly, and the oxidized GSH should be recycled back to the reduced form for 
maintaining intracellular redox homeostasis and preventing the next round of oxidative 
insult. This research showed that intracellular GSH was not recovered over time when the 
initial intracellular GSH concentration in HMDM cells was decreased by 50% upon 200 
μM HOCl exposure (Figure 3.14).  
 
One possibility for the lack of recovery at high HOCl concentrations is that the initial 
intracellular GSH was lost through the ruptured cell membranes. However, this was less 
likely as HOCl-induced cell viability loss was not significant when the intracellular GSH 
concentration was decreased by approximately 50% (Figure 3.6). Another possibility was 
that higher HOCl concentrations (above 200 μM HOCl) favoured the irreversible 
formation of sulfonamide and thiosulfonate (Pullar et al., 2001) (see also Figure 3.1), 
which could not be regenerated to the reduced state. Other possibilities are the generation 
of mixed disulfides with proteins (Carr and Winterbourn, 1997), inactivation of glutathione 
reductase at higher HOCl concentration (Vissers and Winterbourn, 1995) and depletion of 
NADPH by HOCl (required for glutathione reductase) (Auchere and Capeillere-Blandin, 
1999). Inactivation of GSH re-synthesis could also prevent GSH recovery. Both ATP (see 
Chapter 4) and cysteine (Pattison and Davies, 2001) are essential substrates of GSH 
biosynthesis and can be rapidly oxidized by HOCl, hence possibly limiting GSH synthesis. 
HOCl was shown to induce activation of calpains in HMDM cells (see Chapter 5). 
Calpains are Ca2+-dependent cysteine proteases that cleave a diverse range of cellular 
proteins (see section 1.8 and Chapter 5). It is possible that those activated calpains 
damaged γ-glutamylcysteine synthetase and glutathione synthetase, hence inhibiting GSH 
re-synthesis and recovery. However, further investigation is required to prove this theory.  
 
Pullar et al. (2001) have suggested that the irreversible products (sulfonamide and 
thiosulfonate) can be exported into the extracellular space via the cell’s transport 
mechanism, which possibly explains why intracellular GSH was further lost after the initial 
loss in HMDM cells treated 200 μM HOCl. The progressive loss was also possibly due to 
further oxidative stress generated. HMDM cells have demonstrated generation of 
superoxide radicals after HOCl treatment (see Chapter 4). HOCl can also react with amine 
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groups to form chloramines. Cell permeable chloramines such as glycine-chloramine can 
oxidize GSH in Jurkat cells (Midwinter et al., 2006). However, chloramines were only 
detected in red cells at HOCl concentrations above those required to oxidize all available 
thiols (Vissers and Winterbourn, 1995).  
 
The data from the time course study also showed that intracellular GSH was recovered 
when the initial intracellular GSH loss was only 25% in HMDM cells after treatment with 
100 μM HOCl (Figure 3.14). This was possibly because lower HOCl concentrations 
favoured the formation of GSSG, which could be recycled back to reduced GSH 
(Winterbourn and Brennan, 1997). However, GSH could also be recovered by GSH re-
synthesis, which requires further investigation. 
 
One hypothesis that can be made from the above time course data and the reaction of GSH 
with HOCl (Winterbourn and Brennan, 1997) is that intracellular GSH concentration may 
be one important determinant of whether GSH can recover after HOCl treatment and 
therefore a determinant of whether GSH in HMDM cells is a good antioxidant against 
HOCl. In other words, at a particular HOCl concentration, a cell preparation with higher 
GSH level may favour GSSG formation that can be regenerated to GSH in reduced state, 
while a cell preparation with lower GSH level may favour the formation of irreversible 
GSH products, thereby blocking regeneration of GSH.  
 
The HMDM cell batch used for this time course study (Figure 3.14) contained a GSH 
level of approximately 60 nmol/mg protein. However, GSH level does vary between 
HMDM cell batches (5 x 106 cells/ml) in a range between 20-60 nmol/mg protein (Figure 
3.13a). In comparison, 0.2 x 106 cells/ml human hepatoma cells (Whiteman et al., 2005) 
and human chondrocytes (Whiteman et al., 2007) contained a GSH level of 16 and 8 
nmol/mg protein, respectively.  
 
 
3.3.5 Effect of extracellular 7,8-NP in preventing HOCl-mediated 
HMDM cell damage 
It has been hypothesized that 7,8-NP is synthesised by γ-IFN-stimulated macrophages to 
protect the cells against the oxidants encountered within an inflammatory site; including 
HOCl (Gieseg et al. 2007). HMDM cells were fully protected from 400 μM HOCl-induced 
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cell viability and intracellular GSH loss by addition of 7,8-NP to give a media 
concentration of 300 μM (Figure 3.15). This indicates that extracellular 7,8-NP scavenged 
HOCl efficiently to prevent HOCl from oxidizing intracellular GSH and causing cell death. 
This is in agreement with previous studies, which showed that 7,8-NP is an efficient 
scavenger of HOCl (Widner et al., 2000) and protects monocytic U937 cells (Gieseg et al., 
2001a) and erythrocytes (Gieseg et al., 2001b) from HOCl-induced cellular damage. The 
current result also suggests that in the presence of a highly reactive external substrate, GSH 
in HMDM cells was unable to compete effectively for HOCl. This agrees with Vissers and 
Winterbourn (1995), who showed that intracellular GSH in red cells was unable to 
compete for HOCl effectively in the presence of ascorbate in the extracellular medium.  
 
7,8-NP, at a concentration of 300 μM, was sufficient to fully prevent cell viability and 
intracellular GSH loss in HMDM cells treated with 400 μM HOCl, indicating that every 3 
molecules of 7,8-NP scavenged 4 molecules of HOCl. Yet, this result does not necessarily 
mean that 7,8-NP did not react with HOCl at 1:1 ratio. It was possible that while the 
majority of HOCl reacted with 7,8-NP, some HOCl molecules reacted with cell membrane 
components or entered the cells to react with intracellular components and the effect was 
too minor to damage the cells. HOCl can also react with neopterin (Widner et al., 2000).  
 
The effective concentrations of 7,8-NP added to cells in the above experiments appeared to 
be higher than the in vivo neopterin concentrations reported. Serum concentrations of 
neopterin usually range from 5 nM in healthy individuals to approximately 100 nM in 
severely ill patients (Fuchs et al., 1994). Up to 2 μM neopterin has been reported in 
atherosclerotic plaques from carotid artery (Gieseg et al., 2007). However, the 7,8-NP 
concentrations in the local environment of cells is likely to be higher than the above 
reported values. Also in vivo there is a continuous high level of neopterin and 7,8-NP 
release occurring in body fluids of patients due to continuous stimulation with γ-IFN. In 
contrast, the experiments reported here had 7,8-NP added as a single bolus, at time zero. 
Direct cell-to-cell contact may further facilitate the accumulation of even higher 
concentrations of 7,8-NP in the microenvironment of cells and its effects may be further 
augmented in concert with other inflammatory cytokines, which are induced upon 
activation of cells with IFN-γ such as interleukin-1 and TNF-α (Billiau and Dijkmans, 
1990; Enzinger et al., 2002b).   
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3.3.6 Effect of IFN-γ-stimulated production of 7,8-NP in preventing 
HOCl-mediated HMDM cell damage 
HMDM cells pre-incubated with 500 U/ml of IFN-γ for 24 hours showed increased 
production of 7,8-NP, which was detected in both cells and extracellular media (Figure 
3.17). This is consistent with the previous findings that 7,8-NP was synthesized in human 
macrophages upon induction by IFN-γ and was released into extracellular space (Wachter 
et al., 1989; Wachter et al., 1992). This particular IFN-γ concentration and incubation 
period was chosen because 7,8-NP synthesis was maximized at these conditions (Figure 
3.17) without affecting the HMDM cell viability (Figure 3.18). The γ-IFN-non treated 
control cells showed approximately 40 pmole/5×106 cells of 7,8-NP. This is possibly 
because the HIHS used for pre-incubating the cells already contained the inflammatory 
factor γ-IFN, hence inducing some 7,8-NP synthesis.  
 
IFN-γ-treated HMDM cells exposed to increasing concentrations of HOCl showed 
statistically similar cell viability loss as those of the respective non-IFN-γ-treated cells 
(Figure 3.19). This is not surprising, since the total 7,8-NP synthesized did not appear to 
be enough to scavenge HOCl. The net 7,8-NP released into media after γ-IFN treatment 
was only approximately 47 nM, whereas the intracellular 7,8-NP concentration was 
approximately 1.13 μM, calculated using the cell volume of human macrophage (2.48 μl 
per 106 macrophage cells) calculated by Dorian et al. (2001). In comparison, the 
intracellular GSH level prior to IFN-γ treatment was approximately 10.7 nmol/5×106 cells 
(Figure 3.20), equivalent to approximately 863 μM. The much higher concentration of 
intracellular GSH over that of the total 7,8-NP suggested that 7,8-NP would not compete 
efficiently for HOCl with intracellular GSH, assuming 7,8-NP and GSH have similar rate 
constants reacting with HOCl.   
 
IFN-γ-treated HMDM cells that were treated with or without HOCl showed lower 
intracellular GSH levels than those of the respective IFN-γ-non-treated cells (Figure 3.20). 
This was possibly caused by IFN-γ treatment inducing ROS formation in HMDM cells, 
which led to a decrease or depletion of intracellular GSH and eventually cell death. 
Primary hepatocytes treated with 100 U/ml IFN-γ for 24 hours showed significant ROS 
generation (Watanabe et al., 2003). This theory can also explain why high IFN-γ 
concentrations (750 U/ml) and a long period of IFN-γ incubation (48 hours) caused cell 
viability loss (Figure 3.18).  
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It was also possible that the 7,8-NP synthesized in human macrophages upon IFN-γ 
induction acted as a pro-oxidant by causing intracellular ROS generation and subsequently 
intracellular GSH loss, which eventually led to cell death. Antioxidants ranging form N-
acetylcysteine (NAC) to pyrrolidine dithiocarbamate (PDTC), catalase and superoxide 
dismutase (SOD) have been demonstrated to significantly inhibit 7,8-NP-mediated 
apoptosis (Baier-Bitterlich et al., 1995; Baier-Bitterlich et al., 1996a; Hoffmann et al., 
2003; Spottl et al., 2000), indicating that 7,8-NP induced apoptosis by mediating ROS 
generation. In addition, 7,8-NP at a high concentration (5 mM) superinduced TNF-α-
mediated apoptosis in U937 cells (Baier-Bitterlich et al., 1995) and induced apoptosis in 
Jurkat T-lymphocytes via a Bcl-2-sensitive pathway (Enzinger et al., 2002a). Neopterin or 
7,8-NP with concentrations as low as 10 μM also induced apoptosis and augmented TNF-
α/IFN-γ-mediated apoptosis in rat alveolar epithelial cell line L2 cells (Schobersberger et 
al., 1996). However, the above studies did not mention whether 7,8-NP was taken up by 
cells and how much was taken up to induce ROS generation and apoptosis.  
 
Incubation of HMDM cells with extracellular 7,8-NP (100-300 μM) increased intracellular 
7,8-NP concentrations to much higher values (Figure 3.21a) than that in IFN-γ-treated 
HMDM cells (Figure 3.17), without affecting cell viability (Figure 3.21b) and 
intracellular GSH levels (Figure 3.23). These results indicated that the amount of 7,8-NP 
synthesized in macrophage cells upon induction by IFN-γ was not enough to have caused 
the observed cell viability and intracellular GSH loss after IFN-γ treatment.  
 
 
3.3.7 The effect of 7,8-NP-treated HMDM cells in preventing HOCl-
mediated intracellular GSH and cell viability loss  
As mentioned above, the intracellular 7,8-NP concentration in HMDM cells incubated with 
extracellular 7,8-NP was significantly higher than that of IFN-γ-treated HMDM cells. For 
example, at 300 μM 7,8-NP, the intracellular 7,8-NP concentration was equivalent to 
approximately 19 μM (Figure 3.21). However, this higher concentration of intracellular 
7,8-NP was still not enough to prevent HOCl-mediated intracellular GSH (Figure 3.23) 
and cell viability (Figure 3.22) loss. This was not surprising, as intracellular GSH 
concentration was approximately 36 nmol/mg protein (equivalent to approximately 580 
μM), which was possibly too high to be out-competed by 7,8-NP.  
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3.4 Conclusion 
HOCl caused a concentration-dependent loss of HMDM cell viability rapidly (within 10 
minutes) above critical HOCl concentration thresholds, and the treatment caused no latent 
damaging effect on HMDM cells, regardless of HOCl concentrations. Rapid metabolic 
energy loss (measured by MTT reduction assay), cell membrane integrity loss (measured 
by trypan blue exclusion assay), cell membrane rupture, and cell swelling were observed. 
This implies that HOCl caused HMDM to undergo necrotic cell death.  
 
Depletion of intracellular GSH rendered HMDM cells more sensitive to HOCl exposure, 
whereas HMDM cell preparations with higher intracellular GSH levels showed greater 
resistance to HOCl insult. These results indicate that intracellular GSH played an important 
role in protecting HMDM cells from HOCl insult. However, the time course of GSH loss 
in HMDM cells treated with increasing HOCl concentrations showed that intracellular 
GSH lost initially was not regenerated over time when the initial GSH loss was over 50% 
in HMDM cells, whereas the loss was regenerated when the initial loss was 25%. This 
suggests that intracellular GSH acted as an efficient antioxidant protecting HMDM cells 
from HOCl insult only at relatively low HOCl concentrations, since the parent thiols could 
be regenerated to prevent further rounds of oxidative insult.  
 
Exposing HMDM cells to HOCl in the presence of 7,8-NP significantly reduced 
intracellular GSH and cell viability loss, indicating that 7,8-NP added extracellularly was 
an efficient scavenger of HOCl and out-competed intracellular GSH for HOCl. However, 
7,8-NP synthesized by HMDM cells upon IFN-γ induction or 7,8-NP accumulated in 
HMDM cells after cell incubation with 7,8-NP added extracellularly, did not prevent 
HOCl-mediated intracellular GSH and cell viability loss. This may have resulted because 
the concentrations of 7,8-NP were too low to efficiently scavenge HOCl. 
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4. HOCL MEDIATED NECROTIC CELL DEATH 
IN HMDM CELLS 
 
 
4.1 Introduction  
The acellular areas (often called the necrotic core) of advanced plaques are rich in cell 
debris (Stary et al., 1995), which is suggested to result from the death of macrophages 
(Ball et al., 1995; Berberian et al., 1990). These findings imply that macrophages within 
plaques undergo cell lysis, contributing to advanced plaque formation. The macrophage 
cell death may be caused by the oxidant HOCl, since macrophages, MPO enzyme and 3-
chlorotyrosine (Domigan et al., 1995; Kettle, 1996) were found colocalizing in 
atherosclerotic lesions (Daugherty et al., 1994; Malle et al., 2000; Sugiyama et al., 2001). 
Researchers have emphasized that MPO-H2O2-Cl
--generated HOCl oxidizes (lipo)proteins 
under in vivo conditions. The oxidized (lipo)proteins are then taken up by macrophages, 
resulting in cell death. However, it is also possible that HOCl exerts a toxic effect on 
macrophage cells leading to cell death.  
 
The strong oxidizing nature of HOCl means that it can potentially damage host cells. 
Exposure of cells to HOCl results in the oxidation of a range of critical biomolecules, 
including plasma membrane lipids, proteins, DNA, and small molecules, including 
ascorbate, nucleotides, sulfhydryls, and thioethers (see section 1.5.2). HOCl has been 
shown to cause caspase-3-dependent apoptosis in human umbilical vein endothelial cells 
(HUVESs) (Vissers et al., 1999; Vissers et al., 2001) and HL-60 human leukemia cells 
(Wagner et al., 2000). HOCl also caused human mesenchymal progenitor cells (Whiteman 
et al., 2007) and murine neuronal cells (Yap et al., 2006) to undergo caspase-3-
independent apoptosis. In addition, HOCl caused necrotic cell death in HeLa cells (Park et 
al., 2008), red blood cells (Vissers et al., 1994), endothelial cells (Tatsumi and Fliss, 1994), 
rat type II alveolar epithelial cells (Abernathy and Pacht, 1995), human skin fibroblast cells 
(Vile et al., 2000), human granulocytes (Slivka et al., 1980) and murine macrophage-like 
tumor cells (Schraufstatter et al., 1990).  
 
Collapse of the mitochondrial membrane potential is an important event that occurs in 
mitochondria when a cell dies, whether it is a result of apoptosis or necrosis. Mitochondrial 
membrane potential loss may be induced via the opening of high-conductance membrane 
permeability transition (MPT) pores (see also section 1.7.3). Whiteman et al. (2005b) have 
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demonstrated MPT activation and mitochondrial membrane potential loss in HOCl-treated 
human hepatoma HepG2. The pore is a complex of the voltage-dependent anion channel 
(VDAC; permeable to molecules < 5000 Da) in the outer mitochondrial membrane (OMM), 
the adenine nucleotide translocase (ANT; involved in the exchange of ATP from matrix 
and ADP from cytosol) in the inner mitochondrial membrane (IMM), and the matrix 
isomerase cyclophilin-D (CyP-D) (Crompton, 1999). Under conditions such as oxidative 
stress and excessive calcium ion (Ca2+) uptake by mitochondria, the MPT pores may form, 
allowing free passage of molecules (< 1500 Da) between the mitochondrial matrix and the 
cytosol (Chernyak et al., 1995; Kowaltowski et al., 2001; see also Chapter 5). 
Consequently, depolarization and uncoupling of oxidative phosphorylation occur. 
Moreover, the entry of molecules into the mitochondrial matrix from the cytosol is 
accompanied by the entry of water, which results in mitochondrial matrix swelling. 
Eventually, the mitochondrial matrix will swell to an extent that the OMM ruptures 
(because the IMM contains cristae, which have greater surface area than the OMM) (Kim 
et al., 2003a; Kim et al., 2003b). The consequences of OMM rupture are the release of 
molecules such as cytochrome c from the mitochondrial intermembrane space (IMS) with 
the activation of caspases triggering apoptosis, or a drastic loss of ATP production 
followed by necrosis (Kim et al., 2003a; Kim et al., 2003b; Green and Kroemer, 2004; 
Crompton, 1999). Intracellular ATP level is suggested to determine whether cells undergo 
necrosis or apoptosis (Eguchi et al., 1997).   
 
The intracellular redox environment is critical in regulating MPT, as the oxidation of the 
ANT thiol groups results in conformational changes that appear to lead to MPT pore 
opening (Kowaltowski et al., 2001; Armstrong and Jones, 2002; see also Chapter 5). The 
intracellular redox environment is partly controlled by glutathione (GSH). The intracellular 
depletion of GSH creates an increasingly oxidized environment in the cytosol and 
mitochondria due to increased production of mitochondrial ROS by respiratory complex III 
(Armstrong and Jones, 2002). Since HOCl is known to deplete intracellular GSH (Pullar et 
al., 2000), and it was demonstrated in Chapter 3 that significant intracellular GSH loss 
preceded HOCl-mediated HMDM cell death, HOCl may potentially create favourable 
oxidizing conditions for the activation of the MPT during HOCl-induced cytotoxicity to 
HMDM cells.  
 
In this chapter, the mode of HMDM cell death (apoptosis or necrosis) mediated by HOCl 
was further investigated to confirm the observation from the previous chapter that HOCl-
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treated HMDM cells underwent necrotic cell death. Caspase-3 activation (a hallmark of 
apoptosis) and the influx of propidium iodide (PI) were examined after HOCl treatment. 
Tyrosine loss was measured as an indication of HOCl damaged proteins. Since 
intracellular ATP levels appear to determine the cell death pathways, ATP level, 
mitochondrial membrane potential and GAPDH activity (an indicator of glycolysis 
efficiency) were examined. The occurrence of HOCl-mediated MPT activation and its role 
in mitochondrial membrane potential loss and HMDM cell death were also examined. 
 
 
4.2 Results  
4.2.1 Effect of HOCl on caspase-3 activation in HMDM cells   
Caspase-3 activation is a hallmark of apoptosis (Reed, 2000). Caspase-3 activation in 
HMDM cells upon HOCl treatment was examined as an indicator of apoptosis. HMDM 
cells were treated with HOCl and examined for caspase-3 activation after 20 hours by 
measuring caspase-3 enzyme activity and Western blotting analysis. Upon activation, the 
inactive 32 kDa procaspase-3 (p32) is proteolyticly cleaved to release the active 17 and 20 
kDa subunits (p17 and p20). The active caspase-3 subunits cleave the synthetic substrate 
Ac-DEVD-AMC to release the fluorescent AMC, which can be detected by the 
fluorometry and acts as an indicator of caspase-3 activation.  
 
HMDM cells treated with increasing HOCl concentrations showed no statistically 
significant increases in free AMC levels compared to that of the HOCl-free control cells 
(Figure 4.1a), indicating that caspase-3 was not activated. The western blotting analysis 
showed no decreased intensity of pro-caspase-3 band with increasing HOCl concentration 
(Figure 4.1b). Faint 17 kDa bands appeared in the lanes representing 0, 50 and 100 μM 
HOCl samples. This suggests that the 17 kDa bands that appeared in the 50 and 100 μM 
HOCl lanes did not result from HOCl-induced pro-caspase-3 cleavage (Figure 4.1b). 
Actin staining confirmed that there was similar loading of protein samples in each well of 
the SDS-PAGE gel. Taken together, HOCl did not induce caspase-3 activation in HMDM 
cells at concentrations up to 300 μM.  
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Figure 4.1 Caspase-3 enzyme is not activated in HMDMS after HOCl treatment. 
HMDM cells (5×106 cells/ml) were treated with increasing HOCl concentrations for 10 
minutes, followed by incubation in HMDM culture medium for 20 hours. Subsequently, a) 
caspase-3 enzyme activity and b) the presence of activated caspase-3 enzymes in HMDM 
cells were examined by fluorescence spectrophotometry and Western blotting, respectively. 
The Western blot photo was modified using Photoshop.  
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H2O2-treated T lymphocytes (Hampton and Orrenius, 1997), HOCl-treated human 
endothelial cells (Vissers et al., 1999), and HOCl-treated human fetal liver cells 
(Whiteman et al., 2005b) have shown caspase-3 activation 1-3 hours after treatment. To 
determine whether caspase-3 activation occurred at much earlier times, HMDM cells 
treated with HOCl were measured for caspase-3 activation at time intervals. An HOCl 
concentration of 150 μM was used, because it caused approximately 50% cell viability loss 
in this particular cell preparation 20 hours after HOCl treatment. The free AMC levels 
measured over time in HOCl-treated HMDM cells were statistically comparable to the 
control cells (Figure 4.2a). The variability in free AMC levels over time was possibly due 
to the low levels of AMC fluorescence, which were below the accurate detection limit of 
the fluorometer. Western blotting analysis showed decreased intensities of procaspase-3 
band, but no active p17 and p20 caspase-3 subunits in HOCl-treated HMDM cells over 
time (Figure 4.2b). This will be further discussed in section 4.3. Overall, HOCl did not 
induce caspase-3 activation in HMDM cells at any time point.    
 
Monocytic THP-1 cells treated with 6% ethanol showed a significant increase in free AMC 
after 5 hours, compared to the 0 hr and 5 hr non-treated controls (Figure 4.3a), implying 
the presence of active caspase-3 enzyme. Western blotting analysis also showed the active 
p17 subunits in 6% ethanol-treated THP-1 cells after 5 hours (Figure 4.3b), and the p17 
band of the ethanol-treated sample was 1.5 times higher in intensity than that of the control 
(Figure 4.3c). These results suggest that 6% ethanol induced caspase-3 activation in 
monocytic THP-1 cells, and that no caspase-3 activation being detected in HOCl-treated 
HMDM cells was not due to the failure of the experimental systems for detecting caspase-3 
activation. 
 
 
4.2.2 HOCl induced rapid necrotic cell death in HMDM cells 
HOCl induced rapid HMDM cell death, possibly via necrosis (Chapter 3). Whether 
HMDM cells undergo necrosis after HOCl treatment was further examined by incubating 
HOCl-treated HMDM cells with the fluorescent propidium iodide (PI) dye, which is used 
for detecting necrotic cells. The intact cell membranes of viable and apoptotic cells exclude 
PI, whereas disrupted membranes of necrotic cells are permeable to PI.  
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Figure 4.2 Time course of caspase-3 enzyme activation in HMDMs treated with HOCl. 
HMDMs (5×106 cells/ml) were treated with 150 μM HOCl for 10 minutes, followed by 
incubation in HMDM culture media. The cells were then collected at time intervals for 
determining a) caspase-3 enzyme activity and b) the presence of activated caspase-3 
enzymes by fluorescence spectrophotometry and Western blotting, respectively. The 
Western blot photo was modified using Photoshop. 
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Figure 4.3 Caspase-3 enzyme is activated in THP-1 cells treated with 6% ethanol. 
a) THP-1 cells (1×106 cells/ml) were treated in the absence (white bars) or presence (gray 
bars) of 6% ethanol in HMDM culture media at 37°C for 5 hours. The cells were 
subsequently analysed for caspase-3 enzyme activity at 0 hour and 5 hour post-treatment. b) 
THP-1 cells (1×106 cells/ml) were treated in the absence or presence of 6% ethanol in 
HMDM culture media at 37°C for 5 hours, followed by Western blotting analysis for the 
presence of activated caspase-3 enzymes. c) The intensity of the 17 kDa caspase-3 band in 
b) was quantified by the Image J software. The Western blot photo was modified using 
Photoshop. 
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HMDM cells were pre-incubated with PI and examined for fluorescence intensity straight 
after the 10-minute HOCl exposure (Figure 4.4). HOCl at 50 μM did not cause an increase 
in PI fluorescence intensity in HMDM cells compared to the control, and the differential 
interference contrast (DIC) image was comparable to that of the control. The fluorescence 
intensity in HMDM cells treated with HOCl concentrations above 50 μM increased with 
increasing HOCl concentrations, indicating that HOCl caused a concentration-dependent 
cell membrane disruption in HMDM cells above a particular HOCl concentration threshold. 
Apoptotic cells in the late stages can also undergo necrosis (termed secondary necrosis) 
and stain positive for PI. However, the rapid PI uptake in combination with the lack of 
caspase-3 activity in HOCl-treated HMDM cells (figures 4.1 and 4.2) provided enough 
evidence that HMDM cells underwent necrosis upon HOCl treatment. PI fluorescent 
staining was found to spread across the entire cytosol. Yet, it also appeared to accumulate 
at one spot inside the HOCl-treated HMDM cells. This will be discussed in section 4.3. 
HMDM cells. This will be discussed in section 4.3.  discussed in  
 
4.2.3 se Effect of HOCl on cellular tyrosine residues 
The damaging effect of HOCl on HMDM cell proteins was studied by examining HOCl- 
induced tyrosine loss in HMDM cells. Tyrosine residues were measured by their native 
fluorescence (λex/λem = 280 nm/320 nm) via reverse phase gradient HPLC following the 
acid hydrolysis of the protein into free amino acids (Gieseg et al., 1993) (Figure 4.5).  
 
Control HMDM cells had a tyrosine concentration of 139.7 ± 3.2 nmol/mg protein. A 
HOCl concentration of 50 μM did not induce statistically significant loss of cell viability 
and cellular tyrosine residues. In contrast, HOCl concentrations above 50 μM caused 
concentration-dependent decrease in both cellular tyrosine residues and cell viability of 
HMDM cells, with 100 μM HOCl causing approximately 50% loss in both parameters 
(Figure 4.6a). The tyrosine residue loss correlated very strongly with cell viability loss (r2 
= 0.9925) (Figure 4.6b). This suggests that HOCl caused concentration-dependent protein 
damage once an HOCl concentration threshold was reached, and the tyrosine residue loss 
might be related to the cell viability loss..,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,...........................................
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Figure 4.4 HMDM cells showed necrotic cell death with increasing HOCl concentrations.   
HMDM cells were treated with 0, 50, 100, 150, and 200 μM HOCl for 10 minutes. Necrotic cells were identified by uptake of  
propidium iodide (PI) fluorescent dye by HMDMs and viewed under a fluorescence microscope with 40× magnification (A to E).  
A’, B’, C’, D’ and E’ represent differential interference contrast (DIC) photos of A, B, C, D and E, respectively.  
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Peak # Retention time Area 
1 5.747 30193 
2 8.033 2738315 
3 16.813 18056 
                                            
  
 
Figure 4.5 HPLC tyrosine analysis of cellular protein hydrolysates from HMDM cells 
treated with or without HOCl. 
HMDM cells were treated a) without or b) with 100 μM HOCl for 10 minutes, followed by 
incubation in HMDM culture media for 1 hour. The cells were subsequently processed for 
tyrosine measurement using the HPLC analysis (see section 2.2.7.3). Peak 2 of 
chromatogram a) and peak 3 of chromatogram b) represent the tyrosine traces in control 
HMDM cells and HOCl-treated HDMM cells, respectively. 
Peak # Retention time Area 
1 5.673 17278 
2 6.727 16695 
3 7.893 1352118 
4 16.767 50775 
0.24
Minutes
0 5 10 15 20
V
ol
ts
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
0.16
0.18
0.20
0.22
1 2
3
4
Detector A (Ex:280nm, Em:320nm)
10
TY 41907 tyrosine loss005
01
 0
Pk #
Minutes
0 5 10 15 20
V
ol
ts
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
0.16
0.18
0.20
0.22
0.24
1
2
3
Detector A (Ex:280nm, Em:320n
Y 041907 tyrosine loss002
m)
01
T
Pk #
  
a) 
Tyrosine 
b)
Tyrosine 
Chapter 4 114
_____________________________________________________________________________________________________________ 
0 50 100 150 200
0
25
50
75
100
*** ***
a)
[HOCl] (μM)
C
el
l v
ia
bi
lit
y/
 c
el
lu
la
r t
yr
os
in
e
(%
 o
f c
on
tro
ls
)
 
 
 
0 25 50 75 100
0
25
50
75
100
r2 =0.9925
p < 0.001
b)
Cell viability (% of control)
C
el
lu
la
r t
yr
os
in
e
(n
m
ol
/m
g 
pr
ot
ei
n)
 
 
Figure 4.6 HOCl induced concurrent loss of tyrosine residues and HMDM cell 
viability. 
HMDM cells (5×106 cells/ml) were treated with increasing HOCl concentrations for 10 
minutes, followed by incubation in HMDM culture medium for 1 hour. a) The cells were 
then analysed for cell viability (white bars) and cellular tyrosine level (gray bars) using the 
MTT reduction assay and HPLC analysis, respectively. The data was expressed as a 
percentage of the respective 0 μM HOCl controls and significance is indicated from the 
respective 0 μM HOCl. b) A correlation analysis is included to illustrate the correlation 
between the tyrosine residue loss and cell viability loss.  
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4.2.4 Effect of HOCl on metabolic energies in HMDM cells 
4.2.4.1 Effect of HOCl on GAPDH enzyme activity 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is an essential enzyme in 
glycolysis, the pathway converting glucose to pyruvate and 2 ATP molecules. The effect of 
HOCl on HMDM metabolic energy was hence studied by examining the loss of GAPDH 
enzymatic activity in HMDM cells. HOCl at 50 μM reduced the GAPDH activity in 
HMDM cells from a control value of 23.6 ± 0.8 to 20.6 ± 2.5 μM/min/mg protein (13% 
decrease), though it was statistically insignificant. HOCl at 100, 150, 200, and 500 μM 
reduced the GAPDH activity in HMDM cells to 11.9 ± 1.9 (50% decrease), 3.7 ± 1.1 (84% 
decrease), 1.8 ± 0.8 (92% decrease), and 0.4 ± 0.1 (100% decrease) μM/min/mg protein, 
respectively (Figure 4.7a).  
 
The GAPDH activity was measured concurrently with cell viability and intracellular GSH 
(see Figure 3.6). HOCl at 100 μM caused statistically insignificant cell viability loss, 
while 150 μM HOCl caused approximately 50% loss in cell viability. Moreover, GAPDH 
activity loss directly correlated with intracellular GSH loss (r2 = 0.9298) (Figure 4.7b). 
Taken together, HOCl caused a concentration-dependent decrease in GAPDH activity at 
HOCl concentrations above 50 μM, which occurred concurrently with intracellular GSH 
loss but preceded the cell viability loss.  
 
4.2.4.2 Effect of HOCl on intracellular ATP 
The effect of HOCl on metabolic energy in HMDM cells was also studied by treating 
HMDM cells with HOCl and examining intracellular adenosine triphosphate (ATP) loss 
after 20 hours via HPLC analysis (see section 2.2.7.4). HOCl at 50 μM did not cause a 
statistically significant decrease in intracellular ATP concentration compared to the control 
(containing 31.2 ± 3.4 nmol/mg protein). In contrast, HOCl at 100, 150 and 200 μM 
reduced intracellular ATP concentrations by approximately 33, 52 and 82% of the control, 
respectively. Cell viability loss directly correlated with the ATP loss. HOCl at 50 μM did 
not cause statistically significant HMDM cell viability loss, while 100, 150 and 200 μM 
HOCl caused approximately 40, 75 and 86% cell viability loss, respectively (Figure 4.8). 
By using HMDM cells from the same cell preparation used in Figure 4.8, intracellular 
ATP depletion following the HOCl treatment was measured for the next 24 hours (Figure 
4.9). This showed that the ATP loss only occurred during the HOCl treatment. There was 
no further loss, nor was there a significant recovery.  
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Figure 4.7 GAPDH activity loss in HOCl-treated HMDM cells occurred before cell 
viability loss and correlated directly with intracellular GSH loss.  
HMDM cells (5×106 cells/ml) were treated with varying HOCl concentrations for 10 
minutes, followed by incubation in HMDM culture medium for 1 hour. a) The cells were 
then analysed for cell viability ( ? ) and GAPDH enzyme activity ( ? ). Cell viability is 
presented as a percentage of the 0 μM HOCl control. Significance is indicated from the 
respective 0 μM HOCl controls. b) The GAPDH enzyme activity was compared with 
intracellular GSH after HOCl treatment using a trend line to illustrate the correlation.  
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Figure 4.8 Effect of HOCl on intracellular ATP and cell viability. 
HMDM cells (5×106 cells/ml) were treated with increasing HOCl concentrations for 10 
minutes, followed by incubation in HMDM culture medium for 20 hours. The cells were 
subsequently analysed for cell viability (white bars) by the MTT assay, and intracellular 
ATP (grey bars) by the HPLC analysis. Each parameter is presented as a percentage of the 
respective 0 μM HOCl control. Significance is indicated from the respective 0 μM HOCl 
control.  
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Figure 4.9 Time course of ATP loss in HMDM cells after HOCl treatment.   
HMDM cells (5×106 cells/ml) were treated with ( ? ) or without ( ? ) 100 μM HOCl for 
10 minutes, followed by incubation in HMDM culture medium. The cells were then 
removed at time intervals for the analyses of intracellular ATP by HPLC analyses. 
Significance is indicated from the respective 0 hr data. 
Chapter 4 118
_____________________________________________________________________________________________________________ 
4.2.4.3 Effect of HOCl on mitochondrial membrane potential 
The loss of cell viability as measured by the MTT assay and ATP depletion in HOCl-
treated HMDM cells suggested that HOCl may also induce mitochondrial dysfunction. To 
study the effect of HOCl on mitochondria, HOCl-treated HMDM cells were examined for 
mitochondrial membrane potential loss using a mitochondria-specific potentiometric probe, 
tetramethylrhodamine methyl ester (TMRM), with assessment of fluorescence intensities.  
 
With increasing HOCl concentrations, there was a rapid decrease in mitochondrial 
membrane potential within 10 minutes, indicated by the fluorescence intensity decrease of 
the TMRM (Figure 4.10a). The concurrent analysis of HMDM cell viability loss showed 
that the fluorescence intensity decrease occurred before significant cell viability loss was 
observed (Figure 4.10b). This indicates that mitochondrial membrane potential loss may 
precede and contribute to HMDM necrotic cell death.  
 
To investigate whether HOCl-induced loss of mitochondrial membrane potential was due 
to the opening of high-conductance membrane permeability transition pores (MPT), 
HMDM cells were incubated with cyclosporin A (CSA) together with TMRM before 
HOCl treatment. CSA is an inhibitor of the cyclophilin D protein of the MPT complex. 
This inhibitor improves loading of TMRM due to inhibition of the multi-drug resistance 
(MDR) pump (Bernardi et al., 1990). Therefore, all the samples (both controls and HOCl-
treated) were treated identically with CSA to increase the fluorescence intensities. HOCl at 
150 μM induced significant and rapid mitochondrial membrane potential loss by 
approximately 80%, while 5 and 10 μM CSA inhibited the mitochondrial membrane 
potential loss completely (not different from the control (p > 0.05)) (Figure 4.11a and b). 
This suggested that HOCl induced MPT pore opening in HMDM cells via CSA-sensitive 
site such as cyclophilin D, which then led to mitochondrial membrane potential loss.  
 
Cell viability in HOCl-treated HMDM cells was also analysed in the presence or absence 
of CSA. HMDM cells exposed to 150 μM HOCl showed approximately 50% cell viability 
loss, whereas HMDM cells pre-incubated with 5 and 10 μM CSA before HOCl treatment 
completely prevented the cell viability loss (Figure 4.12). This suggests that HOCl-
induced cell viability loss can be prevented by inhibiting opening of the MPT. 
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Figure 4.10 Effect of HOCl on HMDM mitochondrial membrane potential.   
HMDM cells (5×106 cells/ml) on coverslips were pre-incubated with 100 nM of 
tetramethylrhodamine methyl ester (TMRM) for 30 minutes (see section 2.2.12.4). a) The 
cells were then treated with increasing HOCl concentrations for 10 minutes, followed by 
immediate examination under a fluorescence microscope (λex/λem = 548/574nm). DIC 
photos for each of the respective fluorescence photos are shown. b) Fluorescence 
intensities of the cells are converted to numerical values using Image J software. HMDM 
cells of the same cell preparation were also examined for cell viability by the MTT assay 
after the 10-minute HOCl treatment. Both data were presented as percentages of the 
respective 0 μM HOCl controls. Significance is indicated from the respective 0 μM HOCl 
control. 
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Figure 4.11 Mitochondrial membrane potential loss was inhibited in HMDM cells 
treated with 150 μM HOCl by cyclosporin A (CSA).   
a) HMDM cells (5×106 cells/ml) on coverslips were pre-incubated with 100 nM TMRM in 
the presence of 0, 5 or 10 μM CSA for 30 minutes. The cells were then treated with 150 
μM HOCl for 10 minutes. A control without CSA and HOCl treatments was also prepared. 
The cells were then examined under a fluorescence microscope (λex/λem = 548/574nm). 
The photos on the right hand side (labelled with ’) represent the DIC photos of the 
respective fluorescence photos on the left hand side. b) Fluorescence intensities are 
converted to numerical values, which are presented as percentages of the control. 
Significance is indicated from the same control. 
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Figure 4.12 Cell viability loss was inhibited in HMDM cells treated with 150 μM 
HOCl by cyclosporin A (CSA).   
HMDM cells (5×106 cells/ml) were pre-incubated with 0, 5 or 10 μM CSA for 30 minutes. 
The cells were then treated with 150 μM HOCl for 10 minutes. A control without CSA and 
HOCl treatments was also prepared. The cells were examined for cell viability after 6 
hours using the MTT reduction assay. Cell viability is presented as a percentage of the 
control and significance is indicated from the same control. 
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4.2.5 Effect of HOCl on superoxide generation in HMDM cells  
HOCl was shown to cause mitochondrial membrane potential loss in HMDM cells as 
mentioned before. Mitochondrial membrane potential loss may lead to ROS generation in 
cells, such as superoxide (Cai and Jones, 1998; Stridth et al., 1998; Gottlieb et al., 2000). 
To study whether HOCl induces superoxide generation in HMDM cells, the cells were 
treated with 150 μM HOCl, followed by incubation with dihydroethidium (DHE) dye (see 
section 2.2.14.1) and examination of fluorescence intensities. The cells treated with HOCl 
showed increased fluorescence intensities compared to the control cells (Figure 4.13), 
indicating that HOCl induced superoxide generation.  
 
 
 Control 
   
150 μM HOCl 
 
   
 
 
Figure 4.13 Effect of HOCl on superoxide production in HMDM cells.   
HMDM cells (5×106 cells/ml) on coverslips were treated with (B) or without (A) 150 μM 
HOCl for 10 minutes, followed by incubation with 10 μM DHE for 20 minutes for the 
fluorescence probing of superoxide in HMDM cells. The cells were then viewed under a 
fluorescence microscope (λex/λem of 500-530nm/590-620nm). The photos at the bottom 
represent the DIC photos of the respective fluorescence photos at the top.  
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4.3 Discussion 
4.3.1 Effect of HOCl on caspase-3 activation in HMDM cells 
The results in Chapter 3 showed that HOCl caused rapid necrotic cell death within 10 
minutes of treatment, as determined by the loss of plasma membrane integrity (measured 
by trypan blue assay) and the rapid loss of metabolic energy (measured by MTT reduction 
assay). To further validate that HMDM cells underwent necrotic cell death upon HOCl 
treatment, caspase-3 activation in HOCl-induced HMDM cells was examined. Caspase-3 is 
an effector caspase involved in inducing a large number of apoptotic processes within the 
cells (Reed, 2000). Its activation would hence be a reliable indicator of caspase-mediated 
apoptosis in cells (see section 1.7.1.2 for the mechanism of caspase-3 activation). 
 
Enzyme activity and Western blotting analyses of caspase-3 showed that HOCl did not 
induce caspase-3 activation in HMDM cells at any of the concentrations tested and at any 
time post treatment (Figures 4.1 and 4.2). These results agree with some previous studies, 
which showed that oxLDL and HOCl did not activate caspase-3 in HMDM cells (Asmis 
and Begley, 2003) and neuronal cells (Yap et al., 2006), respectively. By using the same 
methodologies, caspase-3 activation was detected in monocytic THP-1 cells treated with 
6% ethanol for 5 hours (Figure 4.3). This suggests that the lack of detection of caspase-3 
activation in HOCl-treated HMDMs was not due to methodological errors.   
 
HMDM cells treated with 150 μM HOCl showed decreases in procaspase-3 band 
intensities compared to the non-treated control (Figure 4.2b), although no caspase-3 
activity was observed. This was possibly because HOCl caused procaspase-3 protein 
fragmentation. In Chapter 5, HOCl was shown to cause calpain activation and lysosomal 
destabilisation. Hence, it was possible that cathepsin proteases from ruptured lysosomes 
and calpains caused procaspase-3 cleavage and degradation. Indeed, calpains have been 
shown to cleave caspases and prevent them processing into active forms (Lankiewicz et al., 
2000; Bizat et al., 2003). 
 
The lack of pro-caspase-3 activation or caspase-3 enzyme activity in HOCl-treated HMDM 
cells can be attributed to the possible inactivation of caspase-9. HMDM cell viability 
occurred only after intracellular GSH was significantly decreased (see Figure 3.6). It was 
highly likely that HOCl in the presence of insufficient amount of antioxidant GSH oxidised 
the critical cysteine thiol group at the active site of caspase-9, resulting in inactivation. 
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Loss of protein thiols was observed in endothelial cells exposed to HOCl (Pullar et al., 
1999). Hampton and Orrenius (1997) have also suggested that H2O2 inhibited Fas-
mediated caspase activity in Jurkat T lymphocytes, possibly via oxidative inactivation at 
the critical cysteine group. In addition, dithiocarbamate was shown to inactivate caspases 
at critical thiol-containing residues (Orrenius et al., 1996).  
 
HOCl can also indirectly inactivate caspase-9 by interacting with the components that form 
apoptosome and hence preventing its formation. Apoptosome (composed of Apaf-1, 
cytochrome c, and dATP or ATP) activates caspase-9, which in turn activates pro-caspase-
3 (Kroemer and Martin, 2005). HOCl has been shown to oxidize cytochrome c at lysine 
residues (Chen et al., 2004). Post-translational modification of the lysine residue of yeast 
isocytochrome c results in a low affinity for Apaf-1 and consequently an inability to induce 
caspase activation (Kluck et al., 2000). Hence oxidized cytochrome c possibly prevented 
the formation of apoptosome due to its lowered affinity for Apaf-1. Furthermore, ATP or 
dATP are required for caspase-3 activation (Liu et al., 1996; Hampton et al., 1998a). Since 
intracellular ATP concentration was rapidly decreased in HMDM cells within 10 minutes 
of HOCl treatment (Figure 4.9), there was possibly insufficient energy in HMDM cells to 
drive apoptosome formation and caspase-3 activation.  
 
Finally, calpain enzymes can cleave several apoptosis regulatory proteins, including Apaf-
1 (Reimertz et al., 2001). Furthermore, as mentioned above, calpain enzymes cleave 
caspases and therefore prevent them from being processed into the active forms. HOCl was 
shown to activate calpains in HMDM cells (see Chapter 5), indicating that calpains might 
have inhibited the activation of caspases.  
 
Although the lack of caspase-3 activation in HOCl-treated HMDM cells suggests that 
HMDM cells undergo necrotic cell death upon HOCl treatment, apoptosis can still occur 
via a caspase-3-independent pathway (Kroemer and Martin, 2005). However, HOCl caused 
a rapid and concentration-dependent increase of propidium iodide (PI) in HMDM cells at 
concentrations above 50 μM (Figure 4.4). This was indicative of increased cell membrane 
disruption and hence necrosis above a particular HOCl concentration threshold. This result 
was in agreement with the results in Chapter 3, which demonstrated that HOCl caused 
HMDM cell swelling and cell membrane rupture (Figure 3.5).  
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Taken the above results together, HOCl caused HMDM cells to undergo rapid necrotic cell 
death once a concentration threshold was reached, below which no cell viability loss was 
observed. This agrees with Park et al. (2008), who demonstrated that HOCl caused HeLa 
cells to undergo necrosis at HOCl concentrations above 50 μM. In contrast to the current 
result, some studies have shown that a low dose of HOCl (less than 100 μM) triggered 
apoptosis in human endothelial cells and human fetal liver cells, while a higher dose 
induced necrosis (Vissers et al., 1999; Whiteman et al., 2005b; Sugiyama et al., 2004). 
HMDM cells did not undergo apoptosis and lose cell viability at lower HOCl concen-
trations like the cell types mentioned above, possibly because of the difference in cell 
defense mechanisms and hence tolerance to HOCl. It is possible that at relatively low 
HOCl concentrations, the intracellular GSH level of HMDM cells was sufficient to 
scavenge all HOCl to prevent apoptosis and the reduced GSH was able to regenerate.  
 
 
4.3.2 Effect of HOCl on general protein damage in HMDM cells  
Tyrosine loss is an indicator of general protein damage. HOCl caused cellular tyrosine loss 
in a concentration-dependent manner once an HOCl concentration threshold was reached 
(Figure 4.6a), indicating that HOCl inflicted damage on the cellular proteins. The tyrosine 
loss strongly correlated with the cell viability loss in HMDM cells upon HOCl treatment 
(Figure 4.6). Cell viability in this research was measured by both MTT reduction assay (a 
measure of mitochondrial activity) and trypan blue assay (a measure of cell membrane 
integrity). Hence, it can be hypothesized that HOCl-mediated tyrosine residue loss and 
therefore general protein oxidation either led to or was caused by mitochondrial 
dysfunction and the loss of cell membrane integrity.  
 
A tyrosine residue (called Y1176) was found to locate in the calpain cleavage site of 
spectrin, which is a component of the cell membrane skeleton (Nicolas et al., 2002). Since 
HOCl has demonstrated to mediate calpain activation and calpains were previously 
demonstrated to cause cytoskeleton damage and hence plasma membrane deformation (see 
Chapter 5), one speculation was that calpains cleaved at site where tyrosine is located in 
spectrin and damaged it to a form that could not be identified by the HPLC analysis. 
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4.3.3 Effect of HOCl on metabolic energies in HMDM cells  
HOCl caused a concentration-dependent decrease in glyceraldehyde 3-phosphate dehydro- 
genase (GAPDH) activity at HOCl concentrations above 50 μM, which occurred con-
currently with intracellular GSH loss but preceded cell viability loss (Figure 4.7). GAPDH 
is an enzyme in glycolysis, which is responsible for converting glucose into pyruvate with 
a net production of 2 ATP and 2 NADH molecules. It catalyses the conversion of 
glyceraldehyde-3-phosphate to 1,3-bis-phosphoglycerate with the generation of 2 NADH 
(Mathews and van Holde, 1995). As a result of GAPDH activity loss in HMDM cells after 
HOCl treatment, the efficiency of the Krebs cycle and oxidative phosphorylation in 
mitochondria might reduce, resulting in decreased ATP production.  
 
The loss of GAPDH activity could be partly attributed to the loss of NAD+, a cofactor 
required for the activity of GAPDH, since Schraufstatter et al. (1990) showed that HOCl 
can react with NAD+ within 10 minutes in murine macrophage-like cells. However, this 
was less likely the major cause of GAPDH inactivation in HOCl-treated HMDM cells, 
because GAPDH activity was measured in this research by supplementing the HOCl-
treated cell samples with required substrates including NAD+, after which GAPDH activity 
was still not recovered. A more likely explanation for GAPDH inactivation in HOCl-
treated HMDM cells was that HOCl induced thiol oxidation at critical site. GAPDH 
contains an essential reduced cysteine (Cys149) at the active site (Pullar et al., 2000), and 
HOCl has been shown to oxidise GAPDH thiol groups with parallel loss of activity (Peskin 
and Winterbourn, 2006). The same study also showed that dithiothreitol (DTT) treatment 
reversed the HOCl-induced thiol oxidation and inactivation of GAPDH by at least 70%. 
This suggested that the most likely products of HOCl reacting with GAPDH thiol groups 
were disulfides and sulfenic acids. In addition, GAPDH in colon epithelial cells (Mckenzie 
et al., 1999), human endothelial cells (Pullar et al., 1999), and human mononuclear 
leukocyte (Smit and Anderson, 1992) were found susceptible to HOCl oxidation. GAPDH 
inactivation by thiol oxidation was also found in inflamed mucosa of patients with 
inflammatory bowel disease (Mckenzie et al., 1996).   
 
The loss of GAPDH activity strongly correlated to the GSH loss in HMDM cells treated 
with increasing HOCl concentrations (Figure 4.7b). One possible speculation for this 
strong correlation was that GAPDH and GSH show similar abundance in HMDM cells and 
reactivity with HOCl. GAPDH thiol group is very susceptible to HOCl oxidation as 
mentioned above, implying that it is highly reactive with HOCl. Macrophages show a high 
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metabolic rate to provide fuels for their function regarding immune responses (Newsholme 
and Newsholme, 1989). Disruption of the respiratory chain induced by the uncoupler 
adriamycin and inhibition of ATP synthase by oligomycin promote macrophage lysis 
within 24 hours (Asmis and Begley, 2003). Based on these findings, GAPDH should be 
abundant in HMDM cells in order to maintain glycolysis and provide substrates for the 
Krebs cycle and electron transport chain at high rate. It has also been suggested that 
GAPDH and some other glycolytic enzymes are localized in erythrocyte membrane as an 
enzyme complex (Campanella et al., 2005). It is possible that as HOCl passed through 
membrane, it encountered GAPDH thiols first or at the same time as GSH, hence causing 
the same degree of loss as intracellukar GSH loss.  
 
In this research, GAPDH activity loss in HMDM cells was measured only 1 hour after 
HOCl treatment, not at time intervals (Figure 4.7). Hence, it was unknown whether the 
GAPDH activity loss could be recovered over time. GAPDH recovery was unlikely to 
occur, as the ATP levels in HOCl-treated HMDM cells remained low over time (Figure 
4.9). NO caused the thiols at the active site of GAPDH enzyme to form sulfenic acid, 
resulting in activity loss (Ishii et al., 1999). This suggests that the lack of GAPDH activity 
recovery could be due to HOCl oxidising the essential cysteine thiol group to a sulfenic 
acid or another high oxidation product(s) that could not be repaired (see also section 3.3).  
 
Effect of HOCl on metabolic energies was further investigated by examining the ATP loss 
in HOCl-treated HMDM cells. HOCl caused a concentration-dependent decrease in ATP 
above 50 μM concentration, which was strongly correlated to the cell viability loss (Figure 
4.8). The time course study showed that 100 μM HOCl-induced ATP depletion occurred 
within 10 minutes of the treatment and did not decrease further or recover over time 
(Figure 4.9). These results suggest that HOCl-mediated intracellular ATP loss in HMDM 
cells contributed to the resulting necrotic cell death, since rapid ATP loss is suggested to 
result in necrosis (Eguchi et al., 1997).  
 
The rapid decrease in intracellular ATP in HOCl-treated HMDM cells is in corroboration 
with Spragg et al. (1985), who showed 83% decrease in ATP level in murine macrophage 
like cells within the first few minutes of H2O2 treatment. In contrast to the current result, 
rat type II alveolar epithelial cells treated with HOCl showed an increase in ATP level in 
the first 30 minutes of treatment, followed by a decrease (Abernathy and Pacht, 1995). The 
same study also showed that HOCl only caused approximately 5% cell viability loss. The 
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differences between their result and the current result might be attributed to the different 
media used during HOCl treatment. Abernathy and Pacht (1995) used Dulbecco's modified 
eagle medium (DMEM) during HOCl treatment, whereas EBSS buffer was used in this 
research. DMEM contained amino acids and proteins, which could be oxidized by HOCl 
forming chloramines, which can also damage biomolecules (Pullar et al., 2000). For 
instance, taurine chloramines at 500 μM concentration caused approximately 15-20% ATP 
loss in erythrocytes within 1 hour (Thomas et al., 1985). This indicates that chloramines, 
not HOCl, might be the primary oxidant attacking ATP in rat type II alveolar epithelial 
cells in Abernathy and Pacht’s experimental system.  
 
The rapid ATP loss in HMDM cells upon HOCl treatment might be attributed to HOCl 
reacting directly with ATP (Prutz, 1996). In addition, the results in Chapter 5 will show 
that HOCl-induced mitochondrial membrane potential loss was attributed to calcium ion 
(Ca2+) accumulation in matrix, as a result of mitochondria taking up excess cytosolic Ca2+ 
via the Ca2+ uniporter in the inner mitochondrial membrane (IMM). This uniporter is 
gated/activated by ATP (Bianchi et al., 2004). Therefore, the HOCl-induced Ca2+ uptake 
process might have consumed ATP, resulting in ATP loss. Intracellular ATP decrease 
could also be attributed to increased activity of the membrane associated cation ATPase 
pumps. Modest damage to lipid components of the cell membrane might allow augmented 
passive leak of Na+, K+, or Ca2+ across the membrane, stimulating ATPase activity, at the 
expense of ATP (Spragg et al., 1985). However, this was less likely to happen in HOCl-
treated HMDM cells, because HOCl was shown to inactivate Na+-K+-ATPase (Kato et al., 
1998) and Ca2+-ATPase (Eley et al., 1991).  
 
As mentioned above, intracellular ATP loss was not recovered in HMDM cells over time 
after the initial HOCl treatment. This could be due to HOCl causing mitochondrial 
membrane potential loss (Figure 4.10), suggesting dysfunction of electron transport chain 
(ETC) and therefore ATP synthesis. Succinate dehydrogenase enzymes in the Krebs cycle 
in mitochondria were also inactivated by HOCl. MTT reduction assay relies on the activity 
of cellular succinate dehydrogenase enzymes (see section 2.2.5.1). The cell viability loss 
(measured by MTT reduction assay) in HMDM cells upon HOCl treatment hence indicated 
that HOCl caused the activity loss of succinate dehydrogenase enzymes in HMDM cells. 
The consequent effect would be impairment of the Krebs cycle, dysfunction of the ETC, 
and hence decreased ATP generation. Furthermore, the generation of superoxide within 10 
minutes of HOCl treatment (Figure 4.13) suggested dysfunction of complex III in the ETC. 
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HOCl was also found to inactivate GAPDH enzyme (Figures 4.7), which might have 
impaired glycolysis. ATPase-synthase enzyme complex catalyzing the phosphorylation of 
ADP in mitochondrial matrix could be inhibited in alveolar type II cells after H2O2 
treatment, resulting in decreased ATP generation (LaCagnin et al., 1990). It was possible 
that HOCl could also inhibit this enzyme complex in HMDM cells. Glucose transport 
inhibition has been demonstrated in HOCl-treated murine macrophage-like tumor cells 
(Schraufstatter et al., 1990), which may also affect ATP generation. Accumulation of Ca2+ 
in mitochondrial matrix can induce cysteine protease calpain 10 that are present in the 
mitochondrial matrix, which can inhibit complex I of the ETC (Arrington et al., 2006). It 
will be hypothesized in Chapter 5 that mitochondrial calpains might be activated in 
HMDM cells upon HOCl treatment, indicating that they might have damaged complex I 
and prevent ATP generation.  
 
 
4.3.4 Effect of HOCl on MPT activation and mitochondrial membrane 
potential in HMDM cells 
ATP depletion in HOCl-treated HMDM cells suggests that HOCl might have caused 
damage to mitochondria, the major machinery for ATP generation in cells. In this research, 
HOCl was shown to cause mitochondrial membrane potential loss in HMDM cells in a 
concentration-dependent manner, and the loss occurred before significant cell viability was 
observed (Figures 4.10). This suggests that this mitochondrial membrane potential loss 
might contribute to the HMDM necrotic cell death.  
 
The probe used in this thesis for detecting mitochondrial membrane potential was the 
methyl ester of tetramethylrhodamine (TMRM). A number of probes for mitochondrial 
membrane potential detection exist. Yet, none of them are perfect sensors as they all 
generate artifacts that can confound the interpretations of fluorescence emission in 
determining mitochondrial function. Such artifacts include toxicity, photobleaching, 
binding passively to mitochondria or other intracellular organelles, and activation of the 
MDR pump. Nonetheless, Bernardi et al. (1999) have suggested that the rhodamine group 
is the least problematic, in particular TMRM. Low nanomolar range of TMRM exclusively 
stains the mitochondria and it does not accumulate in cell membranes or interact with 
membrane proteins. Therefore, it is not retained by the mitochondria upon mitochondrial 
membrane potential loss.  
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It was unlikely that the detected mitochondrial membrane potential loss in HOCl-treated 
HMDM cells was an artifect, caused by HOCl directly reacting with TMRM. HMDM cells 
treated with HOCl in Ca2+-free EBSS medium showed a TMRM fluorescence intensity that 
was comparable to that of the HOCl-non-treated cells, whereas HMDM cells treated with 
HOCl in Ca2+-rich EBSS medium showed a significant decrease in TMRM fluorescence 
intensity (Figure 5.12). This result indicates that HOCl did not directly react with TMRM, 
because a direct reaction should lead to TMRM fluorescence intensity decrease in HOCl-
treated HMDM cells in both the Ca2+-free and Ca2+-rich EBSS media.  
 
The observed mitochondrial membrane potential loss in HMDM cells after HOCl 
treatment was prevented by cyclosporin A (CSA) with as low as 5 μM concentration 
(Figure 4.11). CSA is a potent immunosuppressant widely used to reduce rejection in 
transplantation surgery. It is also known to bind and block the peptidylprolyl isomerase 
activity of matrix CyP-D, which is required to form an ANT/CyP-D protein complex for 
MPT pore opening (Connern and Halestrap, 1992; Halestrap and Davidson, 1990; 
Woodfield et al., 1998; McStay et al., 2002; Vieira et al., 2000). MPT was significantly 
activated by mitochondria taking up excess Ca2+ from the cytosol (see chapter 5). 
Whiteman et al. (2004) have shown that CSA did not prevent MPT activation by 
preventing Ca2+ uptake by mitochondria. Taken together, the observed inhibitory effect of 
CSA confirmed the involvement of the MPT activation in mitochondrial membrane 
potential loss. This is in agreement with Park et al. (2008) and Whiteman et al. (2005b), 
who showed MPT-induced mitochondrial membrane potential loss in HOCl-treated HeLa 
cells and human hepatoma HepG2 cells, respectively.  
 
CSA, at 5 μM concentration, prevented HOCl-induced cell viability loss completely 
(Figure 4.12). CSA at the same concentration also significantly prevented cell morpho-
logical changes (i.e. cell swelling and cell membrane rupture) (Figure 4.11 DIC photos). 
This suggests that HOCl-mediated MPT activation induced mitochondrial membrane 
potential loss, which resulted in HMDM necrotic cell death. This agrees with Asmis and 
Begley (2003), who showed that oxLDL-induced peroxyl radical generation caused 
mitochondrial membrane potential loss and subsequently necrotic cell death in 
macrophages. HOCl can inactivate Na+-, K+-, and Ca2+-ATPase ion pumps (Eley et al., 
1991; Kato et al., 1998), which are essential for maintaining plasma membrane potential. 
Inactivation of these ion pumps would directly promote macrophage lysis. In this research, 
blocking the L- and T-type calcium ion channels in HMDM cell membranes, inhibiting 
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calpain activation (see Chapter 5) and preventing MPT activation (in this chapter) 
prevented HOCl-induced HMDM cell viability loss. This suggests that HOCl caused 
necrotic cell death in HMDM cells via HOCl-induced cytosolic calcium ion accumulation, 
calpain activation and MPT activation (discussed in Chapter 5), not by directly damaging 
HMDM cell membrane and causing inactivation of Na+-, K+- and Ca2+-ATPase ion pumps.  
 
MPT activation has been suggested to be a common pathway leading to both apoptosis and 
necrosis (Kim et al., 2003a). The MPT pore formation allows the solutes (< 1500 Da) to 
pass non-selectively between cytosol and matrix, leading to rapid depolarization, matrix 
swelling and eventually outer membrane rupture (Kim et al., 2003b). The consequences for 
the cell include either release of cytochrome c, activation of caspase cascades, and 
apoptosis or the drastic loss of ATP via disruption of the inner mitochondrial membrane 
(IMM) and necrotic cell death. However, it has also been suggested that a clear distinction 
between these two death pathways may not always be possible (Lemasters, 1999; Jacschke 
and Lemasters, 2003). In this thesis, HMDM cells treated with HOCl showed several 
necrotic features, including cell swelling, cell membrane disruption, caspase-3 inactivation, 
and rapid metabolic energy loss. It can be concluded that the predominant mode of HMDM 
cell death induced by HOCl was necrotic, rather than apoptotic.  
  
HOCl induced superoxide generation in HMDM cells within 10 minutes of HOCl 
treatment (Figure 4.13). This radical was detected by the cell-permeable dihydroethidium 
fluorescent dye (DHE). This dye is oxidized by superoxide radicals to form ethidium, 
which then binds to DNA/RNA leading to enhancement of red fluorescence (Budd et al., 
1997; Zhao et al., 2003). The red fluorescence was enhanced significantly in a localized 
area in HOCl-treated HMDM cells, possibly mitochondria, because mitochondria are the 
main source of superoxide radicals and DNA/RNA are present there to react with the 
resulting ethidium. The red fluorescence was also increased in cytosol of HMDM cells 
treated with HOCl. This implied that ethidium bound to mitochondrial DNA/RNA were 
leaked out of mitochondria, supporting the hypothesis of MPT activation and 
mitochondrial outer membrane rupture as mentioned earlier. The enhanced red 
fluorescence intensity in HOCl-treated HMDM cells was not caused by HOCl reacting 
directly with DHE, because HMDM cells were treated with DHE after HOCl treatment. 
 
The results in this research have demonstrated that HOCl caused MPT pore opening in 
HMDM cells (Figure 4.11), which might have contributed to the superoxide generation. 
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The components of the ETC, such as cytochrome c, could be leaked out of mitochondria 
through the activated MPT pore. This loss of ETC components can lead to the escape of 
electrons from complex III, which can then reduce oxygen molecules and form superoxide 
radicals (Luetjens et al., 2000). In contrast, some studies suggest that mitochondria-
mediated ROS generation, as a result of exposing cells to oxidative stress or apoptotic 
stimulus, can cause MPT activation (Kim et al., 2003b; Kowaltowski et al., 2001). Further 
studies are required to understand how exactly HOCl mediated superoxide generation in 
HMDM cells.  
 
MPT is regulated by a number of factors. High membrane potential, Mg2+, ADP, 
NAD(P)H, and low pH keep the pore in a closed conformation, while Ca2+, Pi, NAD(P)+, 
oxidizing agents, and high pH tend to open the pore (Hansson et al., 2003). This research 
will focus on the effect of Ca2+ and oxidizing agent (i.e. HOCl) on MPT activation, 
together with how MPT activation leads to necrotic cell death (Chapter 5).  
 
 
4.4 Conclusion 
HOCl caused HMDM cells to undergo necrotic cell death, demonstrated by the influx of 
propidium iodide dye (PI) into the cells, lack of caspase-3 activation, and intracellular ATP 
loss within 10 minutes of HOCl treatment. The initial intracellular ATP loss was not 
recovered over time after the treatment. This was possibly due to HOCl compromising the 
intracellular machinery for ATP production, since HOCl treatment also led to the loss of 
GAPDH activity and mitochondrial membrane potential in HMDM cells within 10 minutes 
of treatment.  
 
CSA prevented HOCl-mediated loss of mitochondrial membrane potential and cell 
viability by inhibiting MPT pore formation. These results indicate that HOCl caused MPT-
mediated mitochondrial membrane potential loss, which led to necrotic cell death. 
Superoxide generation was detected in HMDM cells upon HOCl treatment, which could be 
attributed to MPT activation and dysfunction of the electron transport chain. HOCl also 
caused cellular tyrosine loss, which correlated strongly with the HMDM cell viability loss. 
This indicates that this HOCl-induced tyrosine loss was in a cause-and-effect relationship 
with the MPT-mediated mitochondrial membrane potential loss and necrotic cell death.  
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5.   THE ROLE OF CALCIUM IN HOCL- 
MEDIATED NECROTIC CELL DEATH IN 
HMDM CELLS  
 
5.1 Introduction  
Free calcium ions (Ca2+) play a key role in signaling in eukaryotic cells. Transient 
increases in cytosolic free Ca2+ can regulate many physiological processes, including cell 
proliferation and neurotransmitter release (Halliwell and Gutteridge, 2007). Influx of Ca2+ 
into the cytosol also leads to mitochondrial accumulation of Ca2+, activation of the Krebs 
cycle, and oxidative phosphorylation with the subsequent ATP production (Maack and 
O’Rourke, 2007; Brookes et al., 2004). Mitochondrial Ca2+ plays a role in allosteric 
activation of pyruvate dehydrogenase, isocitrate dehydrogenase, and α-ketoglutarate 
dehydrogenase (McCormack and Denton, 1993). It also plays a role in stimulation of the 
ATP synthase (complex V) (Das and Harris, 1990), α-glycerophosphate dehydrogenase 
(Wernette et al., 1981), and the adenine nucleotide translocase (ANT) (Mildaziene et al., 
1995). Many other mitochondrial functions are also regulated by Ca2+. For example, Ca2+ 
activation of N-acetylglutamine synthetase generates N-acetylglutamine, a potent allosteric 
activator of carbamoyl-phosphate synthetase, the rate-limiting enzyme in the urea cycle 
(Brookes et al., 2004). Ca2+-sensitive protein kinase (PKC) isoforms and calmodulin have 
also been reported in mitochondria, although their precise targets within the organelle are 
less well understood (Fernandez et al., 1995; Ruben et al., 1980).  
 
Most unstimulated cells tightly regulate free Ca2+ in the range of 100 to 200 nM in both the 
cytosol and the mitochondria, whereas the extracellular free Ca2+ concentration is 
approximately 2 mM. This concentration gradient is maintained by a number of cellular 
systems. For example, Ca2+ is bound to proteins such as calmodulins. Moreover, Ca2+ can 
be extruded out of cells or taken up by endoplasmic reticulum (ER) via ATP-dependent 
Ca2+ pumps in the plasma or ER membrane, respectively. Ca2+ can also be transported out 
of cells (against its concentration gradient) with the entry of Na+ (down its concentration 
gradient) through Na+/Ca2+ exchange transporters across the plasma membrane. The Na+ is 
then exported out of cells by the ATP-dependent sodium pump. In addition, to a lesser 
extent, mitochondria can take up excess cytosolic Ca2+ (Halliwell and Gutteridge, 2007). 
Ca2+ can diffuse through the outer mitochondrial membrane (OMM) into the inter-
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membrane space via the voltage-dependent anion channel (VDAC), which is a large 
conductance channel permeable to ions and small proteins (< 5000 Da) (see Chapter 4). 
Ca2+ can then be transported into the matrix by the Ca2+ uniporter (i.e. a transport across 
the membrane driven only by the electrochemical gradient, with no immediate exchange or 
co-transport of other ions) located in the inner mitochondrial membrane (IMM) (Kirichok 
et al., 2004). The rate of Ca2+ uptake was shown to be significant only above a threshold of 
200-300 nM Ca2+. This uniporter appears to be gated by local adenine nucleotide 
concentrations (ATP > ADP > AMP) at a site located at the outer surface of the IMM 
(Bianchi et al., 2004).  
 
With physiological stimulation, free Ca2+ in both cytosol and mitochondria can rapidly and 
transiently increase by 10 to 20-fold as occurs on a beat to beat basis in cardiac myocytes 
due to mitochondrial Ca2+ uptake (Trollinger et al., 2000). Hormonal and other stimuli 
activate phospholipase C enzyme, which cleaves a phospholipid Hphosphatidylinositol 4,5-
bisphosphate H (PIP2) into Hdiacyl glycerolH (DAG) and Hinositol 1,4,5-triphosphateH (IP3). DAG 
remains bound to the membrane, whereas IP3 is released into the HcytosolH and then bind 
to HIP3 receptorsH, in particularH Ca2+ channelsH in the ER (Lemasters et al., 2009). This causes 
the release of Ca2+ from ER into cytosol. Membrane depolarization of cardiac cells also 
causes Ca2+ entry through voltage-gated Ca2+ channels (Bers, 2002; Fabiato, 1985a; 
Fabiato, 1985b). During the action potential (a transient alteration of the membrane 
potential across a membrane in an excitable cell such as a neuron or myocyte), the voltage-
gated Na+-channels are activated. The inward Na+-current induces a rapid depolarization of 
the cell membrane, facilitating voltage-dependent opening of L-type Ca2+-channels. In 
certain cell types (such as monocytes, neutrophils, lymphocytes and certain neurons), ROS 
such as H2O2 open the NAD+-dependent TRPM2 cation channels in the plasma membrane 
and let Ca2+ in. These channels are non-selective, also transporting Na+ and K+, thus 
depolarizing the membrane and letting even more Ca2+ in by opening voltage-gated 
channels (Halliwell and Gutteridge, 2007). The Ca2+ influx triggers the opening of the 
ryanodine receptor (RyR2 subtype) of sarcoplasmic reticulum (SR) or ER, inducing the 
release of even greater amount of Ca2+, a process termed Ca2+-induced Ca2+-release. The 
Ca2+ released from RyRs floods the space between the SR and the cell membrane 
(junctional cleft), a gap of typically ~10 nm and covering a volume with a radius of ~200 
nm. Computational modeling predicted a temporarily and spatially limited increase of the 
Ca2+ concentration in the range from ~10 μM to ~7 mM within the first couple of 
milliseconds after opening of the RyR2 (Bers, 2002; Peskoff and Langer, 1998; Shannon et 
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al., 2004). However, this high junctional calcium concentration decays rapidly by diffusion 
into the submembrane space (such as mitochondria) and then further into the bulk cytosol, 
where it peaks later and at much lower concentrations than in the cleft (at ~1.5 μM in the 
submembrane space and ~0.5 μM in the bulk cytosol (Shannon et al., 2004; Weber et al., 
2002).   
 
Dysregulation of Ca2+ homeostasis has long been implicated to play an important role in 
cell injury. Pathological Ca2+ overload and calcification are frequent features of tissue 
ischemia and infarction. Previous studies in hepatocytes showed that removal of 
extracellular Ca2+ protects against various hepatotoxicants, suggesting that influx of 
extracellular Ca2+ is responsible for irreversible cell injury (Lemasters et al., 2009). 
Moreover, a range of cell types showed increased cytosolic Ca2+ level after ROS or toxin 
treatment, leading to either caspase-3-dependent or -independent apoptosis (Yap et al., 
2006; Ding et al., 2002; Escargueil-Blanc et al., 1994; Vindis et al., 2005; Mishra et al., 
2006) or necrosis (Escargueil-Blanc et al., 1994; Hurne et al., 2002; Aguilar et al., 1996).  
 
An abnormal rise in free calcium can result in ROS formation (such as superoxide). 
Stimulation of the Krebs cycle and oxidative phosphorylation by Ca2+ would enhance ROS 
output by making the whole mitochondrion work faster and consume more O2, resulting in 
more respiratory chain electron leakage. Mitochondrial ROS generation correlates well 
with metabolic rate (Perez-Campo et al., 1998; Sohal and Allen, 1985). Ca2+ stimulation of 
nitric oxide synthase (NOS) (Alderton et al., 2001) generates nitric monoxide (NO‧), 
which inhibits complex IV (Cleeter et al., 1994), and this would enhance ROS generation 
from the Q cycle on IMM (Alexander et al., 2000), in conjunction with high mitochondrial 
Ca2+ concentration, can inhibit mitochondrial complex I (Jekabsone et al., 2003). It is not 
yet known whether this event would lead to ROS generation (Brookes et al., 2004). Ca2+ 
can enhance cytochrome c dislocation from the inner mitochondrial membrane (IMM), 
either by competing for cardiolipin binding sites or by inducing the mitochondrial 
permeability transition (MPT) pore opening (see below). This results in an effective block 
of the respiratory chain at complex III, which would cause ROS generation (Ott et al., 
2002; Grijalba et al., 1999).  
 
An abnormal rise in free Ca2+ can also lead to activation of phospholipase A2 that cleaves 
membrane phospholipids and leads to disruption of membrane organization, activation of 
Ca2+-dependent endonucleases in the nucleus causing DNA fragmentation, and activation 
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of transglutaminases catalysing the cross-linking of proteins to produce insoluble 
aggregates (Halliwell and Gutteridge, 2007; Kowaltowski et al., 2001). Furthermore, 
excessive rise in extracellular Ca2+ (above 5 μM) often results in membrane blebbing, 
possibly as a result of calpain activation (a class of non-lysosomal cysteine proteases). 
There are two ubiquitous forms, μ-calpain and m-calpain that are activated by micromolar 
and millimolar concentrations of Ca2+ in vitro (Saido et al., 1994b; Huang and Wang, 
2001). They can cleave spectrin (an actin-binding protein that control the polymerization 
and reorganization of actin), or α-actinin and talin (cytoskeletal proteins that connect actin 
filaments with the plasma membrane), eliminating the plasma membrane anchorage to the 
cytoskeleton and allowing it to bleb out (Miyoshi et al., 1996; Weber et al., 2005; 
Halliwell and Gutteridge, 2007). Oxidation of thiol groups on cytoskeletal proteins by ROS 
and loss of intracellular ATP (required for maintenance of cytoskeletal integrity) also 
facilitate blebbing. If blebbing proceeds to such an extent that bleb rupture occurs without 
immediate resealing, the cell loses its ion gradients and is effectively dead. Its contents are 
released into the surrounding area, thus necrotic cell death occurs (Halliwell and 
Gutteridge, 2007). Calpain activation in neuronal cells in response to HOCl also mediated 
lysosomal rupture with the resultant release of cathepsins and caspase- 3-independent 
apoptosis, indicating calpain activation and the subsequent cathepsin release could induce 
apoptosis. Cathepsins are synthesized as inactive precursors and undergo proteolytic 
activation in the optimal acidic pH. They are localized mainly to the lysosomes (B, D, H, L, 
S, C and K subtypes) but also to the nucleus (B and L) and cytosol (B and E). These 
proteases may cause degradation of certain cellular constituents (Yap et al., 2006). 
Calpains were also implicated in inducing Bid (a proaopoptotic BH3-only member of the 
Bcl-2 family) cleavage to form active truncated Bid (tBid), which in turn promotes the 
release of cytochrome c from mitochondria, leading to caspase-3 activation and apoptosis 
(Vindis et al., 2005).  
 
Excessive cytosolic Ca2+ can also be taken up by mitochondria to trigger the MPT pore 
opening (Bianchi et al., 2004; Richter, 1993; Crompton et al., 2002; Whiteman et al., 
2004), which then leads to either apoptotic or necrotic cell death (see section 4.1). In 
addition, cathepsin D caused MPT activation in alveolar macrophage cells exposed to 
silica (Thibodeau et al., 2003). Oxidative stress and calpains also appear to play a role in 
MPT activation, which will be discussed in detail in section 5.3.  
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The results present in Chapter 4 showed that HOCl-induced MPT activation in HMDM 
cells lead to necrotic cell death. But how exactly MPT activation was initiated by HOCl 
and how it led to HMDM necrotic cell death was unknown. This chapter aims to examine 
whether HOCl caused cytosolic Ca2+ level to increase in HMDM cells, and the association 
of this increase with necrotic cell death in relation to MPT activation, calpain activation 
and lysosomal destabilization.  
 
 
5.2 Results 
5.2.1 Effect of HOCl on intracellular calcium ion influx  
Free Ca2+ concentrations in resting cells are maintained between 100 and 200 nM in 
cytosol and mitochondria; abnormal increases can lead to both apoptotic and necrotic cell 
death (see section 5.1). The effect of HOCl on cytosolic Ca2+ level increase in HMDM 
cells was therefore studied. HMDM cells were probed with the cell-permeable fluorescent 
indicator, fluo-3-acetoxymethyl (AM) ester, for the detection of free cytosolic Ca2+. The 
cells were then exposed to a range of HOCl concentrations in EBSS buffer with or without 
Ca2+, followed by examination of their fluorescence intensities (Figure 5.1a). The 
fluorescence intensities were also converted to numerical values (Figure 5.1b).  
 
HOCl in EBSS buffer without Ca2+ caused cytosolic fluorescence intensity to increase by 
approximately 28% at 100 μM concentration compared to the control. There was no 
further statistically significant (P > 0.05) increases in fluorescence intensity above 100 μM 
HOCl (Figure 5.1a and b). HOCl in EBSS buffer with Ca2+ (referred to as Ca2+-enriched 
EBSS in this thesis) at 100, 150 and 200 μM caused cytosolic fluorescence intensity to 
increase by 25%, 60%, and 69%, respectively, compared to the control. The results suggest 
that HOCl induced an increase in cytosolic free Ca2+, which was released mainly from 
intracellular stores at or below 100 μM HOCl, while Ca2+ in the extracellular medium also 
contributed to the cytosolic Ca2+ increase above 100 μM HOCl. Cell swelling and cell 
membrane disruption were observed in cells treated with HOCl above 100 μM 
concentration in Ca2+-enriched EBSS (as shown in the DIC images); these morphological 
changes were less obvious in cells treated with the same HOCl concentrations in Ca2+-free 
EBSS buffer (Figure 5.1a). These results indicate that the increase in cytosolic Ca2+ 
needed to reach a certain intracellular concentration before cell swelling and cell 
membrane rupture were significant. 
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Figure 5.1 HOCl induced an increase in cytosolic Ca2+ in HMDM cells.    
HMDM cells (5×106 cells/ml) on coverslips were pre-incubated with 10 μM of Fluo-3-AM 
ester for 40 minutes, followed by treatment with increasing HOCl concentrations in EBSS 
buffer in the presence (A to E) or absence (F to J) of 0.68 mM CaCl2 for 10 minutes. a) 
The cells were subsequently viewed under a fluorescence microscope (λex/λem = 
488/530nm). A’ to J’ represent the DIC photos of A to J, respectively. b) Fluorescence 
intensities of the cells in the presence (gray bars) or absence (white bars) of Ca2+ are 
converted to numerical values. Each data is presented as a percentage of the 0 μM (with 
Ca2+) control. Significance is indicated from the respective 0 μM controls. 
 
 
Calcium ionophore A23187 is a lipid soluble molecule that is highly selective for Ca2+ and 
greatly increases the ability of Ca2+ to cross cell membranes. It was used here as a positive 
control to confirm that the detected green fluorescence resulted from Ca2+ reacting with 
fluo-3 dye, not from HOCl reacting with the dye. The fluorescence intensities (Figure 5.2a) 
and the numerical values converted from the fluorescence intensities (Figure 5.2b) showed 
that HMDM cells exposed to 3, 5 and 7 μM A23187 caused the cytosolic fluorescence 
intensities to increase by 26%, 53%, and 58% compared to the control, respectively. Cell 
swelling and cell membrane disruption were observed in HMDM cells treated with 
A23187 at concentrations above 5 μM, suggesting that an increase in cytosolic Ca2+ level 
resulted in cell swelling and cell membrane disruption. These results imply that the 
morphological changes in HOCl-treated HMDM cells (Figure 5.1) were attributed to the 
cytosolic Ca2+ increase, not to HOCl causing general damage on cell membranes.   
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Figure 5.2 Ca2+ ionophore A23187 induced an increase in cytosolic Ca2+ in HMDM 
cells.   
HMDM cells (5×106 cells/ml) on coverslips were pre-incubated with 10 μM of Fluo-3-AM 
ester for 40 minutes. The cells were then treated with or without increasing concentrations 
of calcium ionophore A23187 in EBSS buffer containing 0.68 mM Ca2+ (referred to as 
Ca2+-enriched EBSS) for 5 minutes (A to D), followed by viewing under a fluorescence 
microscope (λex/λem = 488/530nm). A’ to D’ represent the DIC photos of A to D, 
respectively. b) Numerical values for the fluorescence intensities are presented as 
percentage of the control and significance is indicated from the same control. 
 
 
5.2.2 Effect of HOCl-induced cytosolic Ca2+ increase on HMDM cell 
death 
To examine the effect of HOCl-induced cytosolic Ca2+ increase on HMDM cell viability 
loss, HMDM cells were exposed to HOCl in EBSS buffer with or without Ca2+ for 10 
minutes and analysed for cell viability over time. HOCl at 100 and 200 μM concentrations 
in EBSS buffer with Ca2+ caused HMDM cell viability to decrease initially by 
approximately 50% and 80%, respectively (Figure 5.3). In contrast, HOCl at 100 and 200 
μM concentrations in EBSS buffer without Ca2+ caused cell viability to decrease initially 
by approximately 12% and 60%, respectively. These results suggest that the initial HOCl-
induced HMDM cell viability loss was mainly caused by the increase in cytosolic Ca2+ 
contributed from both intracellular and extracellular stores. However, when HOCl 
concentration was too high (i.e. 200 μM), the oxidant reacted with cells overwhelmingly 
and even Ca2+ exclusion from extracellular medium could not restore cell viability. 
5.2b) 
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After the 10-minute treatment, the HOCl reaction media (at both 100 and 200 μM) were 
replaced with RPMI culture media. HOCl treatment in Ca2+-enriched EBSS did not cause 
further significant decreases in cell viability over time, while HOCl treatment in Ca2+-free 
EBSS caused significant decreases within 6 hours (especially at 100 μM), which then 
plateaued after 6 hours and were comparable to those of HOCl-treated HMDM cells in 
Ca2+-containing EBSS (Figure 5.3). This observation could be attributed to the 
replacement of HOCl reaction medium (without Ca2+) with RPMI culture medium 
(containing Ca2+) after the initial HOCl treatment, which led to extracellular Ca2+ influx 
and hence cell viability loss. This theory was supported by the observation that HMDM 
cells incubated with HOCl in Ca2+-free EBSS for 6 hours, without replacing the reaction 
medium with HMDM culture medium, showed minor loss of cell viability (Figure 5.6). 
For the future experiments, the HOCl reaction medium was not replaced with HMDM 
culture medium after 10-minute treatment in order to prevent the possible Ca2+ influx from 
the HMDM culture medium. The cells were just incubated with the reaction medium for 6 
hours before analyses.  
 
To further confirm that the cytosolic Ca2+ increase was indeed able to cause rapid HMDM 
cell viability loss, HMDM cells were exposed to Ca2+ ionophore A23187 (0-7 μM) for 5 
minutes and cell viability was analysed (Figure 5.4). A23187 at 3 μM did not cause any 
cell viability loss at 0 and 20 hr post-treatment. At 0 hr post-treatment, 5 and 7 μM A23187 
caused approximately 40% and 76% cell viability loss, respectively, and there was no 
further significant cell viability loss occurring at 20 hr post treatment. The results suggest 
that the cytosolic Ca2+ increase induced by A23187 treatment did cause a rapid loss of cell 
viability. No cell viability loss was observed at 3 μM A23187 indicates that cytosolic Ca2+ 
needed to reach a certain intracellular concentration before cell viability was lost.  
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Figure 5.3 Contribution of HOCl-induced cytosolic Ca2+ increase to cell viability loss. 
HMDM cells (5×106 cells/ml) were treated with a) 100 or b) 200 μM HOCl in Ca2+-free 
EBSS (white bars) or Ca2+-enriched EBSS (gray bars) for 10 minutes, followed by 
incubation in HMDM culture medium. The cells were then analysed at time intervals for 
cell viability using the MTT reduction assay. Cell viability is presented as a percentage of 
the respective 0 μM HOCl controls and significance is indicated from the respective 0 hr 
data. 
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Figure 5.4 A23187-induced cytosolic Ca2+ increase caused HMDM cell viability loss.    
HMDM cells (5×106 cells/ml) were treated with or without increasing concentrations of 
A23187 in Ca2+-enriched EBSS for 5 minutes, followed by incubation in HMDM culture 
medium. The cells were then analysed for cell viability at 0 hr (white bars) and 24 hr (gray 
bars) post-treatment using the MTT reduction assay. Cell viability is presented as a 
percentage of the respective 0 μM HOCl controls and significance is indicated from the 
respective 0 μM HOCl data. 
 
 
To further evaluate the sources of Ca2+ for cytosolic Ca2+ increase and cell injury, HMDM 
cells were incubated with the Ca2+ chelator EGTA and various Ca2+ channel blockers 
before HOCl treatment, followed by immediate fluorescence microscopy analysis (Figure 
5.5) and cell viability analysis after 6 hours (Figure 5.6). The preliminary results showed 
that incubation of HMDM cells with EBSS in the presence or absence of Ca2+, and with 
EBSS in the presence of Ca2+ and various Ca2+ channel blockers and EGTA for 6 hours did 
not affect the cell viability. The extracellular Ca2+ pool is derived from the culture medium, 
whereas ER is the principal intracellular Ca2+ pool. Upon ER stress, Ca2+ from the ER pool 
is released via two types of receptor/channels: the ryanodine receptor (RyR) and the IP3 
receptor (IPR).  
 
Treatment with 150 μM HOCl in the presence of extracellular Ca2+ caused the cytosolic 
fluorescence intensity to increase by approximately 8.6 times and the cell viability to 
decrease by 74% compared to their respective controls. HOCl treatment in the absence of 
extracellular Ca2+ (by using Ca2+-free EBSS and by chelating Ca2+ with EGTA) caused 
cytosolic Ca2+ to increase only by approximately 2.9 and 1.7 times compared to the control, 
respectively, and cell viability loss was prevented significantly. Nifedipine and verapamil 
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(both are L-type Ca2+ channel inhibitors blocking Ca2+ entry into cells), and flunarizine (T-
type Ca2+ channel inhibitor) in the presence of extracellular Ca2+ only induced cytosolic 
Ca2+ to increase by approximately 4.06, 3.07, and 2.07 times compared to the control, 
respectively, while cell viability losses were prevented significantly. Dantrolene (a 
selective blocker of RyR) in the presence of extracellular Ca2+ only induced cytosolic Ca2+ 
to increase by approximately 1.79 times, and surprisingly, it prevented cell viability loss 
completely. This will be discussed further later.  
 
Taken together, both blocking extracellular Ca2+ influx and intracellular Ca2+ release from 
the ER could prevent cytosolic Ca2+ increase and cell viability loss significantly. This 
suggests that cytosolic Ca2+ increase did play an important role in mediating HOCl-
induced HMDM cell viability loss.  
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Figure 5.5 Ca2+ channel blockers or chelator significantly prevented HOCl-induced 
cytosolic Ca2+ increase.  
a) HMDM cells (5×106 cells/ml) on coverslips were pre-incubated with control medium 
(HMDM culture medium), Ca2+-enriched EBSS or Ca2+-free EBSS, 50 μM flunarizine, 50 
μM verapamil, 50 μM nifedipine, 10 μM dantrolene and 1 mM EGTA for 40 minutes, 
followed by the addition of 150 μM HOCl. Cell treatment with EGTA and the Ca2+ 
channel blockers were carried out in Ca2+-enriched EBSS. After 10 minutes of HOCl 
treatment, cytosolic Ca2+ increase was detected using 10 μM of Fluo-3-AM ester and a 
fluorescence microscope (λex/λem = 488/530nm). The photos labelled with ’ represent the 
DIC photos of the respective fluorescence photos. b) Fluorescence intensities are converted 
to numerical values. Each data is presented as a percentage of the 0 μM HOCl control. 
Significance is indicated from the respective 0 μM HOCl controls. 
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Figure 5.6 Blocking HOCl-induced cytosolic Ca2+ increase prevented HMDM cell 
viability loss significantly.  
HMDM cells (5×106 cells/ml) were pre-incubated with control medium (HMDM culture 
medium), Ca2+-enriched EBSS or Ca2+-free EBSS, flunarizine (50 μM), verapamil (50 
μM), nifedipine (10 μM), dantrolene (10 μM), and EGTA (1 mM) for 40 minutes, 
followed by the addition of 150 μM HOCl. Cell treatment with EGTA and the Ca2+ 
channel blockers were carried out in Ca2+-enriched EBSS. After 6 hours, the cells were 
analysed for cell viability using the MTT reduction assay. Cell viability is presented as a 
percentage of the 0 μM HOCl control (in HMDM culture medium) and significance is 
indicated from the same 0 hr control.  
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5.2.3 HOCl-induced cytosolic Ca2+ influx caused HMDM lysosomal 
destabilization 
The changes in lysosomal membrane stability were examined using the lysosomotropic 
fluorescence probe, acridine orange (AO), which freely enters living cells and accumulates 
in the acidic compartiments. AO emits a red fluorescence, under UV excitation, only if it 
has been protonated. Less concentrated AO in cytosol emits a diffuse green fluorescence. 
This property can be exploited to reveal impairments of the lysosomal proton gradient 
(Zdolsek et al., 1990). HMDM cells treated with 150 μM HOCl for 10 minutes 
immediately showed a significant reduction of red fluorescence intensity and increase in 
green fluorescence intensity (Figure 5.7), implicating AO relocation and therefore 
disrupted acidic properties of lysosomes. No further significant AO relocation was 
observed after 6 hours, suggesting that this HOCl-induced lysosomal destabilization 
occurred rapidly within first 10 minutes of HOCl treatment.  
 
HOCl-induced calpain enzyme activation has been found to rupture lysosomes, and 
stabilization of lysosomes rescued cells from HOCl-induced neurotoxicity (Yap et al., 
2006). To study whether this was the case in HOCl-treated HMDM cells, HMDM cells 
were treated with HOCl in the presence of calpain inhibitors, calpeptin and SJA6017 (0-20 
μM). Lysosomal stability and cell viability were subsequently examined. Both calpeptin 
(Figure 5.8) and SJA6017 (Figure 5.9) could completely prevent AO relocation and cell 
viability loss (Figure 5.10) at concentrations as low as 10 μM.  
 
AO also binds to DNA and RNA (Walle and Wong, 1989). To confirm that AO relocation 
was indeed associated with lysosomal destabilization, HMDM cells were treated with 
guanabenz and idazoxan to stabilize lysosomes prior to HOCl treatment, followed by 
examining AO distribution. Guanabenz and idazoxan are imidazoline drugs that have been 
previously used as lysosomal stabilizers (Choi et al., 2002; Yap et al., 2006). Whereas 150 
μM HOCl caused significant AO relocation (indicated by the decreased red fluorescence 
compared to the control), 10 μM guanabenz and idazoxan prevented this HOCl-induced 
AO relocation significantly (indicated by the similar red fluorescence compared to the 
control) (Figure 5.11). This suggests that AO relocation was indeed associated with 
lysosomal destabilization, and calpain activation preceded the provoked lysosomal rupture 
in HOCl-treated cells.   
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Figure 5.7 HOCl induced lysosomal destabilisation in HMDM cells.  
HMDM cells (5×106 cells/ml) on coverslips were treated with (B and D) or without (A and 
C) 150 μM HOCl in Ca2+-enriched EBSS for 10 minutes, followed by incubation in 
HMDM culture medium. The cells were then probed with 10 μg/ml acridine orange (AO) 
for 20 minutes at 0 and 6 hr post-HOCl treatment. Lysosomal integrity was examined 
under a fluorescence microscope (λex 487 nm). A’, B’, and C’ represent the DIC photos of 
A, B, and C, respectively.  
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Figure 5.8 Inhibition of calpain enzyme activity using calpeptin prevented HOCl-
induced lysosomal destabilisation.   
HMDM cells (5×106 cells/ml) on coverslips were pre-incubated with 0 (A and B), 10 (C), 
or 20 (D) μM of a calplain inhibitor calpeptin in Ca2+-enriched EBSS for 1 hour, followed 
by treatment with (B to D) or without (A) 150 μM HOCl. After 6 hours, the cells were 
analysed for lysosomal integrity (A to D) by probing the cells with 10μg/ml AO for 20 
minutes and viewing the cells under a fluorescence microscope (λex 487 nm). A’, B’, C’ 
and D’ represent the DIC photos of A, B, C and D, respectively.  
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Figure 5.9 Inhibition of calpain enzyme activity using SJA6017 prevented HOCl-
induced lysosomal destabilisation.   
HMDM cells (5×106 cells/ml) on coverslips were pre-incubated with 0 (A and B), 10 (C), 
or 20 (D) μM of a calplain inhibitor SJA6017 in Ca2+-enriched EBSS for 1 hour, followed 
by treatment with (B to D) or without (A) 150 μM HOCl. After 6 hours, the cells were 
analysed for lysosomal integrity (A to D) by probing the cells with 10μg/ml AO for 20 
minutes and viewing the cells under a fluorescence microscope (λex 487 nm). A’, B’, C’ 
and D’ represent the DIC photos of A, B, C and D, respectively. 
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Figure 5.10 Inhibition of calpain enzyme activity prevented HOCl-induced HMDM 
cell viability loss.   
HMDM cells (5×106 cells/ml) in 12-well plates were pre-incubated with 0, 10, or 20 μM of 
the calplain inhibitors calpeptin (white bars) and SJA6017 (gray bars) in Ca2+-enriched 
EBSS for 1 hour, followed by treatment with or without 150 μM HOCl. After 6 hours, the 
cells were analysed for cell viability using the MTT reduction assay. Cell viability is 
presented as a percentage of the respective 0 μM HOCl controls and significance is 
indicated from the same respective controls.  
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Figure 5.11 Guanabenz and idazoxan prevented HOCl-induced lysosomal 
destabilization.   
HMDM cells (5×106 cells/ml) on coverslips were pre-incubated with 0 (A and B), 10 μM 
guanabenz (C), or 10 μM idazoxan (D) in Ca2+-enriched EBSS for 1 hour, followed by 
treatment with (B to D) or without (A) 150 μM HOCl. After 6 hours, the cells were 
analysed for lysosomal integrity by probing the cells with 10 μg/ml of AO for 20 minutes 
and viewing the cells under a fluorescence microscope (λex 487 nm). A’, B’, C’ and D’ 
represent the DIC photos of A, B, C and D, respectively. 
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5.2.4 Effect of HOCl-induced cytosolic Ca2+ increase on mitochondrial 
membrane potential loss 
HOCl has been shown to cause mitochondrial membrane potential loss (Figure 4.11). To 
investigate whether HOCl-induced cytosolic Ca2+ increase resulted in mitochondrial 
membrane potential loss, HMDM cells were treated with HOCl in Ca2+-free EBSS (i.e. in 
the absence of extracellular Ca2+) or in Ca2+-free EBSS in the presence of dantrolene (i.e. 
in the absence of both extracellular and cytosolic Ca2+). Mitochondrial membrane potential 
was then analysed by fluorescence microscopy (Figure 5.12a). The fluorescence intensity 
was converted to numerical values (Figure 5.12b). HOCl at 150 μM concentration caused 
significant loss of mitochondrial membrane potential, indicated by the decreased 
fluorescence intensity compared to that of the control. Removing extracellular or both 
extracellular and cytosolic Ca2+ during HOCl treatment completely prevented 
mitochondrial membrane potential loss.  
 
To confirm that it was the cytosolic Ca2+ increase that led to mitochondrial membrane 
potential loss, HMDM cells were treated with Ca2+ ionophore A23187 (0-5 μM) and 
examined for mitochondrial membrane potential (Figure 5.13). HMDM cells treated with 
5 μM A23187 showed mitochondrial membrane potential loss within 5 minutes, indicating 
that A23187-induced extracellular Ca2+ influx caused mitochondrial membrane potential 
loss in HMDM cells. Taken together, HOCl-induced cytosolic Ca2+ increase was 
responsible for the mitochondrial membrane potential loss in HMDM cells.  
 
The next question was whether mitochondrial membrane potential loss and the subsequent 
cell viability loss in HOCl-treated HMDM cells resulted from mitochondria taking up the 
excess cytosolic Ca2+. The mitochondrial uniporter in HMDM cells for taking up cytosolic 
Ca2+ was blocked using ruthenium red (Kirichok et al., 2004) prior to HOCl treatment, 
followed by mitochondrial membrane potential (Figure 5.14) and cell viability (Figure 
5.15) analyses. HMDM cells treated with HOCl alone showed decreases in mitochondrial 
membrane potential and cell viability by approximately 80 and 53% compared to the 
controls, respectively. Ruthenium red at 10 and 50 μM prevented mitochondrial membrane 
potential loss by approximately 40 and 60%, respectively, and prevented cell viability 
losses by approximately 9 and 34%, respectively. The results suggest that blocking Ca2+ 
uptake by mitochondria significantly prevented the mitochondrial membrane potential loss 
and the subsequent cell viability loss in HOCl-treated HMDM cells.  
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Figure 5.12 Preventing cytosolic Ca2+ increase inhibited mitochondrial membrane 
potential loss in HOCl-treated HMDM cells. 
a) HMDM cells (5×106 cells/ml) on coverslips were pre-incubated with 100 nM of TMRM 
in the presence (D) or absence (A to C) of 10 μM dantrolene for 30 minutes. The cells 
were then treated with Ca2+-enriched EBSS (A), 150 μM HOCl in Ca2+-enriched EBSS (B), 
150 μM HOCl in Ca2+-free EBSS (C), and 150 μM HOCl in Ca2+-free EBSS containing 10 
μM dantrolene (D) for 10 minutes. Subsequently, mitochondrial membrane potential of the 
cells was detected by viewing under a fluorescence microscope (λex/λem = 548/574nm). 
A’, B’, C’ and D’ represent the DIC photos of A, B, C and D, respectively. b) The 
numerical values of the fluorescence intensities are presented as percentage of the 0 μM 
HOCl control (A). Significance is indicated from the 0 μM HOCl control. 
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Figure 5.13 A23187-induced cytosolic Ca2+ increase caused mitochondrial membrane 
potential loss in HMDM cells.   
HMDM cells (5×106 cells/ml) on coverslips were pre-incubated with 100 nM TMRM for 
30 minutes, followed by treatment with or without 2.5 or 5 μM Ca2+ ionophore A23187 in 
Ca2+-enriched EBSS buffer for 5 minutes. The cells were subsequently viewed under a 
fluorescence microscope with 40× magnification (λex/λem = 548/574nm).  
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Figure 5.14 Effect of preventing Ca2+ uptake by mitochondria using ruthenium red 
on HOCl-induced HMDM mitochondrial membrane potential loss.   
a) HMDM cells (5×106 cells/ml) on coverslips were pre-incubated with 100 nM of TMRM 
in the presence (C and D) or absence (A and B) of 10 μM or 50 μM ruthenium red for 30 
minutes. The cells were then treated with Ca2+-rich EBSS (A), 150 μM HOCl in Ca2+-
enriched EBSS (B), and 150 μM HOCl in Ca2+-enriched EBSS containing 10 μM (C) or 
50 μM (D) ruthenium red for 10 minutes. Mitochondrial membrane potential was 
examined under a fluorescence microscope. A’, B’, C’ and D’ represent the DIC photos of 
A, B, C and D, respectively. b) Fluorescence intensities are converted to numerical values 
and each data point is presented as a percentage of the control (white bar) (A). Significance 
is indicated from the same control.  
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Figure 5.15 Effect of preventing Ca2+ uptake by mitochondria using ruthenium red 
on HOCl-induced HMDM cell viability loss.   
HMDMs (5×106 cells/ml) were pre-incubated with or without 10 μM or 50 μM ruthenium 
red in Ca2+-enriched EBSS for 30 minutes. The cells were then treated with Ca2+-enriched 
EBSS control medium, 150 μM HOCl in Ca2+-rich EBSS, and 150 μM HOCl in Ca2+-
enriched EBSS containing 10 μM or 50 μM ruthenium red. Cell viability was measured 
after 6 hours using the MTT reduction assay. Cell viability is presented as a percentage of 
the 0 μM HOCl control and significance is indicated from the same control. 
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The effect of HOCl-induced calpain activation in HMDM cells on mitochondrial 
membrane potential was examined. HMDM cells treated with 150 μM HOCl alone showed 
significant mitochondrial membrane potential loss, indicated by the decreased fluorescence 
intensity. Ten μM calpeptin completely prevented the mitochondrial membrane potential 
loss in HMDM cells treated with 150 μM HOCl, as indicated by the comparable 
fluorescence intensity to the control (Figure 5.16a and b). The result suggests that calpain 
activation in HMDM cells after HOCl treatment played an important role in causing 
mitochondrial membrane potential loss.  
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Figure 5.16 Effect of preventing calpain activation in HMDMs using calpeptin on 
HOCl-induced mitochondrial membrane potential loss.  
a) HMDMs (5×106 cells/ml) on coverslips were pre-incubated with 100 nM of TMRM in 
the presence (C) or absence (A and B) of 10 μM calpeptin for 30 minutes. The cells were 
then treated with Ca2+-enriched EBSS control medium (A), 150 μM HOCl in Ca2+-
enriched EBSS (B), or 150 μM HOCl in Ca2+-enriched EBSS containing 10 μM calpeptin 
(C) for 10 minutes. Mitochondrial membrane potential was subsequently examined under a 
fluorescence microscope. A’, B’ and C’ represent the DIC photos of A, B and C, 
respectively. b) Fluorescence intensities are converted to numerical values. Each data point 
is presented as a percentage of the control (A) and significance is indicated from the same 
control.  
 
 
Since calpain activation is important in mediating mitochondrial membrane potential loss 
(Figure 5.16) and lysosomal destabilization (Figures 5.8 and 5.9), it was possible that 
calpains caused mitochondrial membrane potential loss that resulted in lysosomal 
destabilization. To investigate this possibility, HMDM cells were treated with 150 μM 
HOCl in the presence of 10 μM cyclosporin A (CSA) to block MPT activation, followed 
by lysosomal stability analysis using AO. While HOCl-treated HMDM cells in the absence 
of CSA showed significant lysosomal destabilization (indicated by the decreased intensity 
of red fluorescence), HOCl-treated cells in the presence of CSA prevented lysosomal 
destabilization (Figure 5.17). This indicates that MPT activation and mitochondrial 
membrane potential loss resulted in lysosomal destabilization; calpain enzymes might be 
mediating these events. This will be further discussed in section 5.3.  
5.16b) 
Chapter 5 
_____________________________________________________________________________________________________________ 
166
 
 
 
  
 
  
 
  
 
 
Figure 5.17 Effect of preventing MPT by CSA on lysosomal destabilization in HOCl- 
treated HMDM cells.   
HMDM cells (5×106 cells/ml) on coverslips were pre-incubated in the presence (C) or 
absence (A and B) of 10 μM CSA in Ca2+-enriched EBSS for 30 minutes, followed by 
treatment with (B and C) or without (A) 150 μM HOCl. After 6 hours, the cells were 
analysed for lysosomal integrity by probing the cells with 10 μg/ml of AO for 20 minutes 
and viewing the cells under a fluorescence microscope (λex 487 nm). A’, B’ and C’ 
represent the DIC photos of A, B and C, respectively.  
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5.3 Discussion 
The possible mechanism(s) of HOCl-mediated necrotic cell death in HMDM cells in 
relation to cytosolic Ca2+ increase, calpain activation, lysosomal destabilization and MPT 
activation is summarized below (Figure 5.18), which will be discussed in the following 
sections.  
 
 
5.3.1 Effect of HOCl on cytosolic Ca2+ increase and the subsequent 
effect on cell viability 
HOCl induced cytosolic free Ca2+ to increase significantly in a concentration-dependent 
manner above 50 μM HOCl (Figure 5.1a). The source of this Ca2+ increase was mainly 
from intracellular stores when the HOCl concentrations were 100 μM or less. Above 100 
μM HOCl, the extracellular Ca2+ also contributed to the rise in cytosolic Ca2+ (Figure 5.1). 
This result agrees with a number of other studies that used different types of cells treated 
with different oxidants (including HOCl) or toxins, which showed cytosolic Ca2+ increases 
(Yap et al., 2006; Mishra et al. 2006, Vindis et al. 2004; Aguilar et al., 1996; Weber et al., 
2005; Escargueil-Blanc et al., 1994; Hurne et al., 2002). The cytosolic Ca2+ increase 
occurred rapidly within 10 minutes of HOCl treatment, corroborating with the almost 
immediate cytosolic Ca2+ increase observed in neuronal cells treated with HOCl (Yap et al., 
2006). Cell swelling and cell membrane disruption was more evident at HOCl 
concentrations above 100 μM in Ca2+-enriched EBSS buffer (Figures 5.1a). This indicates 
that cytosolic Ca2+ needed to reach a certain level to cause the observed morphological 
changes, and that level could only be reached when both intracellular and extracellular 
sources of Ca2+ were contributing to the cytosolic Ca2+ pool.   
 
The Ca2+ ionophore A23187 caused a concentration-dependent increase in cytosolic Ca2+ 
level, cell swelling and cell membrane disruption (Figures 5.2), and the percentages of 
fluorescence intensity increases after treatment with 3-7 μM A23187 (26-58% of the 
control) were within the similar range as those after 100-200 HOCl treatment (25-69% of 
the control). This indicates that the observed increase in fluorescence intensity in HOCl-
treated HMDM cells was possibly due to the cytosolic Ca2+ reacting with the Fluo-3-AM 
ester dye, not HOCl reacting with the dye. Moreover, since cytosolic Ca2+ increase after 
A23187 treatment also resulted in cell swelling and cell membrane disruption, this implies  
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Figure 5.18 Proposed mechanism of HOCl-mediated cytotoxicity to HMDM cells.   
HOCl activates the voltage-dependent L- and T-type calcium ion (Ca2+) channels on cell 
membrane resulting in Ca2+ influx. HOCl also passes through cell membrane to activate 
ryanodine receptors (RyRs) on endoplasmic reticulum (ER) membrane releasing Ca2+ from 
ER into cytosol. Both events lead to cytosolic Ca2+ increase. The excess Ca2+ in cytosol 
can be taken up into the mitochondrial matrix via Ca2+ uniporter on the inner mitochondrial 
membrane (IMM). Ca2+ accumulation in mitochondrial matrix possibly activates matrix 
calpains, causing transformation of adenine nucleotide translocase (ANT) that favours 
mitochondrial permeability transition (MPT) pore opening. Ca2+ and HOCl may also work 
together to induce ANT transformation and activate MPT. MPT activation results in 
mitochondrial membrane potential loss, which may lead to the outer mitochondrial 
membrane (OMM) rupture. The rupture will release apoptotic factors, Ca2+, possibly the 
activated mitochondrial matrix calpains (green) and other unknown factors. The released 
Ca2+ may activate more calpains in cytosol (orange). Together with the matrix calpains, 
they may lead to necrotic cell death possibly by degrading cytoskeletal proteins, leading to 
cell membrane blebbing and rupture. Calpains can also destabilize lysosomes, resulting in 
the release of cathepsin proteases that may degrade cellular components. There may also 
be some unknown factors released by mitochondria that may trigger cytosolic calpain 
activation or lysosomal destabilization. The arrows with “?” indicates that either the 
pathways are a hypothesis or are not investigated in this research. 
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that the morphological changes in HMDM cells after HOCl treatment were possibly caused 
by cytosolic Ca2+ increase, not due to HOCl damaging cell membranes directly. 
 
The studies with Ca2+ channel blockers and Ca2+ chelator showed that extracellular Ca2+ 
entered HMDM cells upon HOCl treatment mainly through the L- and T-type Ca2+ ion 
channels in HMDM plasma membrane, while intracellular Ca2+ was mainly released from 
ER through the RyR receptors in the ER membrane (Figures 5.5). These results agreed 
with Yap et al. (2006), who demonstrated activation of L-type Ca2+ ion channels in plasma 
membranes and dantrolene-sensitive Ca2+ ion channels in ER membranes in neuronal cells 
upon HOCl treatment. However, the cytosolic Ca2+ increase was never completely 
prevented using any of the Ca2+ channel blockers or Ca2+ chelator, suggesting that 
cytosolic Ca2+ accumulation might also occur through other pathway(s). HOCl was 
previously found to inactivate Na+-Ca2+-ATPase (Eley et al., 1991) and Na+-K+-ATPase 
(Kato et al., 1998). Na+-Ca2+-ATPase functions by expelling one Ca2+ from cytosol into 
extracellular space with one Na+ entering the cell down its gradient, whereas Na+-K+-
ATPase expels excess Na+ from cytosol to extracellular medium to create a Na+ gradient 
across the cell membrane. The inactivation of Na+-K+-ATPase would then disturb the Na+ 
gradient across the plasma membrane and affect the Na+-Ca2+-ATPase. Inactivation of both 
enzymes would therefore result in Ca2+ accumulation in the cytosol. 
    
The opening of Ca2+-channels in the plasma membrane can occur via plasma membrane 
depolarization. Plasma membrane depolarization in cardiocytes caused by voltage-gated 
Na+-channels activation resulted in inward Na+-current, which facilitates L-type Ca2+-
channels on the plasma membrane (Maack and O’Rourke, 2007). The activity of voltage-
gated Na+-channels and plasma membrane potentials in HMDM cells after HOCl treatment 
should be examined in the future to validate this hypothesis. It is also possible that HOCl 
activated the L-type Ca2+ channels by interacting with the essential thiols within the 
protein complex. This is supported by the fact that the thiol oxidizing agent 5,5'-Dithio-
bis(2-nitrobenzoic acid) (DTNB) up-regulated L-type Ca2+ channels at the extracellular 
face of the cell membrane (Campbell et al., 1996). The same study hypothesized that an 
allosteric thiol-containing “redox switch" is present on the L-type Ca2+ channel subunit 
complex. Contradictory to this hypothesis, cumene hydroperoxides and H2O2 were shown 
to decrease Ca2+ current through the L-type Ca2+ channels (Gill et al., 1995; Goldhaber et 
al., 1989). This discrepancy might be due to different oxidants exerting different effects on 
the L-type Ca2+ channels, resulting in different regulation mechanisms. HOCl (10-40 μM) 
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was also found to decrease Ca2+ current through the L-type Ca2+ channels in ventricular 
cardiomyocytes (Hammerschmidt and Wahn, 1998). However, the researchers did not 
address whether the amount of HOCl used caused the onset of apoptosis. Non-lethal HOCl 
concentrations of HOCl have been reported to cause growth arrest (Vissers et al., 1999) 
and enhance cell survival (Midwinter et al., 2001). Moreover, carbon monoxide protects 
cardiomyogenic cells against ischemic death through L-type calcium channel inhibition 
(Uemura et al., 2005). Therefore, it is possible that low HOCl concentrations inhibited L-
type calcium channels as a protective mechanism.  
 
Ca2+ release from ER can be caused by Ca2+ influx from extracellular medium triggering 
the opening of the ryanodine receptor (RyR2 subtype) in the ER membrane, inducing the 
release of Ca2+ from the ER (a process called Ca2+-induced Ca2+-release) (Maack and 
O’Rourke, 2007). This was less likely the scenario in HOCl-treated HMDM cells, as 
incubation of HMDM cells with HOCl in the absence of Ca2+ in extracellular medium (i.e. 
no Ca2+ influx to trigger the RyR2 channel opening) still showed cytosolic Ca2+ increase 
(Figure 5.1). More likely, HOCl interacted with the essential thiols within the RyR protein, 
leading to RyR activity. Favero et al. (2003) have shown that HOCl activated RyR protein 
on skeletal muscle SR and induced Ca2+ release by targeting the critical thiol groups for 
RyR protein function. Similarly, Sun et al. (2001) demonstrated that oxidation of up to 10 
thiol groups does not modify RyR activity, while oxidation of an additional 10–15 thiol 
groups reversibly stimulates RyR activity. Thiol oxidizing agents and ROS (such as 
superoxide radicals and hydroxyl radicals) could also activate RyR receptors (Eager and 
Dulhunty, 1998; Marengo et al., 1998; Zima et al., 2004; Anzai et al., 1998).  
 
The cytosolic Ca2+ increase from intracellular sources (i.e. HMDM cells treated with HOCl 
in the absence of extracellular Ca2+) plateaued at 100 μM HOCl (Figure 5.1). Similar 
result was also observed in a previous study, which showed that the amount of Ca2+ 
released from SR plateaued above 400 μM HOCl (Favero et al., 2003). The same study 
suggested that higher HOCl concentrations (above 100 μM) activated the RyR receptor 
initially, followed by inhibition. This could also be the case in HMDM cells treated with 
HOCl above 100 μM, resulting in the cytosolic Ca2+ level plateauing.  
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5.3.2 Effect of HOCl-induced cytosolic Ca2+ increase on cell viability 
The question then becomes, is the observed cytosolic Ca2+ increase responsible for the 
HOCl- mediated necrotic cell death. HOCl treatment in the presence of the Ca2+ chelating 
agent EGTA prevented HMDM cell viability loss completely (figure 5.6). This suggests 
that HOCl-induced cytosolic Ca2+ rise was responsible for the cell viability loss. To further 
support this conclusion, HOCl treatment with Ca2+ influx inhibited (by using Ca2+-free 
EBSS buffer or L- and T-type Ca2+ channel blockers) also prevented HMDM cell viability 
loss (Figures 5.6 and 5.3). However, the inhibition was not complete, indicating that Ca2+ 
was released from intracellular sources (such as ER) into cytosol resulting in cell death, 
and/or HOCl caused cell death via other pathways. Surprisingly, HOCl treatment with Ca2+ 
release from ER blocked (by using RyR blocker dantrolene) completely prevented cell 
viability loss (Figure 5.6). This agrees with Yap et al. (2006), who showed complete 
prevention of Ca2+-mediated cell viability loss using dantrolene. Although dantrolene is 
generally known as a blocker of RyR receptor on ER/SR so blocking the release of Ca2+, it 
is possible that it has other unknown functions that prevent Ca2+ influx. Even though 
HOCl-induced cytosolic Ca2+ increase appeared to play an important role in HMDM 
necrotic cell death, HOCl at higher concentration (200 μM) reacted non-specifically with 
cellular components contributing to HMDM necrotic cell death (Figure 5.3).  
 
A23187-treated HMDM cells in the presence of extracellular Ca2+ displayed cell swelling 
and cell membrane rupture (Figure 5.2) and concentration-dependent cell viability loss 
(above 3 μM) with no latent cell death observed (Figure 5.4). The similarities between 
HOCl- and A23187-mediated HMDM cell deaths further implicate that HOCl-induced 
cytosolic Ca2+ increase causes a rapid necrotic cell death. A23187 at 7 μM concentration 
did not cause any further cytosolic Ca2+ increase (Figure 5.2), while cell viability was 
decreased further (Figure 5.4). This was possibly due to a limitation to the maximum 
fluorescence intensity that can be detected by the fluorescence microscopy. Furthermore, 
although 10 μM Fluo-3 was applied to the cells, the actual amount of Fluo-3 that moved 
into cells and the actual level of cytosolic Ca2+ increase were unknown. It is possible that 
the cytosolic Ca2+ concentration has reached the upper limit of the actual Fluo-3 
concentration in the cytosol.    
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5.3.3 Effect of HOCl-mediated cytosolic Ca2+ increase on calpain 
activation and lysosomal destabilization  
Alteration of Ca2+ homeostasis can lead to the activation of calpains, which are a class of 
Ca2+-dependent cysteine proteases. μ-Calpain and m-calpain (the two ubiquitous forms) 
are activated by micromolar and millimolar concentrations of Ca2+ in vitro, respectively 
(Saido et al., 1994b). The next question is, therefore, whether HOCl-induced cytosolic 
Ca2+ increase leads to calpain activation in HMDM cells.  
 
Lysosomal stability was examined in this research as an indicator of calpain activation, as 
activated calpains were shown to mediate lysosomal disruption (Yamashima, 2004). HOCl 
caused rapid lysosomal destabilization in HMDM cells within 10 minutes (no further 
destabilization was observed over time) (Figure 5.7), which was prevented significantly 
using the calpain inhibitors calpeptin and SJA6017 (inhibit both μ- and m-calpains) 
(Figures 5.8 and 5.9). Although SJA6017 inhibits both μ- and m-calpains, it preferentially 
inhibited m-calpains (Fukiage et al., 1997). This implies that both μ- and m-calpains were 
activated in HOCl-treated HMDM cells. Furthermore, stabilizing lysosomes with 
guanabenz or idazoxan (Choi et al., 2002; Cheung et al., 2007; Yap et al., 2006) prior to 
HOCl treatment prevented lysosomal destabilization (Figure 5.11). Taken together, these 
results indicate that HOCl mediated calpain activation, which preceded and induced 
lysosomal destabilization. This is in agreement with Yap et al. (2006), who also 
demonstrated lysosomal destabilization downstream of HOCl-mediated calpain activation 
in neuronal cells.  
 
How exactly activated calpains cause lysosomal destabilization and how guanabenz and 
idazoxan stabilize lysosomes is not yet fully understood. Activated calpains have been 
found in disrupted lysosomal membranes in hippocampal neurons of primates after acute 
ischemia (Yamashima, 2004). This observation led to the hypothesis that calpains 
compromise the integrity of lysosomal membranes, causing leakage of their acidic contents 
into the cytoplasm. Alternatively, both lysosomal stabilizers guanabenz and idazoxan share 
the preferential affinity for the imidazoline-2 receptors, bind to α2-adrenergic receptors, 
and block N-methyl-d-aspartate (NMDA)-receptor channels (Cheung et al., 2007). It was, 
therefore, proposed in this research that calpains cleaved the receptors that guanabenz and 
idazoxan acted on, resulting in lysosomal destabilization.  
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HOCl treatment in the presence of calpeptin or SJA6017 also prevented HOCl-mediated 
HMDM cell viability loss completely (Figure 5.10), indicating that HOCl-mediated 
calpain activation consequently led to necrotic cell death in HMDM cells. Calpain 
activation may lead to necrotic cell death via a number of pathways. As mentioned above, 
HOCl-mediated calpain activation induced lysosomal destabilization in HMDM cells 
(Figures 5.8, 5.9 and 5.11). This destabilization might have resulted in HMDM cell 
viability loss by releasing the hydrolytic enzymes, such as cathepsins, which digest the 
cell’s own cytoplasm and cause cell death. For example, the activity of cathepsin L and its 
cytosolic expression are increased in β-amyloid (Aβ)-mediated neuronal apoptosis (Boland 
and Campbell, 2004). Elevated levels of lysosomal cathepsin D are also observed in the 
early stages of Alzheimer’s disease (AD) and co-localize with intraneuronal tangles. In 
addition, cathepsin S is up-regulated in AD brain, and cathepsin S contributes to the 
generation of Aβ in the lysosomal compartment (Munger et al., 1995). Yap et al. (2006) 
have shown that the release of cathepsins D and L from lysosomes appeared to be 
important in causing HOCl-induced neurotoxicity as their inhibitors fully prevented the 
onset of apoptosis. However, HOCl caused cleavage of cathepsin G (Shao et al., 2005), 
suggesting that HOCl can also have a direct effect on other cathepsin proteases. 
Furthermore, 0.4 μmol/L cathepsin G induced injury to human umbilical vein endothelial 
cell (HUVEC) shape and F-actin cytoskeleton within 15 minutes, yet cell viability loss did 
not occur even after 6 hours (Iacoviello et al., 1995). This latent cell death did not fit the 
rapid HOCl-induced cell death observed in HMDM cells. Hence, whether cathepsins were 
released after lysosomal destabilization and whether they were responsible for HOCl-
mediated necrotic cell death requires further investigation.  
 
The activated calpains could also contribute to HOCl-mediated necrotic cell death by 
themselves. Calpains have been found to proteolytically cleave cytoskeletal proteins in 
hippocampal neurons (Lee et al., 1991) and gerbil forebrain (Yokota et al., 2003) within 
minutes of ischemia, and in rat hepatocytes after exposure to tert-butyl hydroperoxide 
(Miyoshi et al., 1996). Degrading of cytoskeletal proteins can result in necrotic cell death 
by promoting bleb formation and rupture (Saido et al., 1994b). It is very likely that HOCl-
mediated cytosolic Ca2+ increase activates calpains, which in turn degrade cytoskeletal 
proteins proteolytically, resulting in bleb formation, cell membrane rupture and necrotic 
cell death. Since HOCl-mediated necrotic cell death in HMDM cells occurred rapidly 
within 10 minutes, this series of events had to occur within 10 minutes. The rapidness of 
calpains damaging cytoskeletal proteins (as mentioned above), the significant Ca2+ rise 
Chapter 5 
_____________________________________________________________________________________________________________ 
174
occurring within seconds of HOCl treatment in neuronal cells (Yap et al., 2006), and the 
activation of calpains occurring within 1 minute of Ca2+ treatment (Saido et al., 1994a) 
suggest that this series of events could occur within 10 minutes. However, the cytoskeletal 
protein damage had to be extensive to cause necrotic cell death in such a short period of 
time. This area requires further investigation. 
 
It is interesting to see that calpains were activated in HOCl-mediated cytotoxicity to 
HMDM cells. Since calpains require a reduced cysteine residue at the active site to 
maintain proteolytic activity, cells exposed to oxidative stress should not favour calpain 
activation. For instance, neurons from rats exposed to hypoglycaemia, which caused a 
more oxidised intracellular redox state, showed little activated calpains despite of abundant 
presence of Ca2+ (Ferrand-Drake et al., 2003). The same neurons exposed to hypoglycemia 
followed by a recovery period (i.e. the cellular redox state was normalized) showed 
significant calpain activation. In addition, Ca2+ ionophore ionomycin-mediated calpain 
activation in human neuroblastoma cells was decreased in the presence of oxidative stress 
induced by the addition of either doxorubicin or 2-mercaptopyridine N-oxide (Guttmann 
and Johnson, 1998). With these findings in mind, the intracellular redox status was more 
oxidised in HMDM cells treated with HOCl, which should not have favoured calpain 
activation even in the presence of excess cytosolic Ca2+. The activation of calpain enzymes 
observed in HOCl-treated HMDM cells seems to suggest that HOCl might have shown 
selectivity towards thiol groups in HMDM cells.  
 
 
5.3.4 Effect of HOCl-mediated cytosolic Ca2+ increase on mitochondria 
The results in Chapter 4 showed that HOCl treatment caused MPT-mediated 
mitochondrial membrane potential loss in HMDM cells. In this chapter, HOCl treatment in 
the presence of ruthenium red (to prevent Ca2+ influx into the mitochondrial matrix by 
blocking Ca2+ uniporter in the IMM) significantly prevented mitochondrial membrane 
potential loss in HMDM cells (Figure 5.14). This suggests that mitochondria taking up 
Ca2+ and Ca2+ accumulation in mitochondrial matrix were essential for the observed MPT 
activation. The conclusion is in agreement with Whiteman et al. (2004), who showed that 
ONOO--mediated mobilization of Ca2+ from the cytosol to the mitochondria led to MPT 
activation in human articular chondrocytes. Ruthenium red did not prevent increases in 
cytosolic Ca2+ (Whiteman et al., 2004; Trollinger et al., 2000), therefore its effect in 
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preventing mitochondrial membrane potential loss was purely by acting on the Ca2+ 
uniporter.  
 
Mitochondrial membrane potential loss was prevented in HMDM cells treated with HOCl 
in the absence of extracellular Ca2+ or both extracellular and intracellular Ca2+ (Figure 
5.12). This indicates that cytosolic Ca2+ rise resulting from the intracellular source alone 
was not enough to induce MPT-activated mitochondrial membrane potential loss. This is 
not surprising, as Bianchi et al. (2004) have shown that the rate of Ca2+ uptake by 
mitochondria was significant only above a threshold of 200-300 nM Ca2+. 
 
Many mechanisms have been hypothesized to explain how mitochondrial Ca2+ leads to 
MPT activation. One hypothesis suggests that cardiolipin molecules (an important 
component of inner mitochondrial membrane) were bound in unusually high amounts to 
the ANT for the normal ANT translocation activity. The negative charges of the cardiolipin 
headgroups bind to the positive charges, particularly on lysine residues, located in the ANT 
primarily on the matrix side (Bogner et al., 1986). At high concentrations, Ca2+ binds to 
the two phosphate headgroups of cardiolipin and thus releases the positive charges at the 
ANT interface. The positive charges repulse each other and convert ANT into a large 
unselective channel, which is a key component in the MTP (Brustovetsky and Klingenberg, 
1996).  
 
It is also hypothesized that the sensitivity of MPT pore to Ca2+ can be increased by an 
“inducing agent” such as an oxidizing agent (it is referred to as the oxidation hypothesis 
in this thesis). MPT was demonstrated to be fully inhibited in the complete absence of ROS 
even in the presence of excess amount of Ca2+ (Kowaltowski et al., 2001). However, the 
mechanisms are not yet fully elucidated. One possible mechanism involves oxidation of 
thiols on the pore complex in cooperation with Ca2+ (Petronilli et al., 1994; Costantini et 
al., 1996). Oxidation or cross-linking of critical dithiol(s) in membrane proteins increase 
its sensitivity to Ca2+ that regulates the MPT pore opening (Chernyak et al., 1995). 
Similarly, McStay et al. (2002) demonstrated that the oxidation of the ANT molecules 
caused cross-linking of Cys160 and Cys257, which stabilizes the c conformation of the 
ANT (a conformation that favours interaction with VDAC), enhances CyP-D binding to 
the ANT and antagonizes the ADP binding. These effects together greatly sensitize the 
MPT pore to Ca2+. The alternative mechanism is that Ca2+ binds to the matrix side of the 
IMM and promotes extensive alterations to the conformation of membrane proteins that 
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change the locations of the thiol groups, which render them more readily oxidized. This 
leads to cross-linking of membrane protein thiol groups and irreversible MPT formation 
(Kowaltowski et al. 1997).  
 
Mitochondrial Ca2+ may also induce MPT pore opening via activation of mitochondrial 
calpains (it is referred to as the matrix calpain hypothesis in this thesis). Investigators 
have reported calpain-like activities in isolated mitochondria (Aguilar et al., 1996; Tavares 
and Duque-Magalhaes, 1991). Active calpain 10 has been demonstrated in the outer 
membrane, intermembrane space, and mostly matrix fractions of isolated mitochondria 
(Arrington et al. 2006). The same study also showed that mitochondrial matrix calpain 10 
triggered MPT and also damaged two proteins of complex I, NDUFV2 and ND6. Aguilar 
et al. (1996) suggested that mitochondrial calpains activate MPT by cleaving proteins to 
generate positively charged peptide fragments that may allosterically modulate pore 
opening by binding at a site that normally binds cations.  
 
It is possible that mitochondrial Ca2+ accumulation in HOCl-treated HMDM cells caused 
all of the above mentioned mechanisms to occur and activate MPT. The oxidation 
hypothesis is possible because HOCl could have served as the oxidizing agent needed for 
the MPT activation. Yet, A23157-induced cytosolic Ca2+ increase also caused 
mitochondrial membrane potential loss rapidly even in the absence of HOCl (Figure 5.13). 
It is possible that mitochondrial Ca2+ accumulation led to ROS generation in mitochondria, 
which served as the oxidizing agent needed for MPT activation. In addition, Grijalba et al. 
(1999) have shown that Ca2+ alters the lipid organization of the IMM by interacting with 
the anionic head of cardiolipin molecules. These alterations in membrane organization may 
affect respiratory chain function, including coenzyme Q mobility, and favor mono-
electronic oxygen reduction (i.e. superoxide radical generation) at intermediate steps of the 
respiratory chain. The same study also showed that this event occurred within 5 minutes of 
Ca2+ treatment to inverted bovine heart submitochondrial particles. The detection of 
superoxide radicals in HMDM cells immediately after the 10-minute treatment (Figure 
4.13) supported the mitochondrial Ca2+-mediated ROS generation theory. 
 
The matrix calpain hypothesis is even more plausible than the oxidative hypothesis to 
explain mitochondrial Ca2+-mediated MPT activation in HOCl-treated HMDM cells. HOCl 
treatment in the presence of calpeptin prevented mitochondrial membrane potential loss in 
HMDM cells significantly (Figure 5.16), implicating a role of calpains in MPT activation. 
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Since calpeptin can also prevent mitochondrial matrix calpain-10 activity (Giguere and 
Schnellmann, 2008; Giguere et al., 2008), it was highly possible that mitochondrial Ca2+ 
caused matrix calpain activation that subsequently induced MPT activation. Moreover, 
matrix calpain-mediated MPT activation in isolated mitochondria was shown to occur in 
less than 1 minute after Ca2+ treatment in isolated mitochondria (Aguilar et al., 1996). This 
implies that this event may occur within the time frame (i.e. within 10 minutes) of MPT-
mediated mitochondrial membrane potential loss in HOCl-treated HMDM cells.  
 
It is less possible that cytosolic calpains, rather than mitochondrial calpains, caused MPT 
activation in HOCl-treated HMDM cells. HOCl treatment in the presence of CSA (i.e. 
preventing MPT activation) prevented lysosomal destabilization in HMDM cells (Figure 
5.17). If cytosolic calpains were activated upstream of MPT activation, those calpains 
could have destabilized lysosomes in cytosol before or at the same time as the MPT 
activation, and CSA treatment should have not been able to prevent lysosome 
destabilization completely. This theory agrees with Ding et al. (2002), who showed that 
CSA prevented toxin-induced calpain activation and suggested that calpain activation may 
be a post-mitochondrial event (Ding et al., 2002). Hence, calpeptin and SJA6017 prevented 
cell viability loss and lysosomal destabilization (Figures 5.8-5.10) could be due to these 
calpain inhibitors preventing mitochondrial calpain activation. The inhibition of 
mitochondrial calpain activation then prevented MPT activation, cytosolic calpain 
activation and lysosomal destabilization. However, there is currently no documentation on 
whether SJA6017 can prevent mitochondrial calpains. Further studies are required for 
validation of the above hypothesis; the time line of mitochondrial and cytosolic calpain 
activation, and MPT activation.  
 
The above hypothesis leads to the questions why cytosolic calpains were not activated 
before MPT activation and how do MPT activation and the subsequent mitochondrial 
membrane potential loss lead to cytosolic calpain activation. One possibility is that the 
cytosolic volume diluted the increased Ca2+ concentration in HOCl-treated HMDM cells, 
preventing the cytosolic Ca2+ concentration reaching the required level for cytosolic 
calpain activation. One future direction is to measure cytosolic Ca2+ concentration in 
HMDM cells upon HOCl treatment to see whether it reaches the level required for 
cytosolic calpain activation. The excess Ca2+ may then diffuse into IMS of mitochondria 
via VDAC, and taken up into the mitochondrial matrix via the Ca2+ uniporter (Maack and 
O’Rourke, 2007). Since mitochondrial volume is supposed to be less than the cytosolic 
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volume, Ca2+ concentrations in matrix or IMS should be able to reach high concentrations 
easily in comparison to Ca2+ concentrations in the cytosol. Hence, mitochondrial calpains 
may be more easily activated than cytosolic calpains. The activated mitochondrial calpains 
then cause MPT activation, mitochondrial membrane potential loss, matrix swelling, and 
mitochondrial outer membrane rupture. This series of events may result in the release of 
Ca2+ and other unknown factors from the mitochondria into the cytosol, which can activate 
cytosolic calpains. Activated mitochondrial calpains may also be released into the cytosol. 
Consequently, necrotic cell death ensues.  
 
The presence of ruthenium red during HOCl treatment also prevented cell viability loss in 
HMDM cells (Figure 5.15). As mentioned in Chapter 4, blocking MPT activation (by 
using CSA) prevented HOCl-induced cell viability loss. Together these results imply that 
mitochondrial Ca2+-mediated MPT activation resulted in HOCl-mediated necrotic cell 
death in HMDM cells. However, ruthenium red did not prevent cell viability loss 
completely, suggesting other mechanisms might also be at work inducing MPT activation. 
Since calpains are also found in intermembrane space of mitochondria (Tavares and 
Duque-Magalhaes, 1991), it is possible Ca2+ diffused to the intermembrane space via 
VDAC and activated calpains there, which somehow triggered MPT. Moreover, MPT 
might have been activated via Ca2+ binding to an extramitochondrial site. Mitochondrial 
membrane permeabilization induced by phenylarsine oxide is inhibited by EGTA, but not 
by ruthenium red. This result suggests that phenylarsine oxide leads to MPT through a 
mechanism independent of matrix Ca2+, but dependent on Ca2+ binding to an 
extramitochondrial site (Kowaltowski et al., 1997).  
 
 
5.4 Conclusion 
In Chapters 3 and 4, it was shown how HOCl-treated HMDM cells underwent rapid MPT-
mediated mitochondrial membrane potential loss, resulting in necrosis. In this chapter, it 
was demonstrated that HOCl-mediated cytosolic free calcium ion (Ca2+) increase in 
HMDM cells was responsible for this necrotic cell death. ER and extracellular media were 
the major Ca2+ sources contributing to the HOCl-mediated cytosolic Ca2+ increase when 
HOCl concentrations applied were above 100 μM, whereas ER was the only major source 
when HOCl concentrations were 100 μM or below. Inhibitors of the RyR proteins in ER 
membrane (dantrolene), the L-type (nifedipine and verapamil) and T-type (flunarizine) 
Ca2+ ion channels inhibited HOCl-mediated cytosolic Ca2+ rise significantly. This suggests 
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that Ca2+ in ER was released into the cytosol via the RyR proteins, while Ca2+ in media 
entered HMDM cells via the voltage-dependent L- and T-type Ca2+ ion channels.  
 
HOCl caused calpain activation within the 10-minute treatment, possibly mediated by the 
HOCl-induced cytosolic Ca2+ increase. This calpain activation was implicated in the 
HOCl-mediated necrotic cell death in HMDM cells, since calpain inhibitors as low as 10 
μM (calpeptin and SJA6017) completely inhibited HOCl-induced cell viability loss. 
Lysosomal destabilization was also observed in HMDM cells within 10 minutes of HOCl 
treatment; and was prevented by calpain inhibitors and lysosomal stabilizers (guanabenz 
and idazoxan). This suggests that lysosomal destabilization was mediated by calpains. The 
cathepsins released from destabilized lysosomes and activated calpains would lead to 
degradation of cellular components, especially cytoskeletal proteins, causing membrane 
rupture and hence necrotic cell death.   
 
It was shown in this chapter that the excess cytosolic Ca2+ in HOCl-treated HMDM cells, 
after reaching a critical level, was taken up by mitochondria into the matrix via the Ca2+ 
uniporter in IMM (inhibited by ruthenium red), resulting in MPT-mediated mitochondrial 
membrane potential loss and subsequently necrotic cell death. Calpeptin was found to 
prevent HOCl-mediated mitochondrial membrane potential loss in HMDM cells. The 
results indicate that HOCl-mediated Ca2+ accumulation in matrix resulted in mitochondrial 
calpain activation, which in turn activated MPT. MPT activation possibly occurred 
upstream of lysosomal destabilization, as blocking MPT activation prevented lysosomal 
destabilization completely. The proposed mechanism of HOCl killing HMDM cells is 
described in Figure 5.18.  
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6. GENERAL DISCUSSION AND 
CONCLUSIONS 
The major findings of this research is HOCl causes HMDM cells to undergo rapid necrotic 
cell death, which is caused by rapid HOCl-mediated accumulation of cytosolic calcium ion 
(Ca2+). The cytosolic Ca2+ increase results in MPT activation, calpain activation, lysosomal 
destabilization and ultimately necrotic cell death. Intracellular GSH plays an important role 
in preventing this HOCl-mediated necrotic cell death. 7,8-NP prevents HOCl-induced cell 
death and intracellular GSH loss. However, the amount of 7,8-NP synthesized by HMDM 
cells upon IFN-γ treatment is insufficient to prevent the HOCl-induced loss of intracellular 
GSH and HMDM cell viability. The chronological order of the HOCl-induced events 
described above leading to HMDM necrotic cell death is hypothesized and summarised in 
Figure 6.1.  
 
 
6.1 HOCl induced rapid necrotic cell death in HMDM cells 
HOCl caused a concentration-dependent cell viability loss in HMDM cells above a critical 
HOCl concentration. There was no further significant cell viability loss after the 10-minute 
treatment, indicating that HOCl caused no latent damaging effect on HMDM cells. 
Incubating HMDM cells with HOCl for 30 or 60 minutes showed similar level of cell 
viability loss compared to the corresponding loss after 10-minute treatment. This indicates 
that the main reactions of HOCl affecting cell viability occurred within the first 10 minutes. 
The rapid uptake of PI dye by HMDM cells, loss of regulation of intracellular ion 
homeostasis (see below for HOCl-induced cytosolic Ca2+ increase), loss of intracellular 
ATP, and cell morphological changes (i.e. cell swelling, cell membrane blebbing and 
rupture) after HOCl exposure were all features of necrosis (Halliwell and Gutteridge, 
2007). These results indicated that HMDM cells underwent necrotic cell death in response 
to HOCl.  
 
There was no caspase-3 activation in HMDM cells upon HOCl treatment, further 
supporting that HOCl-treated HMDM cells underwent necrotic cell death. Although cells 
can also undergo caspase-3-independent apoptosis (Whiteman et al., 2007; Yap et al., 2006; 
Kroemer and Martin, 2005), it was not the case in HOCl-treated HMDM cells, since those 
cells have shown features of necrosis as mentioned above. The lack of pro-caspase-3 
activation or caspase-3 enzyme activity in HOCl-treated HMDM cells can be attributed to 
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Figure 6.1 Proposed time line of HOCl-induced events leading to necrotic cell death in 
HMDM cells.  
The solid arrows represent the findings in this research, and the dotted arrows represent 
hypotheses.  
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the possible inactivation of caspase-9. Caspases require the critical cysteine thiol group at 
their active site in the reduced state for activity. Since HMDM cell viability only started to 
decrease once intracellular GSH was significantly lost, the lack of intracellular GSH might 
have rendered the critical thiol group of caspase-9 susceptible to oxidation by the 
remaining HOCl and therefore to inactivation. In addition, calpain enzymes can cleave 
several apoptosis regulatory proteins, including Apaf-1 (Reimertz et al., 2001), as well as 
caspases to prevent their processing into active forms (Lankiewicz et al., 2000; Bizat et al., 
2003). In this research, HOCl was shown to cause calpain activation in HMDM cells (see 
section 6.3), indicating that this scenario is possible. Moreover, activation of pro-caspase-3 
requires ATP or dATP (Liu et al., 1996; Hampton et al., 1998) for apoptosome formation, 
which activates caspase-9 that in turn activates pro-caspase-3 (Kroemer and Martin, 2005). 
This research has demonstrated rapid and drastic loss of ATP in HMDM cells upon HOCl 
treatment (see below), indicating that intracellular ATP was possibly not sufficient for 
caspase-3 activation. 
 
The current finding showed that ATP in HMDM cells was rapidly and significantly lost 
after 10 minutes of HOCl treatment. Intracellular ATP level is an important determinant 
factor of cells undergoing apoptosis or necrosis (Kim et al., 2003a; Green and Kroemer, 
2004; Crompton, 1999; Kim et al., 2003b). Treatment of a human T-cell line with the Ca2+ 
ionophore induces apoptosis under ATP-supplying conditions, but induces necrotic cell 
death under ATP-depleting conditions (Eguchi et al., 1997). Based on these findings, the 
current data implied that HMDM cells underwent necrotic cell death. This ATP loss might 
have also contributed to cell membrane integrity loss observed in HOCl-treated HMDM 
cells. Falls in ATP is suggested to facilitate blebbing and eventually cell membrane rupture, 
as ATP is required for maintenance of cytoskeletal integrity (Halliwell and Gutteridge, 
2007). GSH loss might have preceded ATP loss in HMDM cells, as intracellular GSH loss 
preceded cell viability loss (see section 6.2), and intracellular ATP loss was directly 
correlated to cell viability loss.  
 
The rapid intracellular ATP loss might be caused by HOCl reacting directly with ATP 
(Prutz, 1996). HOCl was also found to induce mitochondrial membrane potential loss in 
HMDM cells by mitochondria taking up excess cytosolic Ca2+ via the Ca2+ uniporter at the 
IMM (see section 6.3). This uniporter is gated/activated by ATP (Bianchi et al., 2004). 
Hence, the Ca2+ uptake by mitochondria might have consumed ATP, resulting in ATP loss.  
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The lack of intracellular ATP recovery in HMDM cells over time after the initial HOCl 
treatment was possibly due to the impaired glycolytic pathway, as HOCl was shown in this 
research to inactivate GAPDH enzyme (see below). Another possibility was the breakdown 
of the electron transport chain (ETC), which was supported by the finding of superoxide 
radical generation in HMDM cells within 10 minutes of HOCl treatment. Luetjens et al. 
(2000) showed that the ETC components, such as cytochrome c, can escape the ETC 
through the opened MPT pores (MPT activation was observed in this research; see section 
6.3). This loss of ETC components can lead to escape of electrons from complex III, which 
can then reduce oxygen molecules and form superoxide radicals. In this research, Ca2+ was 
found to be taken up by mitochondria, which might also have caused superoxide radical 
generation. It was previously found that Ca2+ alters the lipid organization of the inner 
mitochondrial membrane (IMM) by interacting with the anionic head of cardiolipin 
molecules (an important component of IMM). These alterations in membrane organization 
may affect respiratory chain function, including coenzyme Q mobility, and favour mono-
electronic oxygen reduction (i.e. superoxide radical generation) (Grijalba et al., 1999). In 
addition, Ca2+ accumulation in mitochondria may activate mitochondrial calpains, which 
can damage the two proteins of complex I, NDUFV2 and ND6, resulting in the ETC 
dysfunction (Arrington et al. 2006).    
 
In this research, GAPDH enzyme activity decreased in HMDM cells with increasing HOCl 
concentrations at the same rate as intracellular GSH loss, suggesting that GAPDH enzyme 
and GSH show similar reactivity towards HOCl and abundance in HMDM cells. GAPDH 
contains an essential reduced cysteine (Cys149) at the active site (Pullar et al., 2000), 
which is susceptible to HOCl oxidation that results in its inactivation (Peskin and 
Winterbourn, 2006). GAPDH oxidation by HOCl was also observed in colon epithelial 
crypt cells (Mckenzie et al., 1999), human endothelial cells (Pullar et al., 1999), human 
mononuclear leukocyte (Smit and Anderson, 1992) and in inflamed mucosa of patients 
with inflammatory bowel disease (Mckenzie et al., 1996). These findings imply high 
reactivity of GAPDH towards HOCl. GAPDH enzyme should also be as abundant as GSH 
in HMDM cells in order to compete for HOCl with GSH. Macrophages show a high 
metabolic rate for providing fuels for their function in an immune response (Newsholme 
and Newsholme, 1989). Hence, theoretically, GAPDH should be abundant in HMDM cells 
in order to keep glycolysis going and provide substrates for the Krebs cycle and ETC at 
high rate. Furthermore, it has been suggested that GAPDH along with some other 
glycolytic enzymes are also localized in erythrocyte membrane as an enzyme complex 
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(Campanella et al., 2005). Hence it is possible that HOCl passed through membrane and 
encountered GAPDH thiols first or at the same time as GSH, causing similar rate of loss.  
 
HOCl also caused rapid tyrosine residue loss, indicating damages on cellular proteins. The 
loss could be caused by direct interaction between HOCl and tyrosine residues, forming 
products such as 3-chlorotyrosine, which was detected in a number of inflammatory tissues 
(Winterbourn, 2002; Domigan et al., 1995; Kettle, 1996; Hazen and Heinecke, 1997). The 
current research did not examine formation of 3-chlorotyrosine in HOCl-treated HMDM 
cells, which should be considered as an important future direction for proving the afore-
mentioned theory. In addition, a tyrosine residue (called Y1176) was located in the calpain 
cleavage site of spectrin, which are components of the cell membrane skeleton (Nicolas et 
al., 2002). Since HOCl has been shown in this research to cause calpain activation and it 
has been hypothesized that this calpain activation might result in cytoskeleton damage and 
hence plasma membrane deformation (see Chapter 5), one speculation was that activated 
calpains cleaved at the site where tyrosine is located in spectrin and damaged it to a form 
that could not be identified by HPLC analysis. 
 
 
6.2 The protective effect of intracellular GSH and 7,8-NP on 
HOCl-mediated HMDM cell damage 
Glutathione (GSH) acts as an important intracellular antioxidant in HMDM cells against 
HOCl insult. This research shows that cell viability decreased significantly only after 
intracellular GSH level was significantly decreased in HMDM cells upon HOCl treatment. 
Furthermore, HMDM cells depleted of intracellular GSH were more susceptible to HOCl 
compared to HMDM cells with intact GSH.  
 
The intracellular GSH level is an important factor in determining whether GSH is an 
efficient antioxidant against HOCl. HMDM cell batches prepared from different donors 
showed different sensitivity towards the same concentration of HOCl, attributed greatly to 
their varying intracellular GSH levels. This agrees with other authors (Ballatori et al., 2009; 
Fadeel et al., 1999; Pastore et al., 2003), who suggested that low intracellular GSH levels 
increase susceptibility of cells towards oxidative stress, resulting in damage that lead to 
onset and/or progression of a number of diseases. In addition, increasing intracellular GSH 
concentrations by administering liposomal GSH to a mouse model of atherosclerosis 
reduced macrophage oxidative stress levels and cholesterol mass (Rosenblat et al., 2007).  
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The effectiveness of GSH in preventing HOCl insult also depends on whether the parent 
thiols can be regenerated (Pullar et al., 2000), and therefore prevent further rounds of 
HOCl insult. In this research, intracellular GSH was recovered over time when the initial 
GSH loss in HMDM cells was 25% after exposure to 100 μM HOCl. This suggested that 
intracellular GSH would act as an effective antioxidant against HOCl at relatively low 
HOCl concentrations. This was possible because GSH reacted with HOCl at lower 
concentration to form GSSG, which could be regenerated to the reduced state 
(Winterbourn and Brennan, 1997). In contrast, intracellular GSH was not recovered over 
time when the initial loss was 50% in HMDM cells after exposure to 200 μM HOCl. This 
was possible because intracellular GSH reacted with higher concentrations of HOCl all the 
way to form irreversible products including sulfonamide and thiosulfonate (Winterbourn 
and Brennan, 1997; Pullar et al., 2001). HOCl was shown in this research to cause calpain 
activation. Whether this calpain activation caused degradation of the GSH re-synthesis 
system or GSH reductase at higher HOCl concentrations, hence preventing GSH recovery, 
requires further study.  
 
This research demonstrated that 300 μM 7,8-NP in the extracellular medium was able to 
fully prevent cell viability and intracellular GSH loss in HMDM cells caused by treatment 
with 400 μM HOCl. This agrees with a previous study that extracellular 7,8-NP protects 
monocytic U937 cells from HOCl-induced cellular damage (Gieseg et al., 2001a). This 
data also suggest that in the presence of a highly reactive external substrate, intracellular 
GSH was unable to compete effectively for HOCl. This agrees with Vissers et al. (1995), 
who showed that intracellular GSH in red cells was unable to compete for HOCl 
effectively in the presence of ascorbate in the extracellular medium. 
 
The concentration of 7,8-NP is important in determining whether it can effectively prevent 
HOCl insult. 7,8-NP is synthesized in vivo and released from human macrophages upon 
induction by IFN-γ (Wachter et al., 1989; Wachter et al., 1992). This is consistent with the 
current finding that 7,8-NP was found both in and out of HMDM cells after incubation 
with 500 U/ml IFN-γ for 24 hours. After IFN-γ induction, the 7,8-NP level was only 
approximately 47 nM in the medium and 1 μM in the HMDM cells, based on the human 
macrophage cell volume (2.48 μl/million cells) calculated by Dorian et al. (2001). This 
amount of 7,8-NP production was not sufficient to prevent HOCl-induced intracellular 
GSH and cell viability loss. Comparatively, the GSH concentration in HMDM cells 
measured concurrently as the intracellular 7,8-NP was approximately 863 μM. This 
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suggests that intracellular GSH would out-compete 7,8-NP for HOCl, assuming that both 
GSH and 7,8-NP have similar rate constants when reacting with HOCl. 
 
Intracellular GSH level was found to decrease after treatment with 500 U/ml IFN-γ, while 
750 U/ml IFN-γ caused cell viability loss. These were possibly caused by IFN-γ increasing 
production of reactive nitrogen and oxygen species in macrophages (Hansson et al., 2006), 
hence oxidizing intracellular GSH and resulting in cell death. Incubation of U937 cell line 
(Baier-Bitterlich et al., 1995), Jurkat T-lymphocytes (Enzinger et al., 2002a), PC12 cells 
(Enzinger et al., 2002b) and rat alveolar epithelial cell line (Schobersberger et al., 1996) 
with high concentrations of 7,8-NP induced apoptosis. In contrast, the current finding 
showed that HMDM cells treated with extracellular 7,8-NP (up to 300 μM) increased 
intracellular 7,8-NP concentration to a much higher value (approximately 19 μM) than that 
in IFN-γ-treated HMDM cells without affecting cell viability and intracellular GSH levels.  
 
The intracellular 7,8-NP concentration measured (approximately 19 μM) after HMDM cell 
incubation with 7,8-NP was still insufficient to prevent HOCl-mediated intracellular GSH 
and cell viability loss in HMDM cells. The current findings suggest that IFN-γ-induced 
7,8-NP synthesis was not enough to prevent HOCl-mediated HMDM cell damage. 
 
 
6.3 The role of Ca2+ in HOCl-mediated necrotic cell death in 
HMDM cells  
HOCl induced cytosolic Ca2+ increase rapidly within 10 minutes of treatment. This agrees 
with Yap et al. (2006), who showed almost immediate cytosolic Ca2+ increase in neuronal 
cells upon HOCl treatment. The source of cytosolic Ca2+ increase in HMDM cells was 
mainly from intracellular store at or below 100 μM HOCl, and from both intracellular store 
and extracellular medium above 100 μM HOCl. This cytosolic Ca2+ increase contributed 
greatly to the HOCl-induced cell viability loss, as HMDM cells treated with the Ca2+ 
chelator EGTA and various Ca2+ channel blockers (dantrolene, nifedipine, verapamil and 
flunarizine) significantly prevented HOCl-induced cell viability loss.  
 
In this research, Ca2+ from extracellular medium entered HMDM cells mainly through the 
L- and T-type Ca2+ channels on the cell membranes, as blocking both Ca2+ channels greatly 
prevented HOCl-induced Ca2+ influx. The intracellular Ca2+ was mainly released into the 
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cytosol from ER via the RyR2 channels, as blocking the RyR2 protein on ER significantly 
inhibited cytosolic Ca2+  increase in HOCl-treated HMDM cells. HOCl possibly reacted 
with the essential thiol groups within the Ca2+ channels to induce their opening. Oxidation 
of thiol groups of L-type Ca2+ channels using the thiol oxidizing agent (DTNB) up-
regulated L-type Ca2+-channels (Campbell et al., 1996). The thiol oxidizing agents and 
ROS (superoxide and hydroxyl radicals) were also found to activate RyR receptors (Eager 
and Dulhunty, 1998; Marengo et al., 1998; Zima et al., 2004; Anzai et al., 1998). 
 
Micromolar and millimolar concentrations of Ca2+ were known to activate μ- and m-
calpains, respectively (Saido et al., 1994b). By using both μ- and m-calpain inhibitors, 
HOCl-induced HMDM cell viability loss was found to be completely prevented. This 
indicated that HOCl induced calpain activation, which led to necrotic cell death in HMDM 
cells. HOCl-induced calpain activation was also found to destabilise lysosomes. The 
cathepsin proteases released from destabilised lysosomes was important in causing HOCl-
induced neurotoxicity (Yap et al., 2006). Furthermore, cathepsin G induced injury to 
human umbilical vein endothelial cells and F-actin cytoskeleton within 15 minutes 
(Iacoviello et al., 1995). However, whether cathepsins were released after lysosomal 
destabilization in HOCl-treated HMDM cells and whether they were in active state causing 
HOCl-mediated necrotic cell death requires further investigation.  
 
The activated calpains could also contribute to HOCl-mediated necrotic cell death by 
themselves. Calpains have been found to proteolytically cleave cytoskeletal proteins in 
hippocampal neurons (Lee et al., 1991) and gerbil forebrain (Yokota et al., 2003) within 
minutes of ischemia, and in rat hepatocytes after exposure to tert-butyl hydroperoxide 
(Miyoshi et al., 1996). This degradation of cytoskeletal proteins can result in necrotic cell 
death by promoting bleb formation and cell rupture (Saido et al., 1994b). Moreover, 
calpain activation was rapid, with both μ- and m-calpains activated by Ca2+ within 1 
minute (Saido et al., 1994a). HOCl-induced cytosolic Ca2+ rise was also found to occur 
within seconds in neuronal cells (Yap et al., 2006). The rapidness of HOCl-induced 
cytosolic Ca2+ rise and Ca2+-mediated calpain activation agrees with the rapid (i.e. within 
10 minutes) necrotic cell death in HMDM cells treated with HOCl. Hence, it was very 
likely that HOCl-mediated cytosolic Ca2+ increase activated calpains, which in turn 
proteolytically degraded cytoskeletal proteins. This then resulted in bleb, formation, cell 
membrane rupture and necrotic cell death.  
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This cytosolic Ca2+ increase also caused mitochondrial Ca2+ accumulation and MPT 
activation, as preventing Ca2+ influx into mitochondria (by blocking the IMM Ca2+ 
uniporter) (Kirichok et al., 2004) significantly prevented MPT-mediated mitochondrial 
membrane potential and cell viability loss in HOCl-treated HMDM cells. This agrees with 
previous studies, which showed that excessive cytosolic Ca2+ can be taken up by 
mitochondria to trigger the MPT pore opening (Bianchi et al., 2004; Richter, 1993; 
Crompton et al., 2002; Whiteman et al., 2004). HOCl also caused rapid MPT-mediated 
mitochondrial membrane potential loss within 10 minutes, leading to necrotic cell death in 
HMDM cells, as blocking MPT activation with CSA prevented both mitochondrial 
membrane potential and cell viability losses in HOCl-treated HMDM cells.  
 
HOCl was also found to cause rapid MPT-mediated mitochondrial membrane potential 
loss within 10 minutes, as blocking MPT pore formation using CSA prevented 
mitochondrial membrane potential loss. This agrees with previous findings, which showed 
MPT-induced mitochondrial membrane potential loss in HOCl-treated HeLa cells and 
human hepatoma HepG2 cells (Park et al., 2008; Whiteman et al., 2005b). MPT activation 
in HOCl-treated HMDM cells was found in this research to be induced by mitochondria 
taking up excess Ca2+ in cytosol via the Ca2+ uniporter, which was located in the IMM 
(Kirichok et al., 2004). This agrees with Whiteman et al. (2004), who showed that ONOO- 
mediated mobilization of cytosolic Ca2+, sequestration of Ca2+ into the mitochondria, and 
subsequently MPT activation within 10 minutes of treatment. MPT can also be triggered 
by cathepsins in silica-mediated cytotoxicity in alveolar macrophage cells (Thibodeau et 
al., 2003). MPT activation in HOCl-treated HMDM cells was less likely to be triggered by 
cathepsins, since blocking MPT activation using CSA prevented lysosomal destabilisation. 
This suggested that lysosomal destabilisation was downstream of MPT activation.  
 
Blocking MPT activation was found to prevent cell viability loss in HOCl-treated HMDM 
cells. To make the matter more complicated, preventing calpain activation was also found 
to inhibit MPT activation and cell viability loss. This indicates that MPT activation and 
calpain activation were in a cause and effect relationship. Cytosolic calpain activation 
possibly did not occur upstream of MPT activation, because if that was the case, blocking 
MPT activation would have no effect on preventing lysosomal destabilisation, as the 
activated cytosolic calpains could still destabilise lysosomes.  
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Previous studies have demonstrated calpain-like activities in isolated mitochondria 
(Aguilar et al., 1996; Tavares and Duque-Magalhaes, 1991). Furthermore, calpain 10 and 
its activity have been identified in the outer mitochondrial membrane (OMM), 
intermembrane mitochondrial space (IMS) and mitochondrial matrix fractions of isolated 
mitochondria (Arrington et al., 2006). The same study also showed that Ca2+-activated 
mitochondrial matrix calpain 10 caused MPT activation. In addition, Aguilar et al. (1996) 
have shown that Ca2+-induced MPT occurred less than 1 minute after Ca2+ treatment in 
isolated mitochondria, which could be inhibited by CSA or the protease inhibitor. These 
findings indicate that mitochondrial calpain activation can cause MPT pore formation. 
Based on these findings, it was possible to speculate that the calpain inhibitor (calpeptin) 
used in this research prevented mitochondrial calpain activation as well, hence explaining 
why calpain inactivation could prevent HOCl-mediated MPT activation in HMDM cells. 
This theory was possible, because calpeptin has been shown to inhibit the mitochondrial 
matrix calpain 10 (Giguere and Schnellmann, 2008; Giguere et al., 2008). There was no 
documentation on whether the other calpain inhibitor used (SJA6017) could also prevent 
mitochondrial matrix calpain activation. This theory also suggests that mitochondrial 
calpain activation occurred upstream of MPT activation in HOCl-treated HMDM cells.  
 
It was interesting to theorize that HOCl-mediated cytosolic Ca2+ increase did not activate 
cytosolic calpains first. But it was not surprising, considering that μ- and m-calpains 
require μM and mM concentrations of Ca2+ for activation, respectively (Halliwell and 
Gutteridge, 2007). Since cytosolic volume should be much greater than mitochondrial 
volume, Ca2+ possibly did not reach the expected concentration in cytosol for calpain 
activation, whereas Ca2+ concentration reached the required value for calpain activation 
more easily in the relatively smaller volume of mitochondria.  
 
It requires further investigation to understand how exactly MPT activation led to cytosolic 
calpain activation in HOCl-treated HMDM cells. Ding et al. (2002) showed that MPT 
inactivation prevented toxin-induced cytosolic calpain activation, and suggested that 
cytosolic calpain activation might be a result of Ca2+ release from mitochondria after MPT 
activation. It was also possible that some other unknown factors were released from 
mitochondria after MPT activation to activate cytosolic calpains.  
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7. FUTURE DIRECTIONS 
The lack of caspase-3 activation in HOCl-treated HMDM cells (Figures 4.1 and 4.2) might 
be caused by the inactivation of the upstream initiator caspases, such as caspase-9. One 
future direction will be to measure the activity of various upstream initiator caspases in 
HOCl-treated HMDM cells in order to see whether HOCl drives necrosis while blocking 
the apoptotic pathways in HMDM cells. 
 
Calpain activation in HOCl-treated HMDM cells was found to cause lysosomal 
destabilisation (Figures 5.8 and 5.9). One consequence of lysosomal destabilisation is the 
release of cathepsin proteases, which can degrade intracellular components of the cells. It 
would be interesting to measure the activity of cathepsins in HMDM cells after HOCl 
treatment and examine their association with HOCl-induced viability loss.  
 
One of the hypotheses proposed in this thesis was that mitochondrial calpains are activated 
in response to Ca2+ influx into mitochondria. To test this hypothesis, calpain activity in 
mitochondria should be examined in HMDM cells after HOCl treatment. The presence of 
activated calpains in atherosclerotic plaques, and whether they are colocalized with dead 
macrophages and HOCl-modified proteins in plaques should also be examined. This is to 
confirm whether the proposed calpain-mediated macrophage cell death in response to 
HOCl is likely to happen in real situations.  
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1. ABSTRACT 
Macrophage cells within inflammatory lesions 
are exposed to a wide range of degrading and cytotoxic 
molecules including reactive oxygen species. Unlike 
neutrophils, macrophages do not normally die in this 
environment but continue to generate oxidants, 
phagocytose cellular remains, and release a range of cytoactive 
agents which modulate the immune response. It is 
this potential of the macrophage cell to survive in an 
oxidative environment that allows the growth and 
complexity of advanced atherosclerotic plaques. This 
review will examine the oxidants encountered by 
macrophages within an atherosclerotic plaque and describe 
some of the potential antioxidant mechanisms which enable 
macrophages to function within inflammatory lesions. 
Ascorbate, a-tocopherol, and glutathione appear to be 
central to the protection of macrophages yet additional 
antioxidant mechanisms appear to be involved y-Interferon 
causes macrophages to generate 7,8- 
dihydroneopterinlneopterin and 3-hydroxyanthranilic acid 
both of which have antioxidant properties. Manganese 
superoxide dismutase is also upregulated in macrophages. 
The evidence that these antioxidants provide further 
protection, so allowing the macrophage cells to survive 
within sites of chronic inflammation such as atherosclerotic 
plaques, will be described. 
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